Table of Contents








 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10–Q10-Q
 
(Mark One)
ýQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 20172019
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number: 000-50976
 
HURON CONSULTING GROUP INC.HURON CONSULTING GROUP INC.
(Exact name of registrant as specified in its charter)
 
Delaware 01-0666114
(State or other jurisdiction of
incorporation or organization)
 
(IRS Employer
Identification Number)
550 West Van Buren Street
Chicago, Illinois
60607
(Address of principal executive offices)
(Zip Code)
(312)583-8700
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareHURNNASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yesý    No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yesý    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated FilerýAccelerated filerFilero
Non-accelerated filerFiler
o (Do not check if a smaller reporting company)Smaller Reporting 
Company
Smaller reporting companyo
Emerging growth companyGrowth Companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  ý
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of October 26, 2017, 22,129,39322, 2019, 22,913,192 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.
 



Table of Contents








Huron Consulting Group Inc.
HURON CONSULTING GROUP INC.
INDEX


  Page
 
   
Item 1. 
 
 
 
 
 
   
Item 2.
   
Item 3.
   
Item 4.
  
 
   
Item 1.
   
Item 1A.
   
Item 2.
   
Item 3.
   
Item 4.
   
Item 5.
   
Item 6.
  





Table of Contents








PART I - FINANCIAL INFORMATION
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS


HURON CONSULTING GROUP INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
September 30,
2017
 December 31,
2016
September 30,
2019
 December 31,
2018
Assets      
Current assets:      
Cash and cash equivalents$8,660
 $17,027
$49,410
 $33,107
Receivables from clients, net94,025
 94,246
116,318
 109,677
Unbilled services, net65,432
 51,290
99,784
 69,613
Income tax receivable4,018
 4,211
713
 6,612
Prepaid expenses and other current assets15,106
 13,308
14,211
 13,922
Total current assets187,241
 180,082
280,436
 232,931
Property and equipment, net47,075
 32,434
39,972
 40,374
Deferred income taxes, net15,159
 
1,108
 2,153
Long-term investment31,937
 34,675
60,943
 50,429
Operating lease right-of-use assets52,342
 
Other non-current assets26,149
 24,814
45,005
 30,525
Intangible assets, net80,861
 81,348
36,141
 47,857
Goodwill689,375
 799,862
645,986
 645,263
Total assets$1,077,797
 $1,153,215
$1,161,933
 $1,049,532
Liabilities and stockholders’ equity      
Current liabilities:      
Accounts payable$10,259
 $7,273
$10,440
 $10,020
Accrued expenses and other current liabilities22,846
 19,788
22,719
 17,207
Accrued payroll and related benefits62,451
 82,669
108,111
 109,825
Accrued contingent consideration for business acquisitions7,743
 1,985

 9,991
Current maturities of long-term debt250,525
 243,132
Current maturities of operating lease liabilities10,529
 
Deferred revenues25,495
 24,053
31,224
 28,130
Total current liabilities128,794
 135,768
433,548
 418,305
Non-current liabilities:      
Deferred compensation and other liabilities20,336
 24,171
26,308
 20,875
Accrued contingent consideration for business acquisitions, net of current portion14,726
 6,842

 1,450
Long-term debt, net of current portion374,328
 292,065
53,457
 53,853
Operating lease liabilities, net of current portion59,460
 
Deferred lease incentives15,236
 10,703

 13,693
Deferred income taxes, net
 35,633
1,603
 732
Total non-current liabilities424,626
 369,414
140,828
 90,603
Commitments and contingencies
 

 

Stockholders’ equity      
Common stock; $0.01 par value; 500,000,000 shares authorized; 24,560,468 and 24,126,118 shares issued at September 30, 2017 and December 31, 2016, respectively241
 235
Treasury stock, at cost, 2,428,971 and 2,408,343 shares at September 30, 2017 and December 31, 2016, respectively(121,395) (113,195)
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,337,297 and 25,114,739 shares issued at September 30, 2019 and December 31, 2018, respectively248
 244
Treasury stock, at cost, 2,416,530 and 2,568,288 shares at September 30, 2019 and December 31, 2018, respectively(128,048) (124,794)
Additional paid-in capital431,211
 405,895
469,257
 452,573
Retained earnings210,543
 351,483
223,536
 196,106
Accumulated other comprehensive income3,777
 3,615
22,564
 16,495
Total stockholders’ equity524,377
 648,033
587,557
 540,624
Total liabilities and stockholders’ equity$1,077,797
 $1,153,215
$1,161,933
 $1,049,532
The accompanying notes are an integral part of the consolidated financial statements.


1

Table of Contents








HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
September 30,
 Nine Months Ended
September 30,
Three Months Ended
September 30,
 Nine Months Ended
September 30,
2017 2016 2017 20162019 2018 2019 2018
Revenues and reimbursable expenses:              
Revenues$176,376
 $183,400
 $546,643
 $548,148
$219,289
 $198,448
 $644,488
 $589,671
Reimbursable expenses17,982
 19,093
 55,862
 54,636
23,636
 21,296
 65,787
 59,648
Total revenues and reimbursable expenses194,358
 202,493
 602,505
 602,784
242,925
 219,744
 710,275
 649,319
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
              
Direct costs113,775
 108,354
 343,185
 323,310
143,034
 128,596
 422,442
 388,956
Amortization of intangible assets and software development costs2,657
 4,052
 8,388
 11,278
1,162
 1,009
 3,450
 3,195
Reimbursable expenses18,079
 18,956
 55,901
 54,747
23,571
 21,246
 65,897
 59,710
Total direct costs and reimbursable expenses134,511
 131,362
 407,474
 389,335
167,767
 150,851
 491,789
 451,861
Operating expenses and other losses (gains), net:       
Operating expenses and other losses (gains), net       
Selling, general and administrative expenses41,576
 38,256
 132,137
 119,937
48,123
 45,915
 151,409
 138,481
Restructuring charges1,347
 1,049
 5,295
 4,129
127
 (31) 2,156
 2,665
Other losses (gains), net880
 494
 (222) 494
Litigation and other losses (gains), net(630) 887
 (1,571) (4,990)
Depreciation and amortization9,946
 8,092
 28,549
 23,064
6,962
 8,561
 21,285
 26,281
Goodwill impairment charge
 
 209,600
 
Total operating expenses and other losses (gains), net53,749
 47,891
 375,359
 147,624
54,582
 55,332
 173,279
 162,437
Operating income (loss)6,098
 23,240
 (180,328) 65,825
Operating income20,576
 13,561
 45,207
 35,021
Other income (expense), net:              
Interest expense, net of interest income(4,880) (4,176) (13,811) (12,270)(4,374) (4,628) (13,156) (14,636)
Other income, net930
 489
 3,204
 1,236
Other income (expense), net(82) 707
 2,830
 (5,131)
Total other expense, net(3,950) (3,687) (10,607) (11,034)(4,456) (3,921) (10,326) (19,767)
Income (loss) from continuing operations before income tax expense2,148
 19,553
 (190,935) 54,791
Income tax expense (benefit)(1,984) 7,265
 (49,740) 19,498
Net income (loss) from continuing operations4,132
 12,288
 (141,195) 35,293
Income from continuing operations before taxes16,120
 9,640
 34,881
 15,254
Income tax expense2,414
 1,391
 7,256
 4,365
Net income from continuing operations13,706
 8,249
 27,625
 10,889
Income (loss) from discontinued operations, net of tax238
 4
 690
 (1,830)(52) 228
 (195) (304)
Net income (loss)$4,370
 $12,292
 $(140,505) $33,463
Net earnings (loss) per basic share:       
Net income (loss) from continuing operations$0.19
 $0.58
 $(6.59) $1.67
Net income$13,654
 $8,477
 $27,430
 $10,585
Net earnings per basic share:       
Net income from continuing operations$0.62
 $0.38
 $1.26
 $0.50
Income (loss) from discontinued operations, net of tax0.01
 
 0.03
 (0.08)
 0.01
 (0.01) (0.01)
Net income (loss)$0.20
 $0.58
 $(6.56) $1.59
Net earnings (loss) per diluted share:       
Net income (loss) from continuing operations$0.19
 $0.57
 $(6.59) $1.65
Net income$0.62
 $0.39
 $1.25
 $0.49
Net earnings per diluted share:       
Net income from continuing operations$0.61
 $0.37
 $1.23
 $0.50
Income (loss) from discontinued operations, net of tax0.01
 
 0.03
 (0.09)
 0.01
 (0.01) (0.02)
Net income (loss)$0.20
 $0.57
 $(6.56) $1.56
Net income$0.61
 $0.38
 $1.22
 $0.48
Weighted average shares used in calculating earnings per share:              
Basic21,505
 21,076
 21,413
 21,084
22,052
 21,745
 21,973
 21,683
Diluted21,622
 21,445
 21,413
 21,427
22,561
 22,110
 22,425
 21,947
Comprehensive income (loss):       
Net income (loss)$4,370
 $12,292
 $(140,505) $33,463
Comprehensive income:       
Net income$13,654
 $8,477
 $27,430
 $10,585
Foreign currency translation adjustments, net of tax609
 50
 1,835
 52
(630) (579) (673) (1,499)
Unrealized loss on investment, net of tax(2,200) (2,038) (1,669) (1,163)
Unrealized gain (loss) on investment, net of tax1,168
 (852) 7,740
 4,473
Unrealized gain (loss) on cash flow hedging instruments, net of tax23
 121
 (4) (27)(149) 206
 (998) 821
Other comprehensive income (loss)(1,568) (1,867) 162
 (1,138)389
 (1,225) 6,069
 3,795
Comprehensive income (loss)$2,802
 $10,425
 $(140,343) $32,325
Comprehensive income$14,043
 $7,252
 $33,499
 $14,380
The accompanying notes are an integral part of the consolidated financial statements.


2

Table of Contents








HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTSTATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands, except share amounts)
(Unaudited)

 Three Months Ended September 30,
 Common Stock Treasury Stock 
Additional
Paid-In
Capital
 
Retained
Earnings
 
Accumulated Other
Comprehensive
Income
 
Stockholders’
Equity
 Shares Amount Shares Amount    
Balance at June 30, 201924,711,193
 $247
 (2,742,826) $(127,133) $463,190
 $209,882
 $22,175
 $568,361
Comprehensive income          13,654
 389
 14,043
Issuance of common stock in connection with:               
Restricted stock awards, net of cancellations58,164
 1
 (3,741) (169) 168
     
Exercise of stock options10,000
 
     235
     235
Share-based compensation        5,664
     5,664
Shares redeemed for employee tax withholdings    (12,657) (746)       (746)
Balance at September 30, 201924,779,357
 $248
 (2,759,224) $(128,048) $469,257
 $223,536
 $22,564
 $587,557
                
Balance at June 30, 201824,325,302
 $244

(2,633,755)
$(123,215)
$441,813

$184,507

$15,390

$518,739
Comprehensive income          8,477
 (1,225) 7,252
Issuance of common stock in connection with:               
Restricted stock awards, net of cancellations45,485
 
 (13,688) (583) 583
     
Exercise of stock options10,000
 
     234
     234
Share-based compensation        4,019
     4,019
Shares redeemed for employee tax withholdings    (8,241) (371)       (371)
Balance at September 30, 201824,380,787
 $244
 (2,655,684) $(124,169) $446,649
 $192,984
 $14,165
 $529,873
 Nine Months Ended September 30,
 Common Stock Treasury Stock 
Additional
Paid-In
Capital
 
Retained
Earnings
 
Accumulated Other
Comprehensive
Income
 
Stockholders’
Equity
 Shares Amount Shares Amount    
Balance at December 31, 201824,418,252
 $244
 (2,671,962) $(124,794) $452,573
 $196,106
 $16,495
 $540,624
Comprehensive income          27,430
 6,069
 33,499
Issuance of common stock in connection with:               
Restricted stock awards, net of cancellations331,105
 4
 21,433
 1,952
 (1,956)     
Exercise of stock options30,000
 
     703
     703
Share-based compensation        17,937
     17,937
Shares redeemed for employee tax withholdings    (108,695) (5,206)       (5,206)
Balance at September 30, 201924,779,357
 $248
 (2,759,224) $(128,048) $469,257
 $223,536
 $22,564
 $587,557
                
Balance at December 31, 201724,098,822
 $241
 (2,591,135) $(121,994) $434,256
 $180,443
 $10,370
 $503,316
Comprehensive income          10,585
 3,795
 14,380
Issuance of common stock in connection with:               
Restricted stock awards, net of cancellations251,965
 3
 20,407
 916
 (919)     
Exercise of stock options30,000
 
     703
     703
Share-based compensation        12,609
     12,609
Shares redeemed for employee tax withholdings    (84,956) (3,091)   
   (3,091)
Cumulative-effect adjustment from adoption of ASC 606          1,956
   1,956
Balance at September 30, 201824,380,787
 $244
 (2,655,684) $(124,169) $446,649
 $192,984
 $14,165
 $529,873
 Common Stock Treasury Stock 
Additional
Paid-In
Capital
 
Retained
Earnings
 
Accumulated Other
Comprehensive
Income
 
Stockholders’
Equity
 Shares Amount Shares Amount    
Balance at December 31, 201623,478,016
 $235
 (2,420,913) $(113,195) $405,895
 $351,483
 $3,615
 $648,033
Comprehensive income (loss)          (140,505) 162
 (140,343)
Issuance of common stock in connection with:               
Restricted stock awards, net of cancellations367,278
 4
 (56,315) (3,750) 3,746
     
Business acquisition221,558
 2
     9,558
     9,560
Share-based compensation        11,577
     11,577
Shares redeemed for employee tax withholdings    (102,179) (4,450)       (4,450)
Cumulative-effect adjustment from adoption of ASU 2016-09        435
 (435)   
Balance at September 30, 201724,066,852
 $241
 (2,579,407) $(121,395) $431,211
 $210,543
 $3,777
 $524,377
The accompanying notes are an integral part of the consolidated financial statements.



3









HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Nine Months Ended
September 30,
Nine Months Ended
September 30,
2017 20162019 2018
Cash flows from operating activities:      
Net income (loss)$(140,505) $33,463
Adjustments to reconcile net income (loss) to net cash provided by operating activities:   
Net income$27,430
 $10,585
Adjustments to reconcile net income to net cash provided by operating activities:   
Depreciation and amortization37,881
 34,344
31,823
 29,965
Lease impairment charge805
 
Share-based compensation11,711
 13,145
18,094
 12,840
Amortization of debt discount and issuance costs7,604
 7,171
8,066
 7,721
Goodwill impairment charge209,600
 
Allowances for doubtful accounts and unbilled services3,812
 7,107
191
 573
Deferred income taxes(51,062) 4,980
(262) 179
Gain on sale of business(931) 
Loss on sale of business
 5,863
Change in fair value of contingent consideration liabilities

(222) 494
(1,506) (2,463)
Changes in operating assets and liabilities, net of acquisitions:   
(Increase) decrease in receivables from clients9,025
 9,442
(Increase) decrease in unbilled services(12,251) (21,492)
Changes in operating assets and liabilities, net of acquisitions and divestiture:   
(Increase) decrease in receivables from clients, net(6,817) (9,103)
(Increase) decrease in unbilled services, net(30,163) (16,714)
(Increase) decrease in current income tax receivable / payable, net(32) (3,039)10,561
 1,400
(Increase) decrease in other assets(1,802) 12,669
(4,160) (3,768)
Increase (decrease) in accounts payable and accrued liabilities1,850
 (2,860)
Increase (decrease) in accounts payable and other liabilities(3,565) 186
Increase (decrease) in accrued payroll and related benefits(21,928) (17,707)(1,850) 9,445
Increase (decrease) in deferred revenues(318) 2,028
3,098
 2,158
Net cash provided by operating activities52,432
 79,745
51,745
 48,867
Cash flows from investing activities:      
Purchases of property and equipment, net(20,139) (9,372)(10,024) (6,662)
Investment in life insurance policies(1,826) (1,890)(4,434) (1,689)
Distributions from life insurance policies2,889
 
Purchases of businesses, net of cash acquired(106,915) (69,133)
Purchases of businesses(2,500) (215)
Capitalization of internally developed software costs(938) (838)(7,462) (3,611)
Proceeds from note receivable177
 

 1,040
Proceeds from sale of business1,499
 
Divestiture of business
 (2,359)
Net cash used in investing activities(125,253)
(81,233)(24,420)
(13,496)
Cash flows from financing activities:      
Proceeds from exercise of stock options
 123
703
 703
Shares redeemed for employee tax withholdings(4,450) (4,837)(5,206) (3,091)
Share repurchases
 (55,265)
Proceeds from borrowings under credit facility241,000
 168,000
105,500
 179,800
Repayments of debt(170,082) (156,000)(105,885) (213,674)
Payments for debt issuance costs(395) 
(1,498) (1,385)
Payments of contingent consideration liabilities(1,811) 
(4,674) (5,494)
Net cash provided by (used in) financing activities64,262
 (47,979)
Net cash used in financing activities(11,060) (43,141)
Effect of exchange rate changes on cash192
 133
38
 (114)
Net decrease in cash and cash equivalents(8,367) (49,334)
Net increase (decrease) in cash and cash equivalents16,303
 (7,884)
Cash and cash equivalents at beginning of the period17,027
 58,437
33,107
 16,909
Cash and cash equivalents at end of the period$8,660
 $9,103
$49,410
 $9,025
Supplemental disclosure of cash flow information:      
Non-cash investing and financing activities:      
Property and equipment expenditures included in accounts payable and accrued expenses$4,049
 $2,928
Promissory note assumed for purchase of property and equipment$5,113
 $
Contingent consideration related to business acquisitions$15,489
 $8,754
Common stock issued related to a business acquisition$9,560
 $
Property and equipment expenditures and capitalized software included in accounts payable and accrued expenses$3,085
 $1,500
Contingent consideration related to business acquisition$
 $212
The accompanying notes are an integral part of the consolidated financial statements.


4

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)




1. Description of Business
Huron is a global professional services firm committed to achieving sustainable results in partnership with its clients. We bring a depth of expertise in strategy, technology, operations, advisory servicesconsultancy that helps clients drive growth, enhance performance and analytics to drive lasting and measurable resultssustain leadership in the healthcare, higher education, life sciencesmarkets they serve. We partner with clients to develop strategies and commercial sectors. Through focus, passion, and collaboration, we provide guidanceimplement solutions that enable the transformative change our clients need to support organizations as they contend with the changes transformingown their industries and businesses.future.
2. Basis of Presentation and Significant Accounting Policies
The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three and nine months ended September 30, 20172019 and 2016.2018. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”("GAAP") for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 20162018 included in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q for the periods ended March 31, 20172019 and June 30, 2017.2019. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.
On January 1, 2019, we adopted Accounting Standard Update ("ASU") 2016-02, Leases. Below is an update to our lease accounting policy as a result of the adoption. Refer to Note 3 "New Accounting Pronouncements" for additional information on the adoption of ASU 2016-02.
Leases
We determine if an arrangement contains a lease and the classification of such lease at inception. As of September 30, 2019, all of our material leases are classified as operating leases; we have not entered into any material finance leases. For all operating leases with an initial term greater than 12 months, we recognize an operating lease right-of-use ("ROU") asset and operating lease liability. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.
Operating lease ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date and provided by the administrative agent for our senior secured credit facility in determining the present value of lease payments. Operating lease ROU assets exclude lease incentives.
We elected the practical expedient to combine lease and nonlease components. Certain lease agreements contain variable lease payments that do not depend on an index or rate. These variable lease payments are not included in the calculation of the operating lease ROU asset and operating lease liability; instead, they are expensed as incurred. Our leases may contain options to extend or terminate the lease, and we include these terms in our calculation of the operating lease ROU asset and operating lease liability when it is reasonably certain that we will exercise the option.
Operating lease expense is recognized on a straight-line basis over the lease term and recorded within selling, general and administrative expenses on our consolidated statement of operations. In accordance with our accounting policy for impairment of long-lived assets, operating lease ROU assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. We evaluate the recoverability of the asset group based on forecasted undiscounted cash flows. See Note 5 "Leases" for additional information on our leases, including the lease impairment charges recorded in the first nine months of 2019.
3. New Accounting Pronouncements
Recently Adopted
In January 2017,March 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminates Step 2 of the goodwill impairment test, which required us to determine the implied fair value of goodwill by allocating the reporting unit's fair value to each of its assets and liabilities as if the reporting unit was acquired in a business acquisition. Instead, the updated guidance requires an entity to perform its annual or interim goodwill impairment test by comparing the fair value of the reporting unit to its carrying value, and recognizing a non-cash impairment charge for the amount by which the carrying value exceeds the reporting unit's fair value with the loss not exceeding the total amount of goodwill allocated to that reporting unit. We adopted this ASU in the second quarter of 2017 on a prospective basis and applied the new guidance to our interim goodwill impairment tests performed in the second quarter of 2017. Refer to Note 6 “Goodwill and Intangible Assets” for additional information on our interim goodwill impairment tests performed.
In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 simplifies several aspects of the accounting for share-based payment transactions, including the accounting for income taxes, classification of excess tax benefits on the statement of cash flows, and forfeitures. We adopted this guidance in the first quarter of 2017, at which time we began recognizing excess tax benefits and deficiencies as income tax benefit or expense in our consolidated statements of operations on a prospective basis. We recognized $0.1 million and $1.8 million of net excess tax deficiencies as income tax expense in our consolidated statement of operations for the three and nine months ended September 30, 2017, respectively. Refer to Note 13 "Income Taxes" for additional information on our effective tax rate for the three and nine months ended September 30, 2017. Additionally, upon adoption, we began classifying excess tax benefits as an operating activity on the statement of cash flows on a retrospective basis. As a result, we reclassified $0.9 million of excess tax benefits for the first nine months of 2016 from cash flows from financing activities to cash flows from operating activities on our statement of cash flows. We elected to account for share-based award forfeitures as they occur, and applied this accounting change on a modified retrospective basis2016-02, Leases, as a cumulative-effect adjustment to retained earnings of $0.4 million during the first quarter of 2017.
In March 2016, the FASB issued ASU 2016-06, Derivatives and Hedging: Contingent Put and Call Options in Debt Instruments. ASU 2016-06 clarifies that in assessing whether an embedded contingent put or call option is clearly and closely related to the debt host, an entity is required to perform only the four-step decision sequence innew Topic, ASC 815-15-25-42 (as amended by the ASU). The entity does not have to separately assess whether the event that triggers its ability to exercise the contingent option is itself indexed only to interest rates or credit risk. We adopted these amendments in the first quarter of 2017 on a

5

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

modified retrospective basis. The adoption of these amendments did not have any impact on our consolidated financial statements.
Not Yet Adopted
In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. The amendments to the guidance improve and simplify accounting rules for hedge accounting to better present the economic results of an entity’s risk management activities in its financial statements and improve the disclosures of hedging arrangements. Additionally, ASU 2017-12 simplifies the hedge documentation and effectiveness assessment requirements. The updated guidance is effective for us beginning January 1, 2019. We do not expect this guidance to have a material impact on our consolidated financial statements.
In March 2016, the FASB issued ASU 2016-02, Leases,842, which supersedessuperseded ASC Topic 840, Leases, and sets forth the principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and lessors. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record on the balance sheet a right-of-use asset and a lease liability, equal to the present value of the remaining lease payments, for all leases with a term greater than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or a straight-line basis over the term of the lease. ASU 2016-02 will be effective for us beginning January 1, 2019, with early adoption permitted. Entities are required to use a modified retrospective transition method for existing leases. We are currently evaluating the potential impact this guidance will have on our consolidated financial statements.
In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The amendments to the guidance enhance the reporting model for financial instruments, which includes amendments to address aspects of recognition, measurement, presentation, and disclosure. The updated guidance is effective for us beginning January 1, 2018. We do not expect this guidance to have a material impact on our consolidated financial statements.
In May 2014, the FASB issued ASU��2014-09, Revenue from Contracts with Customers, as a new Topic, ASC 606. The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In accordance with the new standard, we will adopt ASU 2014-09 on January 1, 2018. Companies may apply the new guidance using either the full retrospective transition method, which requires restating each prior period presented, or the modified retrospective transition method, under which the new guidance is applied to the current period presented in the financial statements and a cumulative-effect adjustment is recorded as of the date of adoption. We expect to apply the new guidance using the modified retrospective transition method. We are currently evaluating the potential impact this guidance will have on our consolidated financial statements; most notably the impact on our revenue recognition for performance-based fee billing arrangements. Currently, we recognize revenue under performance-based fee billing arrangements once all related performance criteria are met and the amount to be recognized is fixed or determinable. However, ASC 606 will require us to estimate these amounts and recognize a significant portion of the estimated amounts over the term of the engagement. As a result, we expect to recognize revenue under performance-based fee billing arrangements earlier under ASC 606 than we do under current guidance.
4. Discontinued Operations
On December 31, 2015, we sold our Huron Legal segment to Consilio, Inc. ("Consilio"). Huron Legal provided eDiscovery services, consulting services and contract management services related to law department management, information governance and compliance, legal discovery, litigation management, and legal analytics.
The divestiture of the Huron Legal segment represented a strategic shift that had a major effect on our operations and financial results. As such, the operations of our Huron Legal segment have been classified as discontinued operations in our consolidated statements of operations for all periods presented. As of September 30, 2017 and December 31, 2016, no assets or liabilities of the disposed business remained on our consolidated balance sheet.
For the three and nine months ended September 30, 2017, we recognized income from discontinued operations, net of tax, of $0.2 million and $0.7 million, respectively, primarily related to updated lease assumptions for vacated office space directly related to the sale of the Huron Legal segment. For the nine months ended September 30, 2016, we recognized losses from


65

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


discontinued operations, netthan 12 months regardless of tax,the lease classification. The lease classification will determine whether the lease expense is recognized using an effective interest rate method or on a straight-line basis over the term of $1.8 million, primarily relatedthe lease. In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements, which provides an optional transition method that allows entities to obligationsinitially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings on the adoption date. We adopted ASC 842 effective January 1, 2019 on a modified retrospective basis for former employees, legalexisting leases using the transition method allowed by ASU 2018-11, which had no impact on our consolidated financial statements in the prior periods presented. The new lease standard had a material impact on our consolidated balance sheet upon adoption but did not impact our consolidated statement of operations. The most significant impact to our consolidated balance sheet is the recognition of ROU assets and lease liabilities for operating leases. The impact of the new lease standard on our consolidated balance sheet upon adoption follows:
 
As of
December 31, 2018
 
ASC 842
Adjustment
 
As of
January 1, 2019
Assets     
Operating lease right-of-use assets$
 $56,463
 $56,463
     
Liabilities     
Accrued expenses and other current liabilities$17,207
 $(2,557) $14,650
Current maturities of operating lease liabilities$
 $10,537
 $10,537
Deferred compensation and other liabilities$20,875
 $(536) $20,339
Deferred lease incentives$13,693
 $(13,693) $
Operating lease liabilities, net of current portion$
 $62,712
 $62,712

In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This update aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. Capitalized implementation costs are amortized on a straight-line basis generally over the term of the service contract with the amortization recognized in the same financial statement line item as the fees and updated lease assumptions for vacated office space directly related to the sale of the Huron Legal segment.
In connectionservice contract. ASU 2018-15 is effective beginning January 1, 2020, with the sale of Huron Legal, we entered into a transition services agreement ("TSA") with Consilio, under which we provided certain post-closing services, support, and facilities to Consilio to facilitate an orderly transfer of the Huron Legal business operations. Billings under the TSA, which we did not consider to be significant, were recorded as a reduction of the costs to provide the respective services, primarily in selling, general and administrative expensesearly adoption permitted. We adopted this ASU in the consolidated statements of operations. Services under the TSA ended as of June 30, 2017. We have no continuing involvement with the Huron Legal segment.
5. Acquisitions
ADI Strategies, Inc.
On April 1, 2017, we completed our acquisition of the international assets of ADI Strategies, Inc. ("ADI Strategies") in Dubai and India. We acquired the U.S. assets of ADI Strategies in the secondthird quarter of 2016. ADI Strategies is2019 on a leading enterprise performance management, risk management and business intelligence firm.prospective basis. During the third quarter of 2019, we capitalized an immaterial amount of implementation costs for cloud computing arrangements that are service contracts. The acquisition strengthensfuture impact of adoption of this ASU on our technology and analytics competencies and expands our global reach. The international resultsconsolidated financial statements will depend on the magnitude of operations of ADI Strategiesimplementation costs we may incur to implement cloud computing arrangements that are service contracts.
Not Yet Adopted
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which modifies certain disclosure requirements related to fair value measurements. ASU 2018-13 will be effective for us beginning January 1, 2020, with early adoption permitted. We do not expect this guidance to have been included inan impact on the amounts reported on our consolidated financial statements, and results of operations ofwe are currently evaluating the Business Advisory segment frompotential impact this guidance will have on our disclosures within the date of acquisition.
Pope Woodhead and Associates Limited
On January 9, 2017, we completed our acquisition of Pope Woodhead and Associates Limited ("Pope Woodhead"), a U.K.-based consulting firm providing market access capabilities to assist clients in developing value propositions for innovative medicines and technologies. The acquisition expands our life sciences strategy expertise and strengthens our ability to lead clients through complex payer and regulatory environments. Pope Woodhead's results of operations have been included in our consolidated financial statements and the results of operations of our Business Advisory segment from the date of acquisition.
Pro forma results of operations are not presented for ADI Strategies or Pope Woodhead because these acquisitions were not material in relationnotes to our consolidated financial position or results of operations.statements.
Innosight Holdings, LLC
On March 1, 2017, we acquired 100% of the membership interests of Innosight Holdings, LLC ("Innosight"). Innosight is a growth strategy firm focused on helping companies navigate disruptive change and manage strategic transformation. Together with Innosight, we use our strategic, operational, and technology capabilities to help clients across multiple industries develop pioneering solutions to address disruption and achieve sustained growth.


76

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


The acquisition was accounted for using the acquisition method of accounting. Tangible and identifiable intangible assets acquired and liabilities assumed are recorded at fair value as of the acquisition date. The current fair values of assets acquired and liabilities assumed are considered preliminary and are based on the information that was available as of the date of the acquisition. We believe that the information provides a reasonable basis for estimating the preliminary fair values of assets acquired and liabilities assumed, but certain items, such as working capital amounts, may be subject to change as additional information is received. Thus, the provisional measurements of fair value and goodwill are subject to change. We expect to finalize the valuation as soon as practicable, but not later than one year from the acquisition date.
The acquisition date fair value of the consideration transferred for Innosight was $113.6 million, which consisted of the following:
Fair value of consideration transferred 
Cash$90,725
Common stock9,560
Contingent consideration liability12,050
Net working capital adjustment1,272
Total consideration transferred$113,607
We funded the cash component of the purchase price with cash on hand and borrowings of $89.0 million under our senior secured credit facility. We issued 221,558 shares of our common stock as part of the consideration transferred, with an acquisition date fair value of $9.6 million based on our common stock's closing price of $43.15 on the date of acquisition. The preliminary contingent consideration liability of $12.1 million represents the acquisition date fair value of the contingent consideration arrangement, pursuant to which we may be required to pay additional consideration to the sellers if specific financial performance targets are met over a four-year term. The maximum amount that may be paid is $35.0 million. See Note 11 "Fair Value of Financial Instruments" for additional information on the valuation of contingent consideration liabilities.

8

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

The following table summarizes the preliminary allocation of the purchase price to the fair value of assets acquired and liabilities assumed as of the acquisition date.
 March 1, 2017
Assets acquired: 
Accounts receivable$7,752
Unbilled services1,881
Prepaid expenses and other current assets468
Property and equipment419
Intangible assets18,015
Liabilities assumed: 
Accounts payable531
Accrued expenses and other current liabilities916
Accrued payroll and related benefits883
Deferred revenues30
Total identifiable net assets26,175
Goodwill87,432
Total purchase price$113,607
The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the acquisition date.
 Fair Value 
Useful Life in
Years
Customer relationships$9,500
 6
Trade name6,000
 6
Customer contracts1,000
 1
Non-compete agreements1,300
 5
Favorable lease contract215
 1
Total intangible assets subject to amortization$18,015
  
The weighted average amortization period for the identifiable intangible assets shown above is 5.6 years. Customer relationships and customer contracts represent the fair values of the underlying relationships and agreements with Innosight customers. The trade name represents the fair value of the brand and name recognition associated with the marketing of Innosight's service offerings. Non-compete agreements represent the value derived from preventing certain Innosight executives from entering into or starting a similar, competing business. The favorable lease contract represents the difference between the fair value and minimum lease obligations under the current outstanding lease. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed, and largely reflects the expanded market opportunities expected from combining the service offerings of Huron and Innosight, as well as the assembled workforce of Innosight. Goodwill recognized in conjunction with the acquisition of Innosight was recorded in the Business Advisory segment. Goodwill of $87.4 million is expected to be deductible for income tax purposes.
Innosight’s results of operations have been included in our unaudited consolidated statements of operations and results of operations of our Business Advisory segment from the date of acquisition. For the three months ended September 30, 2017, revenues from Innosight were $11.0 million and operating loss was $0.6 million, which included $0.9 million of amortization expense for intangible assets acquired. For the nine months ended September 30, 2017, revenues from Innosight were $27.2 million and operating income was $0.8 million, which included $2.7 million of amortization expense for intangible assets acquired. In connection with the acquisition of Innosight, we incurred $1.7 million of transaction and acquisition-related expenses. Of the $1.7 million of expense, $1.4 million was incurred in the first quarter of 2017 and $0.3 million was incurred in the second quarter in 2017. These costs are recorded in selling, general and administrative expenses.

9

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

The following unaudited supplemental pro forma information summarizes the combined results of operations of Huron and Innosight as though the companies were combined on January 1, 2016.
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 2017 2016 2017 2016
Revenues$176,376
 $194,968
 $555,768
 $578,924
Net income (loss) from continuing operations$4,170
 $14,184
 $(137,922) $36,558
Net income (loss) from continuing operations per share - basic$0.19
 $0.67
 $(6.43) $1.72
Net income (loss) from continuing operations per share - diluted$0.19
 $0.65
 $(6.43) $1.69
The historical financial information has been adjusted to give effect to pro forma adjustments consisting of intangible asset amortization expense, acquisition-related costs, interest expense, and the related income tax effects. The unaudited pro forma information above includes adjustments to decrease expense for the three months ended September 30, 2017 by less than $0.1 million and include additional expense of $2.8 million for the three months ended September 30, 2016. We have included additional expense of $0.5 million and $8.4 million, for the nine months ended September 30, 2017 and 2016, respectively. Additionally, the historical financial information has been adjusted to give effect to the shares issued as consideration. All of these adjustments are based upon currently available information and certain assumptions. Therefore, the pro forma consolidated results are not necessarily indicative of what our consolidated results of operations actually would have been had it completed the acquisition on January 1, 2016. The historical results included in the pro forma consolidated results do not purport to project future results of operations of the combined companies nor do they reflect the expected realization of any cost savings or revenue synergies associated with the acquisition.

10

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

6.4. Goodwill and Intangible Assets
The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the nine months ended September 30, 2017.2019.
 

Healthcare
 

Business
Advisory
 Education Total
Balance as of December 31, 2018:       
Goodwill$636,810
 $301,700
 $102,829
 $1,041,339
Accumulated impairment losses(208,081) (187,995) 
 (396,076)
Goodwill, net as of December 31, 2018428,729
 113,705
 102,829
 645,263
Goodwill recorded in connection with a business acquisition (1)

 
 1,060
 1,060
Foreign currency translation
 (337) 
 (337)
Goodwill, net as of September 30, 2019$428,729
 $113,368
 $103,889
 $645,986
 

Healthcare
 Education 

Business
Advisory
 Total
Balance as of December 31, 2016:       
Goodwill$636,802
 $102,906
 $203,137
 $942,845
Accumulated impairment losses
 
 (142,983) (142,983)
Goodwill, net as of December 31, 2016636,802
 102,906
 60,154
 799,862
Goodwill recorded in connection with business acquisitions (1)
7
 10,252
 88,286
 98,545
Goodwill impairment charge(209,600) 
 
 (209,600)
Goodwill reallocation
 (10,794) 10,794
 
Goodwill allocated to disposal of business (2)

 
 (568) (568)
Foreign currency translation
 466
 670
 1,136
Goodwill, net as of September 30, 2017$427,209
 $102,830
 $159,336
 $689,375

(1)Refer to Note 5 "Acquisitions" for additional information onOn September 30, 2019, we completed the goodwill recordedacquisition of a business in connection withour Education segment. The results of operations of the acquired business acquisitions.
(2)On June 16, 2017, we sold our Life Sciences Compliance and Operations practice ("Life Sciences C&O") to a third-party, and allocated a portion of goodwill within the Life Sciences reporting unit to the disposed business based on the relative fair values of Life Sciences C&O and the remaining reporting unit. The allocated goodwill of $0.6 million was written off and included in the gain on sale of Life Sciences C&O. The sale of Life Sciences C&O did not meet the criteria for reporting separately as discontinued operations. In connection with the sale, we recorded a $0.9 million gain which is included in other income, net in our consolidated financial statements and results of operations.operations of our Education segment from the date of acquisition. This acquisition is not significant to our consolidated financial statements.
Second Quarter 2017 Goodwill Impairment Charge
Since the first quarter of 2016, the Healthcare segment, which is also a reporting unit, has experienced declining revenues, primarily driven by softness in our revenue cycle offering within our performance improvement solution. This softness is attributable to decreased demand for our services, the winding down of some of our larger projects, and a growing trend toward smaller projects, as well as fewer large integrated projects. In light of these challenges, several initiatives have been undertaken to improve the segment's financial performance, including repositioning our solutions to address the most critical needs of our clients, the expansion of our existing services such as those in our Studer Group, strategy, physician and technology offerings, and workforce reductions to better align resources with market demand. While the initiatives undertaken to improve the financial performance of our Healthcare segment are yielding some positive impacts, hospitals and health systems continue to face regulatory and funding uncertainty; therefore, we remain cautious about near-term growth. As we have previously disclosed in prior quarters, if the financial performance of our Healthcare segment continued to decline and did not meet our expectations, we could be required to perform an interim impairment analysis with respect to our carrying value of goodwill for the Healthcare reporting unit prior to our usual annual test. Based on forecasts prepared in the second quarter of 2017 in connection with our quarterly forecasting cycle, we determined that the likely time frame to improve the financial results of this segment would take longer than originally anticipated. As such, we concluded, during the second quarter of 2017, that the fair value of the Healthcare reporting unit may no longer exceed its carrying value. In connection with the preparation of our financial statements for the quarter ended June 30, 2017, we performed an interim impairment test on the Healthcare reporting unit.
Our goodwill impairment test was performed by comparing the fair value of the Healthcare reporting unit with its carrying value and, in accordance with ASU 2017-04 which we adopted in the second quarter of 2017, recognizing an impairment charge for the amount by which the carrying value exceeded the fair value. To estimate the fair value of the Healthcare reporting unit, we relied on a combination of the income approach and the market approach, utilizing the guideline company method, with a fifty-fifty weighting. Based on the estimated fair value of the Healthcare reporting unit, we recorded a $209.6

11

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

million non-cash pretax charge in the second quarter of 2017 to reduce the carrying value of goodwill in our Healthcare reporting unit.
In connection with the goodwill impairment test performed on the Healthcare reporting unit, we performed an impairment test on the long-lived assets allocated to the asset groups within the Healthcare reporting unit. Based on the impairment test performed, we concluded that the long-lived assets allocated to the asset groups within the Healthcare reporting unit were not impaired as of June 30, 2017.
Second Quarter 2017 Goodwill Reallocation
Effective June 1, 2017, we reorganized our internal financial reporting structure, which management uses to assess performance and allocate resources, by moving our Life Sciences practice from the Education and Life Sciences segment to the Business Advisory segment. The remaining Education and Life Sciences segment is now referred to as the Education segment. The Life Sciences practice is a separate reporting unit for purposes of goodwill impairment testing. We continue to operate under three reportable segments: Healthcare, Education, and Business Advisory. These three reportable segments are comprised of the following six reporting units for goodwill impairment testing purposes: Healthcare, Education, Business Advisory, Enterprise Solutions and Analytics, Strategy and Innovation, and Life Sciences. The Business Advisory, Enterprise Solutions and Analytics, Strategy and Innovation, and Life Sciences reporting units comprise our Business Advisory segment. See Note 15 "Segment Information" for additional information on our reportable segments.
As a result of the reorganization, we reallocated $10.8 million of the goodwill balance associated with the previous Education and Life Sciences reporting unit to the new Life Sciences reporting unit based on the relative fair values of the Life Sciences reporting unit and the remaining Education reporting unit. The estimated fair values were determined using a combination of the income approach and the market approach, utilizing the guideline company method, with a fifty-fifty weighting.

In conjunction with the goodwill reallocation, we performed a goodwill impairment test for the goodwill balances within our Education reporting unit and Life Sciences reporting unit as of June 1, 2017. Based on the results of the goodwill impairment test, we determined that the fair values of our Education reporting unit and Life Sciences reporting unit exceeded their carrying values. As such, we concluded that there was no indication of goodwill impairment for either reporting unit.

12

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Intangible Assets
Intangible assets as of September 30, 20172019 and December 31, 20162018 consisted of the following:
   As of September 30, 2019 As of December 31, 2018
 
Useful Life 
(in years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Customer relationships3 to 13 $91,614
 $63,109
 $98,235
 $60,462
Trade names5 to 6 28,930
 25,215
 28,930
 23,181
Technology and software3 to 5 5,694
 3,951
 5,694
 2,842
Non-competition agreements3 to 5 2,515
 1,607
 3,650
 2,241
Customer contracts2 1,270
 
 
 
Favorable lease contract3 
 
 720
 646
Total  $130,023
 $93,882
 $137,229
 $89,372
   As of September 30, 2017 As of December 31, 2016
 
Useful
Life in
Years
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Customer relationships4 to 13 $106,174
 $47,325
 $89,279
 $34,827
Trade names2 to 6 29,016
 17,065
 22,930
 11,652
Customer contracts1 to 4 27,554
 25,919
 26,497
 21,295
Technology and software3 to 5 9,340
 4,490
 8,970
 2,667
Non-competition agreements1 to 5 5,295
 2,482
 3,685
 1,697
Publishing content3 3,300
 2,888
 3,300
 2,062
Favorable lease contract3 720
 369
 720
 203
In-process technologyIndefinite 
 
 370
 
Total  $181,399
 $100,538
 $155,751
 $74,403

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships and customer contracts, as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis. In connection with the acquisition

7

Table of MyRounding Solutions, LLC, we acquired in-process technology which was accounted for as an indefinite-lived intangible asset until the development of the technology was complete, which occurredContents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in the first quarter of 2017. Upon completion, we reclassified the technology to definite-lived technology and software, and began amortizing the asset over a five-year useful life on a straight-line basis.thousands, except per share amounts)
(Unaudited)

Intangible asset amortization expense was $8.8$4.2 million and $5.9 million for the three months ended both September 30, 20172019 and 2016. Intangible asset amortization expense was $26.42018, respectively; and $13.0 million and $24.4$18.2 million for the nine months ended September 30, 20172019 and 2016,2018, respectively. The table below sets forth the estimated annual amortization expense for the year ending December 31, 20172019 and each of the five succeeding years for the definite-lived intangible assets recorded as of September 30, 2017.2019.
Year Ending December 31, Estimated Amortization Expense Estimated Amortization Expense
2017 $34,966
2018 $23,936
2019 $17,279
 $17,484
2020 $12,116
 $12,978
2021 $8,070
 $8,306
2022 $6,092
 $6,114
2023 $3,512
2024 $741
Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.
5. Leases
We lease office space, data centers and certain equipment under operating leases expiring on various dates through 2028, with various renewal options that can extend the lease terms by one to ten years. Our operating leases include fixed payments plus, in some cases, scheduled base rent increases over the term of the lease. Certain leases require variable payments of real estate taxes, insurance and operating expenses. We exclude these variable payments from the measurements of our lease liabilities and expense them as incurred. We elected the practical expedient to combine lease and nonlease components. No lease agreements contain any residual value guarantees or material restrictive covenants. As of September 30, 2019, we have not entered into any material finance leases. We sublease certain office spaces to third parties resulting from restructuring activities in certain locations.
Operating lease right-of-use ("ROU") assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. First, we test the asset group for recoverability by comparing the undiscounted cash flows of the asset group, which include expected future lease and nonlease payments under the lease agreement offset by expected sublease income, to the carrying amount of the asset group. If the first step of the long-lived asset impairment test concludes that the carrying amount of the asset group is not recoverable, we perform the second step of the long-lived asset impairment test by comparing the fair value of the asset group to its carrying amount and recognizing a lease impairment charge for the amount by which the carrying amount exceeds the fair value. To estimate the fair value of the asset group, we rely on a discounted cash flow approach using market participant assumptions of the expected cash flows and discount rate. During the first nine months of 2019, we recorded $0.8 million of lease impairment charges for office spaces vacated in the first nine months of 2019, of which $0.6 million was allocated to the operating lease ROU assets and $0.2 million was allocated to the leasehold improvements based on their relative carrying amounts. The $0.8 million lease impairment charge was recognized in restructuring charges on our consolidated statement of operations. See Note 9 "Restructuring Charges" for additional information on our restructuring activities.
Additional information on our operating leases as of September 30, 2019 follows.
Balance Sheet September 30, 2019
Operating lease right-of-use assets $52,342
   
Current maturities of operating lease liabilities $10,529
Operating lease liabilities, net of current portion 59,460
Total lease liabilities $69,989


8

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Lease Cost Three Months Ended
September 30, 2019
 Nine Months Ended
September 30, 2019
Operating lease cost $3,036
 $9,092
Short-term leases (1)
 88
 263
Variable lease costs 995
 3,154
Sublease income (648) (2,075)
Net lease cost (2)(3)(4)
 $3,471
 $10,434
(1)Includes variable lease costs related to short-term leases.
(2)Net lease cost includes $0.1 million and $0.3 million for the three and nine months ended September 30, 2019, respectively, recorded as restructuring charges as they relate to vacated office spaces. See Note 9 "Restructuring Charges" for additional information on our vacated office spaces.
(3)Net lease cost includes $0.1 million and $0.2 million for the three and nine months ended September 30, 2019. respectively, related to vacated office spaces directly related to discontinued operations.
(4)Rent expense, including operating expenses, real estate taxes and insurance, recorded under ASC 840 for the three and nine months ended September 30, 2018 was $3.7 million and $11.3 million, respectively.
The table below summarizes the remaining expected lease payments under our operating leases as of September 30, 2019 and December 31, 2018.
Future Lease Payments September 30,
2019
 

December 31,
2018 (1, 2)
2019 $3,358
 $13,701
2020 13,574
 12,724
2021 12,514
 11,590
2022 11,623
 10,766
2023 11,606
 10,707
Thereafter 28,742
 27,033
Total operating lease payments $81,417
 $86,521
Less: imputed interest (11,428) n/a
Present value of operating lease liabilities 
 $69,989
 n/a
(1)The expected lease payments as of December 31, 2018 represent our future minimum rental commitments as defined by ASC 840.
(2)As of December 31, 2018, the expected total future minimum sublease income to be received was $10.2 million.
Other Information Nine Months Ended
September 30, 2019
Cash paid for operating lease liabilities $10,504
Operating lease right-of-use assets obtained in exchange for operating lease liabilities $3,628
   
Weighted average remaining lease term - operating leases 6.6 years
Weighted average discount rate - operating leases 4.7%

During October 2019, we entered into an amendment to the office lease agreement for our principal executive offices in Chicago, Illinois. Among other items, this amendment i) extends the term of the lease from September 30, 2024 to September 30, 2029; ii) provides a renewal option to extend the lease for an additional five year period to September 30, 2034; iii) terminates the lease with respect to certain leased spaces previously vacated; iv) provides abatement of certain future base rent payments and our pro rata share of operating expenses and taxes; and v) provides a one-time cash payment from the lessor as an incentive.

9

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

6. Revenues
For the three months ended September 30, 2019 and 2018, we recognized revenues of $219.3 million and $198.4 million, respectively. Of the $219.3 million recognized in the third quarter of 2019, we recognized revenues of $4.8 million from obligations satisfied, or partially satisfied, in prior periods, of which $3.7 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments and $1.1 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $198.4 million recognized in the third quarter of 2018, we recognized revenues of $7.6 million from obligations satisfied, or partially satisfied, in prior periods, of which $4.3 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments and $3.3 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements.
For the nine months ended September 30, 2019 and 2018, we recognized revenues of $644.5 million and $589.7 million, respectively. Of the $644.5 million recognized in the first nine months of 2019, we recognized revenues of $2.6 million from obligations satisfied, or partially satisfied, in prior periods, due to the release of allowances on unbilled services as a result of securing contract amendments. During the first nine months of 2019, we recognized a $1.4 million decrease to revenues due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $589.7 million recognized in the first nine months of 2018, we recognized revenues of $10.1 million from obligations satisfied, or partially satisfied, in prior periods, of which $6.5 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $3.6 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments.
As of September 30, 2019, we had $47.3 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude obligations under contracts with an original expected duration of one year or less, variable consideration which has been excluded from the total transaction price due to the constraint, and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the $47.3 million of performance obligations, we expect to recognize approximately $15.9 million as revenue in 2019, $17.4 million in 2020, and the remaining $14.0 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.
Contract Assets and Liabilities
The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.
Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of September 30, 2019 and December 31, 2018 was $28.6 million and $9.1 million, respectively. The $19.5 million increase primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.
Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition policy. Our deferred revenues balance as of September 30, 2019 and December 31, 2018, was $31.2 million and $28.1 million, respectively. The $3.1 million increase primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three and nine months ended September 30, 2019, $3.4 million and $21.4 million, respectively, of revenues recognized were included in the deferred revenue balance as of December 31, 2018.

10

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

7. Earnings Per Share
Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, outstanding common stock options, convertible senior notes, and outstanding warrants, to the extent dilutive. In periods for which we report a net loss from continuing operations, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss from continuing operations per share would be anti-dilutive.

13

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Earnings (loss) per share under the basic and diluted computations are as follows: 
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 2019 2018 2019 2018
Net income from continuing operations$13,706
 $8,249
 $27,625
 $10,889
Income (loss) from discontinued operations, net of tax(52) 228
 (195) (304)
Net income$13,654
 $8,477
 $27,430
 $10,585
        
Weighted average common shares outstanding – basic22,052
 21,745
 21,973
 21,683
Weighted average common stock equivalents509
 365
 452
 264
Weighted average common shares outstanding – diluted22,561
 22,110
 22,425
 21,947
        
Net earnings per basic share:    
 
Net income from continuing operations$0.62
 $0.38
 $1.26
 $0.50
Income (loss) from discontinued operations, net of tax
 0.01
 (0.01) (0.01)
Net income$0.62
 $0.39
 $1.25
 $0.49
        
Net earnings per diluted share:       
Net income from continuing operations$0.61
 $0.37
 $1.23
 $0.50
Income (loss) from discontinued operations, net of tax
 0.01
 (0.01) (0.02)
Net income$0.61
 $0.38
 $1.22
 $0.48

 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 2017 2016 2017 2016
Net income (loss) from continuing operations$4,132
 $12,288
 $(141,195) $35,293
Income (loss) from discontinued operations, net of tax238
 4
 690
 (1,830)
Net income (loss)$4,370
 $12,292
 $(140,505) $33,463
        
Weighted average common shares outstanding – basic21,505
 21,076
 21,413
 21,084
Weighted average common stock equivalents117
 369
 
 343
Weighted average common shares outstanding – diluted21,622
 21,445
 21,413
 21,427
        
Net earnings per basic share:    
 
Net income (loss) from continuing operations$0.19
 $0.58
 $(6.59) $1.67
Income (loss) from discontinued operations, net of tax0.01
 
 0.03
 (0.08)
Net income (loss)$0.20
 $0.58
 $(6.56) $1.59
        
Net earnings per diluted share:       
Net income (loss) from continuing operations$0.19
 $0.57
 $(6.59) $1.65
Income (loss) from discontinued operations, net of tax0.01
 
 0.03
 (0.09)
Net income (loss)$0.20
 $0.57
 $(6.56) $1.56
The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above were as follows:
 As of September 30,
 2019 2018
Unvested restricted stock awards
 11
Convertible senior notes3,129
 3,129
Warrants related to the issuance of convertible senior notes3,129
 3,129
Total anti-dilutive securities6,258
 6,269
 As of September 30,
 2017 2016
Unvested restricted stock awards627
 5
Outstanding common stock options

194
 
Convertible senior notes3,129
 3,129
Warrants related to the issuance of convertible senior notes3,129
 3,129
Total anti-dilutive securities7,079
 6,263

See Note 8 “Financing Arrangements” for further information on the convertible senior notes and warrants related to the issuance of convertible notes.
As of September 30, 2017, we hadWe currently have a share repurchase program authorized by our board of directors, pursuantpermitting us to which we may, from time to time, repurchase up to $125 million of our common stock through October 31, 20172019 (the “Share Repurchase Program”). During the fourth quarter of 2017,2019, our board of directors authorized an extension of the Share Repurchase Program through October 31, 2018.2020. The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. No shares were repurchased during the first nine months of 2017. In the first quarter of 2016, we repurchased2019 and retired 982,192 shares for $55.3 million. No shares were repurchased in the second or third quarter of 2016.2018. As of September 30, 2017,2019, $35.1 million remains available for share repurchases.


1411

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


8. Financing Arrangements
A summary of the carrying amounts of our debt follows:
 September 30, 2019 December 31, 2018
1.25% convertible senior notes due 2019$250,000
 $242,617
Senior secured credit facility50,000
 50,000
Promissory note due 20243,982
 4,368
Total long-term debt$303,982
 $296,985
Current maturities of long-term debt(250,525) (243,132)
Long-term debt, net of current portion$53,457
 $53,853

 September 30, 2017 December 31, 2016
1.25% convertible senior notes due 2019$230,834
 $224,065
Senior secured credit facility139,000
 68,000
Promissory note due 20244,991
 
Total long-term debt$374,825
 $292,065
Current maturities of debt (1)
(497) 
Long-term debt, net of current portion$374,328
 $292,065
(1)The current maturities of debt are included as a component of accrued expenses and other current liabilities on our consolidated balance sheets.
Below is a summary of the scheduled remaining principal payments of our debt as of September 30, 2017.2019.
 Principal Payments of Long-Term Debt
2019$250,130
2020$529
2021$544
2022$559
2023$574
Thereafter$51,646
 Principal Payments of Long-Term Debt
2017$123
2018$501
2019$250,515
2020$139,529
2021$544
Thereafter$2,779

Convertible Notes
In September 2014, the Company issued $250 million principal amount of 1.25% convertible senior notes due 2019 (the “Convertible Notes”) in a private offering. The Convertible Notes are governed by the terms of an indenture between the Company and U.S. Bank National Association, as Trustee (the “Indenture”). The Convertible Notes are senior unsecured obligations of the Company and will pay interest semi-annually on April 1 and October 1 of each year at an annual rate of 1.25%. The Convertible Notes will maturematured on October 1, 2019 unless earlier repurchased by. Upon maturity, we refinanced $217.0 million of the Company or converted in accordanceprincipal amount of the outstanding Convertible Notes with their terms.the borrowing capacity available under our revolving credit facility and funded the remaining $33.0 million principal payment with cash on hand.
UponPrior to maturity, upon conversion, the Convertible Notes will bewould have been settled, at our election, in cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock. Our current intent and policy iswas to settle conversions with a combination of cash and shares of common stock with the principal amount of the Convertible Notes paid in cash, in accordance with the settlement provisions of the Indenture.
The initial conversion rate for the Convertible Notes iswas 12.5170 shares of our common stock per $1,000 principal amount of the Convertible Notes, which iswas equal to an initial conversion price of approximately $79.89 per share of our common stock. The conversion rate will bewould have been subject to adjustment upon the occurrence of certain specified events but willwould not be adjusted for accrued and unpaid interest, except in certain limited circumstances described in the Indenture. Upon the occurrence of a “make-whole fundamental change” (as defined in the Indenture) the Company will,would, in certain circumstances, increase the conversion rate by a number of additional shares for a holder that elects to convert its Convertible Notes in connection with such make-whole fundamental change. Additionally, if the Company undergoesunderwent a “fundamental change” (as defined in the Indenture), a holder will havehad the option to require the Company to repurchase all or a portion of its Convertible Notes for cash at a price equal to 100% of the principal amount of the Convertible Notes being repurchased plus any accrued and unpaid interest. As discussed below, the convertible note hedge transactions and warrants, which were entered into in connection with the Convertible Notes, effectively raiseraised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share.


1512

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


Holders of the Convertible Notes mayhad the option to convert theirthe Convertible Notes at their option at any time prior to July 1, 2019, only under the following circumstances:
during any calendar quarter (and only during such calendar quarter) commencing after December 31, 2014 if, for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on, and including, the last trading day of the immediately preceding calendar quarter, the last reported sale price of the Company’s common stock for such trading day iswas equal to or greater than 130% of the applicable conversion price on such trading day;
during the five consecutive business day period immediately following any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which, for each trading day of the measurement period, the “trading price” (as defined in the Indenture) per $1,000 principal amount of the Convertible Notes for such trading day was less than 98% of the product of the last reported sale price of the Company’s common stock for such trading day and the applicable conversion rate on such trading day; or
upon the occurrence of specified corporate transactions described in the Indenture.
On or after July 1, 2019 until the close of business on the second scheduled trading day immediately preceding the maturity date, a holder may convertcould have converted all or a portion of its Convertible Notes, regardless of the foregoing circumstances.
We have separated the Convertible Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar liability that does not have an associated convertible feature, assuming our non-convertible debt borrowing rate. The carrying value of the equity component representing the conversion option, which is recognized as a debt discount, was determined by deducting the fair value of the liability component from the proceeds of the Convertible Notes. The debt discount iswas amortized to interest expense using an effective interest rate of 4.751% over the term of the Convertible Notes. As of September 30, 2017, the remaining life of the Convertible Notes is 2.0 years. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.
The transaction costs related to the issuance of the Convertible Notes were separated into liability and equity components based on their relative values, as determined above. Transaction costs attributable to the liability component arewere recorded as a deduction to the carrying amount of the liability and amortized to interest expense over the term of the Convertible Notes; and transaction costs attributable to the equity component arewere netted with the equity component of the Convertible Notes in stockholders’ equity. Total debt issuance costs were approximately $7.3 million, of which $6.2 million was allocated to liability issuance costs and $1.1 million was allocated to equity issuance costs.
As of September 30, 20172019, and December 31, 2016,2018, the Convertible Notes consisted of the following:
September 30, 2017 December 31, 2016September 30, 2019 December 31, 2018
Liability component:      
Proceeds$250,000
 $250,000
$250,000
 $250,000
Less: debt discount, net of amortization(16,666) (22,520)
 (6,436)
Less: debt issuance costs, net of amortization(2,500) (3,415)
 (947)
Net carrying amount$230,834
 $224,065
$250,000
 $242,617
Equity component (1)
$39,287
 $39,287
$39,287
 $39,287
(1)Included in additional paid-in capital on the consolidated balance sheet.

(1)Included in additional paid-in capital on the consolidated balance sheet.

1613

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


The following table presents the amount of interest expense recognized related to the Convertible Notes for the periods presented.
Three Months Ended
September 30,
 Nine Months Ended
September 30,
Three Months Ended
September 30,
 Nine Months Ended
September 30,
2017 2016 2017 20162019 2018 2019 2018
Contractual interest coupon$781
 $781
 $2,344
 $2,344
$781
 $781
 $2,344
 $2,344
Amortization of debt discount1,974
 1,883
 5,853
 5,582
2,171
 2,070
 6,436
 6,138
Amortization of debt issuance costs306
 302
 915
 900
317
 312
 947
 931
Total interest expense$3,061
 $2,966
 $9,112
 $8,826
$3,269
 $3,163
 $9,727
 $9,413

In connection with the issuance of the Convertible Notes, we entered into convertible note hedge transactions and warrant transactions. The convertible note hedge transactions arewere intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raiseraised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. For purposes of the computation of diluted earnings per share in accordance with GAAP, dilution willwould occur when the average share price of our common stock for a given period exceeds the conversion price of the Convertible Notes, which initially iswas equal to approximately $79.89 per share. The convertible note hedge transactions and warrant transactions are discussed separately below.
Convertible Note Hedge Transactions. In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions whereby the Company has call options to purchase a total of approximately 3.1 million shares of the Company’s common stock, which is the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89, which corresponds to the initial conversion price of the Convertible Notes, subject to customary anti-dilution adjustments substantially similar to those in the Convertible Notes. The convertible note hedge transactions are exercisable upon conversion of the Convertible Notes and will expire in 2019 if not earlier exercised. We paid an aggregate amount of $42.1 million for the convertible note hedge transactions, which was recorded as additional paid-in capital on the consolidated balance sheets. The convertible note hedge transactions are separate transactions and are not part of the terms of the Convertible Notes.
Warrants. In connection with the issuance of the Convertible Notes, the Company sold warrants whereby the holders of the warrants have the option to purchase a total of approximately 3.1 million shares of the Company’s common stock at a strike price of approximately $97.12. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share. We received aggregate proceeds of $23.6 million from the sale of the warrants, which was recorded as additional paid-in capital on the consolidated balance sheets. The warrants are separate transactions and are not part of the terms of the Convertible Notes or the convertible note hedge transactions.
Convertible Note Hedge Transactions. In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions whereby the Company had call options to purchase a total of approximately 3.1 million shares of the Company’s common stock, which is the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89, which corresponds to the initial conversion price of the Convertible Notes, subject to customary anti-dilution adjustments substantially similar to those in the Convertible Notes. The convertible note hedge transactions were exercisable upon conversion of the Convertible Notes and expired in the third quarter of 2019. We paid an aggregate amount of $42.1 million for the convertible note hedge transactions, which was recorded as additional paid-in capital on the consolidated balance sheet. The convertible note hedge transactions were separate transactions and were not part of the terms of the Convertible Notes.
Warrants. In connection with the issuance of the Convertible Notes, the Company sold warrants whereby the holders of the warrants have the option to purchase a total of approximately 3.1 million shares of the Company’s common stock at a strike price of approximately $97.12. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share. We received aggregate proceeds of $23.6 million from the sale of the warrants, which was recorded as additional paid-in capital on the consolidated balance sheet. The warrants are separate transactions and are not part of the terms of the Convertible Notes or the convertible note hedge transactions.
The Company recorded an initial deferred tax liability of $15.4 million in connection with the debt discount associated with the Convertible Notes and recorded an initial deferred tax asset of $16.5 million in connection with the convertible note hedge transactions. The deferred tax liability and deferred tax asset are included in deferred income taxes, net on the consolidated balance sheets.
Senior Secured Credit Facility
The Company has a $500 million five-year senior secured revolving credit facility, subjectOn September 27, 2019, we entered into an amendment to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Facility"),. The Amended Credit Facility provides the Company a $600 million senior secured revolving credit facility, subject to the terms of the Amended Credit Facility, that becomes due and payable in full upon maturity on March 31, 2020.September 27, 2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $100$150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $600$750 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowingsBorrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

17


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.25%1.125% per annum and 2.00%1.875% per annum, in the case of

14


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

LIBOR borrowings, or between 0.25%0.125% per annum and 1.00%0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.
Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including a requirement to pay all amounts outstanding under the Amended Credit Agreement 90 days prior to the Convertible Indebtedness Maturity Date (as defined in the Amended Credit Agreement) unless (1) the Convertible Indebtedness Maturity Date is waived or extended to a later date, (2) the Company can demonstrate (a) Liquidity (as defined in the Amended Credit Agreement) in an amount at least equal to the principal amount due on the Convertible Indebtedness Maturity Date, and (b) financial covenant compliance after giving effect to such payments and any additional indebtedness incurred on a pro forma basis, or (3) this requirement is waived by the Required Lenders (as defined in the Amended Credit Agreement).circumstances. In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.
The loans and obligations under the Amended Credit Agreement are secured pursuant to a Second Amended and Restated Security Agreement and a Second Amended and Restated Pledge Agreement (the(as amended, the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement).
The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) ranging from 3.25of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.00 to 1.00 to 3.75 to 1.00, depending onupon the measurement period,occurrence of certain transactions, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back share-based compensation costs, non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, and pro forma historical EBITDA for businesses acquired.acquired, and other specified items in accordance with the Amended Credit Agreement. At September 30, 2017,2019, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 3.522.42 to 1.00 and a Consolidated Interest Coverage Ratio of 12.6015.33 to 1.00.
Borrowings outstanding under the Amended Credit Agreement at September 30, 20172019 totaled $139.0$50.0 million. These borrowings carried a weighted average interest rate of 3.4%3.3%, including the effect of the interest rate swap described in Note 10 “Derivative InstrumentsInstrument and Hedging Activity." Borrowings outstanding under the Amended Credit Agreement at December 31, 20162018 were $68.0$50.0 million and carried a weighted average interest rate of 2.5%.3.7%, including the effect of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity." The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At September 30, 2017,2019, we had outstanding letters of credit totaling $2.7$1.5 million, which are primarily used as security deposits for our office facilities. As of September 30, 2017,2019, the unused borrowing capacity under the revolving credit facility was $358.3$548.5 million.
On October 1, 2019, we refinanced $217.0 million of the $250 million outstanding principal amount of the Convertible Notes with the borrowing capacity available under our revolving credit facility, which resulted in outstanding borrowings of $267.0 million. As of October 1, 2019, the unused borrowing capacity under the revolving credit facility was $331.5 million and our pro forma Consolidated Leverage Ratio was 2.16 to 1.00.
Promissory Note due 2024
On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-monthone month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At September 30, 2017,2019, the outstanding principal amount of the promissory note was $5.0 million. As of September 30, 2017,$4.0 million, and the aircraft had a carrying amount of $6.6$5.3 million. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million, and the aircraft had a carrying amount of $5.8 million.


1815



HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


9. Restructuring Charges
Restructuring charges for the three and nine months ended September 30, 2017 totaled $1.32019 were $0.1 million and $5.3$2.2 million, respectively. The $1.3$0.1 million charge recognized in the third quarter of 2019 primarily related to workforce reductions as we continue to better align resources with market demand. During the nine months ended September 30, 2019, we exited a portion of our Lake Oswego, Oregon corporate office resulting in a $0.7 million lease impairment charge on the operating lease right-of-use asset and leasehold improvements and $0.2 million of accelerated depreciation on furniture and fixtures in that office. The lease impairment charge was recognized in accordance with ASC 842, Leases, which we adopted on a modified retrospective basis on January 1, 2019. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" for additional information on our adoption of ASC 842. See Note 5 "Leases" for additional information on the long-lived asset impairment test. Additionally, during the nine months ended September 30, 2019, we exited the remaining portion of our Middleton, Wisconsin office and an office space in Houston, Texas, resulting in restructuring charges of $0.4 million and $0.1 million, respectively, which primarily consisted of accelerated depreciation on furniture and fixtures in those offices. The restructuring charges for the nine months ended September 30, 2019 also include $0.2 million related to workforce reductions as we continue to better align resources with market demand and $0.2 million related to workforce reductions in our corporate operations.
Restructuring charges netted to an immaterial amount for the three months ended September 30, 2018 and were $2.7 million for the nine months ended September 30, 2018. The restructuring charges incurred in the third quarter of 2017 primarily related to2018 consisted of a $0.3 million decrease in the accrual of remaining lease obligations,payments, net of estimated sublease income, due to relocatingas a result of updated lease assumptions for our San Francisco office to a smaller space and consolidating our New York officesvacated in the third quarter of 2017, which was accounted for in accordance with ASC 840, Leases; and accelerated depreciation on leasehold improvements for our San Francisco office. a net $0.2 million charge related to workforce reductions to better align resources with market demand. The $5.3$2.7 million of restructuring chargescharge incurred in the first nine months of 20172018 primarily consisted of $2.5$1.2 million related to workforce reductions to better align resources with market demand; $0.7 million related to the accrual of remaining lease obligations,payments, net of estimated sublease income, and accelerated depreciation on leasehold improvements due to relocatingexiting a portion of our Middleton, Wisconsin office in the second quarter of 2018; $0.3 million related to updated lease assumptions for our San Francisco office vacated in the third quarter of 2017; and $0.3 million related to the divestiture of our Middle East practice within the Business Advisory segment in the second quarter of 2018. During the second quarter of 2018, we sold our Middle East practice to a smaller spaceformer employee who was the practice leader of that business at the time; and consolidatingwe recorded a $5.9 million loss for the nine months ended September 30, 2018, which is included in other income (expense), net in our Chicago and New York officesconsolidated statements of operations. The restructuring charges recorded in the first nine months of 2017, and accelerated depreciation on leasehold improvements for our San Francisco office, $2.0 million2018 related to workforceoffice space reductions were accounted for in our Healthcare segment to better align our resourcesaccordance with market demand, and $0.4 million related to workforce reductions in our corporate operations primarily to adjust our infrastructure to align with the decreased workforce in the Healthcare segment.ASC 840, Leases.
Restructuring charges for the three and nine months ended September 30, 2016 totaled $1.0 million and $4.1 million, respectively. The $1.0 million charge incurred in the third quarter of 2016 primarily related to updated lease assumptions of our Washington, D.C. space vacated in the fourth quarter of 2014. The $4.1 million of restructuring charges incurred in the first nine months of 2016 primarily consisted of $1.5 million related to updated assumptions for lease accruals for the Washington, D.C. space vacated in the fourth quarter of 2014, $1.2 million related to workforce reductions in our Healthcare segment to better align resources with market demand, $0.9 million related to workforce reductions in our corporate operations as we adjusted our infrastructure to align with our Huron Legal divestiture, and $0.2 million related to the wind down of our foreign consulting operations based in the Middle East.
The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the nine months ended September 30, 2017.
2019.
 Employee Costs Office Space Reductions Other Total
Balance as of December 31, 2016$5,182
 $5,773
 $24
 $10,979
Additions (1)
2,889
 2,445
 110
 5,444
Payments(7,226) (2,047) 5
 (9,268)
Adjustments (1)
(117) (1,087) (78) (1,282)
Non-cash items(46) (119) (61) (226)
Balance as of September 30, 2017$682
 $4,965
 $
 $5,647
 Employee Costs Office Space Reductions Total
Balance as of December 31, 2018$443
 $2,468
 $2,911
Adoption of ASC 842 (1)

 (1,119) (1,119)
Balance as of January 1, 2019443
 1,349
 1,792
Additions (2)
500
 9
 509
Payments(852) (383) (1,235)
Adjustments (2)
(16) (518) (534)
Balance as of September 30, 2019$75
 $457
 $532
(1)Additions and adjustments forUpon adoption of ASC 842 on January 1, 2019, we reclassified the nine months ended September 30, 2017 include a restructuring gaincharge liabilities, which represented the present value of $1.1 million related to updatedremaining lease assumptionspayments, net of estimated sublease income, for vacated office spaces directly relatedfrom restructuring charge liabilities to discontinued operations. Refer tooperating lease right-of-use assets. See Note 4 "Discontinued Operations"3 "New Accounting Pronouncements" for additional information on the impact of adoption.
(2)Additions and adjustments exclude non-cash items related to vacated office spaces, such as lease impairment charges and accelerated depreciation on fixed assets, which are recorded as restructuring charges on our discontinuedconsolidated statements of operations.
As of September 30, 2017, ourThe $0.5 million restructuring charge liability related to office space reductions of $5.0 million represented the present value of remaining lease payments, net of estimated sublease income, primarily for our vacated office spaces in Washington, D.C., Houston, San Francisco, and Chicago. This restructuring charge liabilityat September 30, 2019 is included as a component of accrued expenses and other current liabilities and deferred compensation and other liabilities. All of the $0.7The $0.1 million restructuring charge liability related to employee costs at September 30, 20172019 is expected to be paid in the next 12 months. The restructuring charge liability related to employee costsmonths and is included as a component of accrued payroll and related benefits.

16

10. Derivative Instruments and Hedging Activity
On April 4, 2013, we entered into a forward amortizing interest rate swap agreement effective March 31, 2014 which ended August 31, 2017. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. The swap had an initial notional amount of $60.0 million and amortized quarterly until April 2016. In April 2016, the notional amount of this interest rate swap increased to $86.0 million and continued to amortize quarterly until it expired in August 2017. Under the terms of the interest rate swap agreement, we received from the counterparty interest on the notional amount based on one-month LIBOR and we paid to the counterparty a fixed rate of 0.985%.

19



HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


10. Derivative Instrument and Hedging Activity
On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to continue to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-monthone month LIBOR and we pay to the counterparty a fixed rate of 1.900%.
We recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. We have designated thesethis derivative instrumentsinstrument as a cash flow hedges.hedge. Therefore, changes in the fair value of the derivative instrumentsinstrument are recorded to other comprehensive income (“OCI”) to the extent effective and reclassified into interest expense upon settlement. The ineffective portion of the change in fair value of the derivative instruments is recognized in interest expense. Our interest rate swap agreement was effective during the three and nine months ended September 30, 2017. As of September 30, 2017,2019, it was anticipated that $0.1 million of the losses, net of tax, currently recorded in accumulated other comprehensive income will be reclassified into earnings within the next 12 months.
The table below sets forth additional information relating to ourthe interest rate swapsswap designated as a cash flow hedging instrument as of September 30, 20172019 and December 31, 2016.2018.
  Fair Value (Derivative Asset and Liability)
Balance Sheet Location September 30,
2019
 December 31,
2018
Prepaid expenses and other current assets $
 $302
Other non-current assets $
 $451
Accrued expenses and other current liabilities $121
 $
Deferred compensation and other liabilities $482
 $
  Fair Value (Derivative Asset and Liability)
Balance Sheet Location September 30,
2017
 December 31,
2016
Other non-current assets $141
 $
Accrued expenses $200
 $54

All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis on our consolidated balance sheet.
We do not use derivative instruments for trading or other speculative purposes. Refer to Note 12 “Other Comprehensive Income (Loss)” for additional information on our derivative instrument.

20


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

11. Fair Value of Financial Instruments
Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:
Level 1 Inputs Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
  
Level 2 Inputs Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  
Level 3 Inputs Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.


17

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of September 30, 20172019 and December 31, 2016.2018.
  Level 1 Level 2 Level 3 Total
September 30, 2019        
Assets:        
Convertible debt investment $
 $
 $60,943
 $60,943
Deferred compensation assets 
 25,435
 
 25,435
Total assets $
 $25,435
 $60,943
 $86,378
Liabilities:        
Interest rate swap $
 $603
 $
 $603
Total liabilities $
 $603
 $
 $603
December 31, 2018        
Assets:        
Interest rate swap $
 $753
 $
 $753
Convertible debt investment 
 
 50,429
 50,429
Deferred compensation assets 
 18,205
 
 18,205
Total assets $
 $18,958
 $50,429
 $69,387
Liabilities:        
Contingent consideration for business acquisitions $
 $
 $11,441
 $11,441
Total liabilities $
 $
 $11,441
 $11,441

 Level 1 Level 2 Level 3 Total
September 30, 2017       
Assets:       
Promissory note$
 $
 $2,311
 $2,311
Convertible debt investment
 
 31,937
 31,937
Deferred compensation assets
 17,170
 
 17,170
Total assets$
 $17,170
 $34,248
 $51,418
Liabilities:       
Interest rate swap$
 $59
 $
 $59
Contingent consideration for business acquisitions
 
 22,469
 22,469
Total liabilities$
 $59
 $22,469
 $22,528
December 31, 2016       
Assets:       
Promissory note$
 $
 $2,325
 $2,325
Convertible debt investment
 
 34,675
 34,675
Deferred compensation assets
 16,408
 
 16,408
Total assets$
 $16,408
 $37,000
 $53,408
Liabilities:       
Interest rate swap$
 $54
 $
 $54
Contingent consideration for business acquisitions
 
 8,827
 8,827
Total liabilities$
 $54
 $8,827
 $8,881
Deferred compensation assets: We have a non-qualified deferred compensation plan (the "Plan") for the members of our board of directors and a select group of our employees. Interest rate swap: The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets on our consolidated balance sheet. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.

21

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Interest rate swaps: The fair values of our interest rate swaps wereswap was derived using estimates to settle the interest rate swap agreements,agreement, which areis based on the net present value of expected future cash flows on each leg of the swapsswap utilizing market-based inputs and a discount ratesrate reflecting the risks involved.
Promissory note: As part of the consideration received for the sale of our Accounting Advisory practice on December 30, 2011, we received a $3.5 million promissory note payable over four years. During the second quarter of 2014, we agreed to amend and restate the note such that principal payments will be paid to us annually based on the amount of excess cash flows earned each year by the maker of the note until the maturity date of December 31, 2018, at which time the remaining principal balance and any accrued interest is due. The fair value of the note is based on the net present value of the projected cash flows using a discount rate of 17%, which accounts for the risks associated with the note. This fair value measurement is based on significant inputs not observable in the market and thus represent Level 3 inputs. As of September 30, 2017, $0.2 million is recorded in prepaid expenses and other current assets and represents the present value of the payments expected to be received in the next 12 months, and the remaining $2.1 million is recorded in other non-current assets.
The table below sets forth the changes in the balance of the promissory note for the nine months ended September 30, 2017.
  Promissory Note
Balance as of December 31, 2016 $2,325
Interest payments received (140)
Principal payment received (177)
Change in fair value of promissory note 303
Balance as of September 30, 2017 $2,311
Convertible debt investment: In 2014 and 2015, we invested $27.9 million, in the form of zero coupon convertible debt, in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight Education, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. In the second quarter of 2019, we amended the convertible notes to extend the maturity date by one year. The notes will mature on July 1, 2020,2021, unless converted earlier.
To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security.
The convertible debt investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. We estimatedestimate the fair value of our investment using a Monte Carlo simulation model, cash flow projections discounted at a risk-adjusted rate, and certain assumptions related to equity volatility default probability, and recovery rate,applicable holding period, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investment.investment on our consolidated balance sheets.
The table below sets forth the changes in the balance of the convertible debt investment for the nine months ended September 30, 2017.2019.
  Convertible Debt Investment
Balance as of December 31, 2018 $50,429
Change in fair value of convertible debt investment 10,514
Balance as of September 30, 2019 $60,943

Deferred compensation assets: We have a non-qualified deferred compensation plan (the "Plan") for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker

18

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
  Convertible Debt Investment
Balance as of December 31, 2016 $34,675
Change in fair value of convertible debt investment (2,738)
Balance as of September 30, 2017 $31,937

statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets on our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.
Contingent consideration for business acquisitions: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being achieved or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent

22

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and discount rates, which typically reflect a risk-free rate. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates. Refer to Note 5 “Acquisitions” for information on the acquisitions completed in 2017. The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the nine months ended September 30, 2017.2019.
 Contingent Consideration for Business Acquisitions Contingent Consideration for Business Acquisitions
Balance as of December 31, 2016 $8,827
Acquisitions 15,489
Balance as of December 31, 2018 $11,441
Payments (1,938) (10,041)
Remeasurement of contingent consideration for business acquisitions (222) (1,506)
Unrealized loss due to foreign currency translation 313
 106
Balance as of September 30, 2017 $22,469
Balance as of September 30, 2019 $

Financial assets and liabilities not recorded at fair value are as follows:
Senior Secured Credit Facility
The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 8 “Financing Arrangements” for additional information on our senior secured credit facility.
Promissory Note due 2024
The carrying value of our promissory note due 2024 is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the promissory note bears interest at rates based on current market rates as set forth in the terms of the promissory note. Refer to Note 8 “Financing Arrangements” for additional information on our promissory note due 2024.
Convertible Notes
The carrying amount and estimated fair value of the Convertible Notes are as follows:
 September 30, 2019 December 31, 2018
 
Carrying
Amount
 
Estimated
Fair Value
 Carrying
Amount
 Estimated
Fair Value
1.25% convertible senior notes due 2019$250,000
 $249,525
 $242,617
 $242,940
 September 30, 2017 December 31, 2016
 
Carrying
Amount
 
Estimated
Fair Value
 Carrying
Amount
 Estimated
Fair Value
1.25% convertible senior notes due 2019$230,834
 $233,595
 $224,065
 $245,018

The differencesdifference between the $250 million principal amount of the Convertible Notes and the carrying amountsamount shown above representas of December 31, 2018 represents the unamortized debt discount and issuance costs. As of September 30, 20172019, and December 31, 2016,2018, the carrying value of the equity component of $39.3 million was unchanged from the date of issuance. Refer to Note 8 “Financing Arrangements” for additional information on our Convertible Notes. The estimated fair value of the Convertible Notes was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market, which is a Level 2 input, on the last day of trading for the quarters ended September 30, 20172019 and December 31, 2016.2018.
Based on the closing price of our common stock of $34.30 on September 30, 2017, the if-converted value of the Convertible Notes was less than the principal amount.


2319

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


Based on the closing price of our common stock of $61.34 on September 30, 2019, the if-converted value of the Convertible Notes was less than the principal amount.
Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.
12. Other Comprehensive Income (Loss)
The tablestable below setsets forth the components of other comprehensive income (loss), net of tax, for the three and nine months ended September 30, 20172019 and 2016.2018.
 Three Months Ended
September 30, 2019
 Three Months Ended
September 30, 2018
 Before
Taxes
 Tax
(Expense)
Benefit
 Net of
Taxes
 Before
Taxes
 Tax
(Expense)
Benefit
 Net of
Taxes
Other comprehensive income (loss):           
Foreign currency translation adjustments$(630) $
 $(630) $(579) $
 $(579)
Unrealized gain (loss) on investment$1,586
 $(418) $1,168
 $(1,151) $299
 $(852)
Unrealized gain (loss) on cash flow hedges:           
Change in fair value$(158) $42
 $(116) $301
 $(78) $223
Reclassification adjustments into earnings(46) 13
 (33) (23) 6
 (17)
Net unrealized gain (loss)$(204) $55
 $(149) $278
 $(72) $206
Other comprehensive income (loss)$752
 $(363) $389
 $(1,452) $227
 $(1,225)
 Three Months Ended
September 30, 2017
 Three Months Ended
September 30, 2016
 Before
Taxes
 Tax
(Expense)
Benefit
 Net of
Taxes
 Before
Taxes
 Tax
(Expense)
Benefit
 Net of
Taxes
Other comprehensive income (loss):           
Foreign currency translation adjustments$609
 $
 $609
 $50
 $
 $50
Unrealized loss on investment$(3,609) $1,409
 $(2,200) $(3,329) $1,291
 $(2,038)
Unrealized gain (loss) on cash flow hedges:           
Change in fair value$41
 $(16) $25
 $96
 $(35) $61
Reclassification adjustments into earnings(3) 1
 (2) 101
 (41) 60
Net unrealized gain$38
 $(15) $23
 $197
 $(76) $121
Other comprehensive income (loss)$(2,962) $1,394
 $(1,568) $(3,082) $1,215
 $(1,867)

 Nine Months Ended
September 30, 2019
 Nine Months Ended
September 30, 2018
 
Before
Taxes
 
Tax
(Expense)
Benefit
 
Net of
Taxes
 
Before
Taxes
 
Tax
(Expense)
Benefit
 
Net of
Taxes
Other comprehensive income (loss):           
Foreign currency translation adjustments$(673) $
 $(673) $(1,499) $
 $(1,499)
Unrealized gain on investment$10,514
 $(2,774) $7,740
 $6,044
 $(1,571) $4,473
Unrealized gain (loss) on cash flow hedges:           
Change in fair value$(1,164) $308
 $(856) $1,096
 $(285) $811
Reclassification adjustments into earnings(192) 50
 (142) 13
 (3) 10
Net unrealized gain (loss)$(1,356) $358
 $(998) $1,109
 $(288) $821
Other comprehensive income$8,485
 $(2,416) $6,069
 $5,654
 $(1,859) $3,795
 Nine Months Ended
September 30, 2017
 Nine Months Ended
September 30, 2016
 
Before
Taxes
 
Tax
(Expense)
Benefit
 
Net of
Taxes
 
Before
Taxes
 
Tax
(Expense)
Benefit
 
Net of
Taxes
Other comprehensive income (loss):           
Foreign currency translation adjustments$1,835
 $
 $1,835
 $52
 $
 $52
Unrealized loss on investment$(2,738) $1,069
 $(1,669) $(1,899) $736
 $(1,163)
Unrealized gain (loss) on cash flow hedges:           
Change in fair value$(41) $16
 $(25) $(367) $146
 $(221)
Reclassification adjustments into earnings36
 (15) 21
 323
 (129) 194
Net unrealized loss$(5) $1
 $(4) $(44) $17
 $(27)
Other comprehensive income (loss)$(908) $1,070
 $162
 $(1,891) $753
 $(1,138)

The before tax amounts reclassified from accumulated other comprehensive income related to our cash flow hedges are recorded to interest expense, net of interest income.
Accumulated other comprehensive income, net of tax, includes the following components:
 
Foreign Currency
Translation
 Available-for-Sale Investment Cash Flow Hedges Total
Balance, December 31, 2018$(665) $16,584
 $576
 $16,495
Current period change(673) 7,740
 (998) 6,069
Balance, September 30, 2019$(1,338) $24,324
 $(422) $22,564

 
Foreign Currency
Translation
 Available-for-Sale Investment Cash Flow Hedges Total
Balance, December 31, 2016$(453) $4,088
 $(20) $3,615
Current period change1,835
 (1,669) (4) 162
Balance, September 30, 2017$1,382
 $2,419
 $(24) $3,777


2420

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


13. Income Taxes
For the three months ended September 30, 2017,2019, our effective tax rate was (92.4)%15.0% as we recognized income tax benefitexpense from continuing operations of $2.0$2.4 million on income from continuing operations of $2.1$16.1 million. The effective tax rate of 15.0% was more favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to a discrete tax benefit of $0.7 million for U.S. federal return to provision adjustments related to the 2018 corporate income tax return, which had a favorable impact of 4.6% on the effective tax rate. In addition, we recognized a $0.7 million discrete tax benefit related to a previously unrecognized tax benefit due to the expiration of statute of limitations on our "check-the-box" election made in 2015 to treat certain wholly-owned foreign subsidiaries as disregarded entities for U.S. federal income tax purposes, which had a favorable impact of 4.6% on the effective tax rate. For the third quarter of 2016,three months ended September 30, 2018, our effective tax rate was 37.2%14.4% as we recognized income tax expense from continuing operations of $1.4 million on income from continuing operations of $9.6 million. The effective tax rate of 14.4% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to a discrete tax benefit of $0.8 million for U.S. federal return to provision adjustments related to the 2017 corporate income tax return, which had a favorable impact of 8.6% on the effective tax rate. In addition, the third quarter of 2018 included a discrete tax benefit of $0.4 million for foreign return to provision adjustments, which had a favorable impact of 3.7% on the effective tax rate.
For the nine months ended September 30, 2019, our effective tax rate was 20.8% as we recognized income tax expense from continuing operations of $7.3 million on income from continuing operations of $19.6$34.9 million. The effective tax rate for the three months ended September 30, 2017of 20.8% was more favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to recognizing$1.0 million of discrete tax benefit recognized primarily in the third quarter of 2019 related to U.S. federal and foreign return to provision adjustments, which had a $2.7favorable impact of 2.8% on the effective tax rate. In addition, we recognized a $0.7 million discrete tax benefit in the third quarter of 2019 related to a previously unrecognized tax benefit fromdue to the expiration of statute of limitations on our "check-the-box" election made in 20142015 to treat one of ourcertain wholly-owned foreign subsidiaries as a disregarded entityentities for U.SU.S. federal income tax purposes. This benefit was partially offset by $0.6 million of tax expense recorded in the third quarter of 2017 to correct an error that occurred in the second quarter of 2017. During the third quarter of 2017, we also recordedpurposes, which had a $3.1 million adjustment to decrease deferred income taxes, net and increase income tax receivable on our consolidated balance sheet to correct an error that occurred in the second quarter of 2017. These errors have no impact on full year 2017 results, and we concluded that thefavorable impact of both errors was not material to2.1% on the second and third quarter financial statements. The effective tax rate for the three months ended September 30, 2016 was lower than the statutory rate, inclusive of state income taxes, primarily due to non-taxable income, valuation allowance reductions, and certain credits and deductions, partially offset by non-deductible business expenses.
rate. For the nine months ended September 30, 2017,2018, our effective tax rate was 26.1% as we recognized income tax benefit from continuing operations of $49.7 million on a loss from continuing operations of $190.9 million. For the nine months ended September 30, 2016, our effective tax rate was 35.6%28.6% as we recognized income tax expense from continuing operations of $19.5$4.4 million on income from continuing operations of $54.8$15.3 million. The effective tax rate for the nine months ended September 30, 2017of 28.6% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to the $61.2 million non-deductible portion of the goodwill impairment charge recorded in the second quarter of 2017, as well as $1.8 million of discrete tax expense of $1.2 million for share-based compensation related toawards that vested during the adoptionfirst quarter of ASU 2016-09 Improvements to Employee Share-Based Payment Accounting. Refer to Note 3 "New Accounting Pronouncements" for additional information2018, which had an unfavorable impact of 8.1% on the adoption of ASU 2016-09. Theseeffective tax rate. This unfavorable discrete items wereitem was partially offset by a $2.7$0.9 million discrete tax benefit recorded in the third quarter of 20172018 related to U.S. federal and foreign return to provision adjustments, which had a previously unrecognized tax benefit from our 2014 "check-the-box" election. Thefavorable impact of 6.1% on the effective tax rate for the nine months ended September 30, 2016 was lower than the statutory rate, inclusive of state income taxes, primarily due to the year-to-date impact of a discrete favorable adjustment to our state tax rate in the second quarter of 2016, non-taxable income, valuation allowance reductions, certain credits and deductions, and a discrete tax benefit related to share-based compensation, partially offset by non-deductible business expenses.rate.
As of September 30, 2017,2019, we had $0.8$0.1 million of unrecognized tax benefits which would affect the effective tax rate of continuing operations if recognized.
14. Commitments, Contingencies and Guarantees
Litigation
During the nine months ended September 30, 2018, we reached a settlement agreement related to Huron's claim in a class action lawsuit, resulting in a gain of $2.5 million.
From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.
Guarantees
Guarantees in the form of letters of credit totaling $2.7$1.5 million and $4.8$1.6 million were outstanding at September 30, 20172019 and December 31, 2016,2018, respectively, primarily to support certain office lease obligations.
In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of September 30, 2017 and December 31, 2016,2019, the total estimated fair value of our contingent consideration liabilities was $22.5 million and $8.8 million, respectively.zero. As of December 31, 2018, the total estimated fair value of our contingent consideration liabilities was $11.4 million.
To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates


2521

Table of Contents


HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.
15. Segment Information
Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under three3 operating segments, which are our reportable segments: Healthcare, Education, and Business Advisory.
During the second quarter of 2017, we reorganized our internal financial reporting structure, which management uses to assess performance and allocate resources, by moving our Life Sciences practice from the Education and Life Sciences segment to the Business Advisory, segment. The remaining Education and Life Sciences segment is now referred to as the Education segment. While our consolidated results have not been impacted, we have restated our historical segment information for consistent presentation.Education.
Healthcare
Our Healthcare segment provides advisory services - from strategy setting through implementation -has a depth of expertise in the areas of organizational and resource alignment, clinicalcare transformation, financial and operational performance, patientexcellence, technology and caregiver engagement,analytics, and technology implementation and optimization.leadership development. We serve national and regional hospitals and integrated health systems, academic medical centers, community hospitals, and medical groups. Our solutions help clients evolve and adapt to the rapidly changing healthcare environment and achieve growth, optimize performance, enhance profitability, improve quality and clinical outcomes, align leaders, improve organizational culture, and drive physician, patient, and employee engagement across the enterprise.enterprise to deliver better consumer outcomes.
Education
We help organizations transform and innovate their delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health. Our Education segment provides management consulting and technology solutions to higher education institutions and academic medical centers. Weconsultants partner with clients to address challenges relatinghelp build and sustain today’s business to businessinvest in the future by reducing complexity, improving operational efficiency and growing market share. We enable the healthcare of the future by identifying, integrating and optimizing technology strategy, financial management,investments to collect data that transforms care delivery and improves patient outcomes. We also develop future leaders capable of driving meaningful operational and organizational effectiveness, research administration,change and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student lifecycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our technology strategy, enterprise applications, and analytic solutionswho transform and optimize operations, deliver time and cost savings, and enhance the studentconsumer experience. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance.
Business Advisory
Our Business Advisory segment provides services to large and middle market and large organizations, not-for-profit organizations, lending institutions, law firms, investment banks and private equity firms. We assist clients in a broad range of industries and across the spectrum from healthy, well-capitalized companies to organizations in transition, as well as creditors, equity owners, and other key constituents. Our Business Advisory professionals resolve complex business issues and enhance client enterprise value through a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Enterprise Solutions and Analytics professionals deliver technology and analytic solutions that enable organizations to manage and optimize their financial performance, operational efficiency, and client or stakeholder experience. Our expertise in full-service enterprise performance management (EPM), enterprise resource planning (ERP), business intelligence and analytics, customer relationship management (CRM), and data management services helps clients identify and execute on business and technology strategies to drive results and gain a competitive advantage. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals providestrategic

26

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.
Education
Our Education segment provides consulting and technology solutions to higher education institutions and academic medical centers. We partner with clients to address challenges relating to business and technology strategy, financial management, operational and organizational effectiveness, research administration, and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student life cycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes. Our technology strategy, enterprise applications, and analytic solutions transform and optimize operations, deliver time and cost savings, and enhance the student experience. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance.
Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative expenses that are incurred directly by the segment. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs

22

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

include costs for corporate office support, certain office facility costs, costs relating to accounting and finance, human resources, legal, marketing, information technology, and Company-widecompany-wide business development functions, as well as costs related to overall corporate management.
The table below sets forth information about our operating segments for the three and nine months ended September 30, 20172019 and 2016,2018, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 2019 2018 2019 2018
Healthcare:       
Revenues$100,000
 $90,417
 $295,621
 $271,812
Operating income$32,863
 $26,640
 $94,058
 $78,172
Segment operating income as a percentage of segment revenues32.9% 29.5% 31.8% 28.8%
Business Advisory:       
Revenues$62,519
 $57,175
 $183,602
 $170,790
Operating income$11,942
 $11,815
 $32,997
 $35,031
Segment operating income as a percentage of segment revenues19.1% 20.7% 18.0% 20.5%
Education:       
Revenues$56,770
 $50,856
 $165,265
 $147,069
Operating income$14,413
 $15,014
 $43,235
 $37,694
Segment operating income as a percentage of segment revenues25.4% 29.5% 26.2% 25.6%
Total Company:       
Revenues$219,289
 $198,448
 $644,488
 $589,671
Reimbursable expenses23,636
 21,296
 65,787
 59,648
Total revenues and reimbursable expenses$242,925
 $219,744
 $710,275
 $649,319

       
Segment operating income$59,218
 $53,469
 $170,290
 $150,897
Items not allocated at the segment level:       
Other operating expenses32,310
 30,460
 105,369
 94,585
Litigation and other losses (gains), net(630) 887
 (1,571) (4,990)
Depreciation and amortization6,962
 8,561
 21,285
 26,281
Other expense, net4,456
 3,921
 10,326
 19,767
Income from continuing operations before taxes$16,120
 $9,640
 $34,881
 $15,254


23

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

The following table illustrates the disaggregation of revenues by billing arrangements, employee types, and timing of revenue recognition, including a reconciliation of the disaggregated revenues to revenues from our three operating segments for the three and nine months ended September 30, 2019 and 2018.
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 2017 2016 2017 2016
Healthcare:       
Revenues$79,582
 $103,425
 $261,261
 $323,531
Operating income$25,778
 $38,824
 $83,580
 $119,229
Segment operating income as a percentage of segment revenues32.4% 37.5% 32.0% 36.9%
Education:       
Revenues$41,422
 $38,621
 $127,629
 $111,816
Operating income$7,762
 $10,896
 $31,772
 $31,474
Segment operating income as a percentage of segment revenues18.7% 28.2% 24.9% 28.1%
Business Advisory:       
Revenues$55,372
 $41,354
 $157,753
 $112,801
Operating income$12,832
 $8,608
 $34,890
 $23,275
Segment operating income as a percentage of segment revenues23.2% 20.8% 22.1% 20.6%
Total Company:       
Revenues$176,376
 $183,400
 $546,643
 $548,148
Reimbursable expenses17,982
 19,093
 55,862
 54,636
Total revenues and reimbursable expenses$194,358
 $202,493
 $602,505
 $602,784

       
Segment operating income$46,372
 $58,328
 $150,242
 $173,978
Items not allocated at the segment level:       
Other operating expenses29,448
 26,502
 92,643
 84,595
Other losses (gains), net880
 494
 (222) 494
Depreciation and amortization9,946
 8,092
 28,549
 23,064
Goodwill impairment charge (1)

 
 209,600
 
Other expense, net3,950
 3,687
 10,607
 11,034
Income (loss) from continuing operations before income tax expense$2,148
 $19,553
 $(190,935) $54,791
 Three Months Ended September 30, 2019
 Healthcare Business Advisory Education Total
Billing Arrangements       
Fixed-fee$65,610
 $24,333
 $12,418
 $102,361
Time and expense12,307
 35,212
 39,688
 87,207
Performance-based16,313
 1,614
 
 17,927
Software support, maintenance and subscriptions5,770
 1,360
 4,664
 11,794
Total$100,000

$62,519

$56,770

$219,289
        
Employee Type (1)
       
Revenue generated by full-time billable consultants$72,142
 $60,131
 $48,928
 $181,201
Revenue generated by full-time equivalents27,858
 2,388
 7,842
 38,088
Total$100,000

$62,519

$56,770

$219,289
        
Timing of Revenue Recognition       
Revenue recognized over time$98,204
 $62,519
 $56,274
 $216,997
Revenue recognized at a point in time1,796
 
 496
 2,292
Total$100,000
 $62,519

$56,770
 $219,289
 Nine Months Ended September 30, 2019
 Healthcare Business Advisory Education Total
Billing Arrangements       
Fixed-fee$188,875
 $72,693
 $37,926
 $299,494
Time and expense39,345
 104,325
 114,122
 257,792
Performance-based50,144
 2,810
 
 52,954
Software support, maintenance and subscriptions17,257
 3,774
 13,217
 34,248
Total$295,621
 $183,602
 $165,265
 $644,488
        
Employee Type (1)
       
Revenue generated by full-time billable consultants$206,508
 $177,279
 $144,338
 $528,125
Revenue generated by full-time equivalents89,113
 6,323
 20,927
 116,363
Total$295,621
 $183,602
 $165,265
 $644,488
        
Timing of Revenue Recognition       
Revenue recognized over time$289,452
 $183,602
 $164,164
 $637,218
Revenue recognized at a point in time6,169
 
 1,101
 7,270
Total$295,621
 $183,602
 $165,265
 $644,488

24

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

 Three Months Ended September 30, 2018
 Healthcare Business Advisory Education Total
Billing Arrangements       
Fixed-fee$60,462
 $24,129
 $9,259
 $93,850
Time and expense15,723
 32,197
 37,654
 85,574
Performance-based8,372
 (60) 
 8,312
Software support, maintenance and subscriptions5,860
 909
 3,943
 10,712
Total$90,417
 $57,175
 $50,856
 $198,448
        
Employee Type (1)
       
Revenue generated by full-time billable consultants$62,409
 $54,379
 $44,876
 $161,664
Revenue generated by full-time equivalents28,008
 2,796
 5,980
 36,784
Total$90,417
 $57,175
 $50,856
 $198,448
        
Timing of Revenue Recognition       
Revenue recognized over time$88,372
 $57,175
 $50,104
 $195,651
Revenue recognized at a point in time2,045
 
 752
 2,797
Total$90,417
 $57,175
 $50,856
 $198,448
 Nine Months Ended September 30, 2018
 Healthcare Business Advisory Education Total
Billing Arrangements       
Fixed-fee$182,491
 $70,103
 $28,699
 $281,293
Time and expense42,755
 94,357
 108,019
 245,131
Performance-based27,776
 3,117
 
 30,893
Software support, maintenance and subscriptions18,790
 3,213
 10,351
 32,354
Total$271,812
 $170,790
 $147,069
 $589,671
        
Employee Type (1)
       
Revenue generated by full-time billable consultants$183,820
 $162,564
 $128,613
 $474,997
Revenue generated by full-time equivalents87,992
 8,226
 18,456
 114,674
Total$271,812
 $170,790
 $147,069
 $589,671
        
Timing of Revenue Recognition       
Revenue recognized over time$266,320
 $170,790
 $144,118
 $581,228
Revenue recognized at a point in time5,492
 
 2,951
 8,443
Total$271,812
 $170,790
 $147,069
 $589,671
(1)The goodwill impairment charge is not allocated at the segment level because the underlying goodwill asset is reflectiveFull-time billable consultants consist of our corporate investment infull-time professionals who provide consulting services to our clients and are billable to our clients based on the segments. We do not include the impactnumber of goodwill impairment charges inhours worked. Full-time equivalent professionals consist of leadership coaches and their support staff within our evaluation of segment performance.Healthcare Leadership solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.
At September 30, 20172019 and December 31, 2016,2018, no single client accounted for greater than 10% of our combined balance of receivables from clients, net and unbilled services, balances.net. During the three and nine months ended September 30, 20172019 and 2016,2018, no single client generated greater than 10% of our consolidated revenues.


2725

Table of Contents








ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.
Statements in this Quarterly Report on Form 10-Q that are not historical in nature, including those concerning the Company’s current expectations about its future requirements and needs,results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “guidance,” or “outlook,” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: failure to achieve expected utilization rates, billing rates, and the number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under Item 1A. "Risk“Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2016 and under Part II, Item 1A. "Risk Factors" in this Quarterly Report on Form 10-Q,2018 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.
OVERVIEW
Our Business
Huron is a global professional services firm committed to achieving sustainable results in partnership with clients. We bring a depth of expertise in strategy, technology, operations, advisory services,consultancy that helps clients drive growth, enhance performance and analytics to drive lasting and measurable resultssustain leadership in the healthcare, higher education, life sciencesmarkets they serve. We partner with clients to develop strategies and commercial sectors. Through focus, passion and collaboration, we provide guidance andimplement solutions that enable the transformative change our clients need to support organizations as they contend with the changes transformingown their industries and businesses.future.
We provide professional services through three operating segments: Healthcare, Education,Business Advisory, and Business Advisory.Education.
Healthcare
Our Healthcare segment provides advisory services - from strategy setting through implementation -has a depth of expertise in the areas of organizational and resource alignment, clinicalcare transformation, financial and operational performance, patientexcellence, technology and caregiver engagement,analytics, and technology implementation and optimization.leadership development. We serve national and regional hospitals and integrated health systems, academic medical centers, community hospitals, and medical groups. Our solutions help clients evolve and adapt to the rapidly changing healthcare environment and achieve growth, optimize performance, enhance profitability, improve quality and clinical outcomes, align leaders, improve organizational culture, and drive physician, patient, and employee engagement across the enterprise.enterprise to deliver better consumer outcomes.
Education
We help organizations transform and innovate their delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health. Our Education segment provides management consulting and technology solutions to higher education institutions and academic medical centers. Weconsultants partner with clients to address challenges relatinghelp build and sustain today’s business to businessinvest in the future by reducing complexity, improving operational efficiency and growing market share. We enable the healthcare of the future by identifying, integrating and optimizing technology strategy, financial management,investments to collect data that transforms care delivery and improves patient outcomes. We also develop future leaders capable of driving meaningful operational and organizational effectiveness, research administration,change and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student lifecycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our technology strategy, enterprise applications, and analytic solutionswho transform and optimize operations, deliver time and cost savings, and enhance the studentconsumer experience. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance.

28

Table of Contents




Business Advisory
Our Business Advisory segment provides services to large and middle market and large organizations, not-for-profit organizations, lending institutions, law firms, investment banks and private equity firms. We assist clients in a broad range of industries and across the spectrum from healthy, well-capitalized companies to organizations in transition, as well as creditors, equity owners, and other key constituents. Our Business Advisory professionals resolve complex business issues and enhance client enterprise value through a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Enterprise Solutions and Analytics professionals deliver technology and analytic solutions that enable organizations to manage and optimize their financial performance, operational efficiency, and client or stakeholder experience. Our expertise in full-service enterprise performance management (EPM), enterprise resource planning (ERP), business intelligence and analytics, customer relationship management (CRM), and data management services helps clients identify and execute on business and technology strategies to drive results and gain a competitive advantage. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals providestrategic solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.
Segment Reorganization
During the second quarter
26

Table of 2017, we reorganized our internalContents




Education
Our Education segment provides consulting and technology solutions to higher education institutions and academic medical centers. We partner with clients to address challenges relating to business and technology strategy, financial reporting structure, which management, uses to assess performance and allocate resources, by moving our Life Sciences practice from the Education and Life Sciences segment to the Business Advisory segment. The remaining Education and Life Sciences segment is now referred to as the Education segment. While our consolidated results have not been impacted, we have restated our historical segment information for consistent presentation.
Acquisitions
ADI Strategies, Inc. (International)
On April 1, 2017, we completed our acquisition of the international assets of ADI Strategies, Inc. ("ADI Strategies") in Dubai and India. We acquired the U.S. assets of ADI Strategies in the second quarter of 2016. ADI Strategies is a leading enterprise performance management, risk management and business intelligence firm. The acquisition strengthens our technology and analytics competencies and expands our global reach. The international results of operations of ADI Strategies have been included in our consolidated financial statements and results of operations of our Business Advisory segment from the date of acquisition.
Innosight Holdings, LLC
On March 1, 2017, we completed our acquisition of Innosight Holdings, LLC ("Innosight"), a growth strategy firm focused on helping companies navigate disruptive change, enable innovation, and manage strategic transformation. Together with Innosight, we use our strategic, operational and organizational effectiveness, research administration, and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student life cycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes. Our technology capabilities to help clients across multiple industries develop pioneeringstrategy, enterprise applications, and analytic solutions to address disruptiontransform and achieve sustained growth. Innosight's results ofoptimize operations, have been included in our consolidated financial statementsdeliver time and results of operations of our Business Advisory segment fromcost savings, and enhance the date of acquisition.
Pope Woodhead and Associates Limited
On January 9, 2017, we completed our acquisition of Pope Woodhead and Associates Limited ("Pope Woodhead"), a U.K.-based consulting firm providing market access capabilities tostudent experience. Our research enterprise solutions assist clients in developing value propositions for innovative medicinesidentifying and technologies. The acquisition expands our life sciencesimplementing institutional research strategy, expertiseoptimizing clinical research operations, improving financial management and strengthens our abilitycost reimbursement, improving service to lead clients through complex payerfaculty, and regulatory environments. Pope Woodhead's resultsmitigating risk compliance.
Huron is a Platinum level member of operations have been included in our consolidated financial statementsthe Oracle PartnerNetwork, an Oracle Cloud Premier Partner within North America, a Workday Services Partner, and results of operations of our Business Advisory segment from the date of acquisition.
See Note 5 "Acquisitions" within our consolidated financial statements for further information regarding our recent acquisitions.
Divestiture
Life Sciences Compliance and Operations
During the second quarter of 2017, we divested our Life Sciences Compliance and Operations practice ("Life Sciences C&O"), which was part of our broader Life Sciences practice within the Business Advisory segment. The sale of Life Sciences C&O did not meet the criteria for reporting separately as discontinued operations.

29

Table of Contents




a Gold level consulting partner with Salesforce.com.
How We Generate Revenues
A large portion of our revenues is generated by our full-time consultants who provide consulting services to our clients and are billable to our clients based on the number of hours worked. A smaller portion of our revenues is generated by our other professionals, also referred to as full-time equivalents, some of whom work variable schedules as needed by our clients. Full-time equivalent professionals consist of our cultural transformation consultants from our Studer Group solution, which includeleadership coaches and their support staff from our Healthcare Leadership solution, specialized finance and operational consultants, and our employees who provide software support and maintenance services to our clients. We translate the hours that these other professionals work on client engagements into a full-time equivalent measure that we use to manage our business. We refer to our full-time consultants and other professionals collectively as revenue-generating professionals.
Revenues generated by our full-time consultants are primarily driven by the number of consultants we employ and their utilization rates, as well as the billing rates we charge our clients. Revenues generated by our other professionals, or full-time equivalents, are largely dependent on the number of consultants we employ, their hours worked, and billing rates charged. Revenues generated by our leadership coaches are largely dependent on the number of coaches we employ and the total value, scope, and terms of the consulting contracts under which they provide services, which are primarily fixed-fee contracts.
We generate our revenues from providing professional services under four types of billing arrangements: fixed-fee (including software license revenue), time-and-expense, performance-based,; time-and-expense; performance-based; and software support, and maintenance and subscriptions.
In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. In these engagements, itIt is the client’s expectation in these engagements that the pre-established fee will not be exceeded except in mutually agreed upon circumstances. We generally recognize revenues under fixed-fee billing arrangements using a proportionate performance approach, which is based on work completed to dateto-date versus our estimates of the total services to be provided under the engagement. Contracts within our Studer GroupHealthcare Leadership solution areinclude fixed-fee partner contracts with multiple deliverables,performance obligations, which primarily consist of coaching services, as well as speaking engagements, conferences, materialspublications and software products (“Partner Contracts”). Revenues for coaching services and software products are generally recognized on a straight-line basis over the length of the contract. All other revenues under Partner Contracts, including speaking engagements, conferences and publications, are recognized at the time the service isgoods or services are provided.
Fixed-fee arrangements also include software licenses for our revenue cycle management software and research administration and compliance software. Licenses for our revenue cycle management software are sold only as a component of our consulting projects, and the services we provide are essential to the functionality of the software. Therefore, revenues from these software licenses are recognized over the term of the related consulting services contract. License revenue from our research administration and compliance software is generally recognized in the month in which the software is delivered.
Fixed-fee engagements represented 46.5%46.7% and 44.5%47.3% of our revenues for the three months ended September 30, 20172019 and 2016,2018, respectively, and 45.9%46.5% and 48.5%47.7% of our revenues for the nine months ended September 30, 20172019 and 2016,2018, respectively.
Time-and-expense billing arrangements require the client to pay based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include certain speaking engagements, conferences and publications purchased by our clients outside of Partner Contracts within our Studer GroupHealthcare Leadership solution. We recognize revenues under time-and-expense billing arrangements as the related services or publications are provided. Time-and-expense engagements represented 43.9%39.7% and 42.2%43.1% of our revenues for the three months ended September 30, 20172019 and 2016,2018, respectively, and 44.4%40.0% and 37.6%41.6% of our revenues for the nine months ended September 30, 20172019 and 2016,2018, respectively.
In performance-based fee billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a

27

Table of Contents




result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we have performance-based engagements in which we earn a success fee when and if certain predefined outcomes occur. Often, performance-based fees supplement our time-and-expensefixed-fee or fixed-feetime-and-expense engagements. We do not recognize revenues under performance-based billing arrangements until all relatedby estimating the amount of variable consideration that is probable of being earned and recognizing that estimate over the length of the contract using a proportionate performance criteria are met.approach. Performance-based fee revenues represented 4.0%8.2% and 8.2%4.2% of our revenues for the three months ended September 30, 20172019 and 2016,2018, respectively, and 4.4%8.2% and 9.1%5.2% of our revenues for the nine months ended September 30, 20172019 and 2016,2018, respectively. Performance-based fee engagementsThe level of performance-based fees earned may cause significant variations in quarterly revenuesvary based on our clients' risk sharing preferences and operating results depending on the timingmix of achieving the performance-based criteria.services we provide.
Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from our cloud-based analytic tools and solutions. Software support, and maintenance and subscription revenues are recognized ratably over the support or subscription period, which ranges from one to three years.period. These fees are billed in advance and included in deferred revenues until recognized. Software support, and maintenance and subscription revenues represented

30

Table of Contents




5.6% and 5.1% 5.4% of our revenues for both the three months ended September 30, 20172019 and 2016, respectively,2018, and 5.3% and 4.8%5.5% of our revenues for the nine months ended September 30, 20172019 and 2016,2018, respectively.
Our quarterly results are impacted principally by our full-time consultants’ utilization rate, the bill rates we charge our clients, and the number of our revenue-generating professionals who are available to work, and the amount of performance-based fees recognized, which often vary significantly between quarters.work. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.
Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.
Business Strategy, Opportunities and Challenges
Our primary strategy is to meet the needs of our clients by providing a balanced portfolio of service offerings and capabilities so that we can adapt quickly and effectively to emerging opportunities in the marketplace. To achieve this, we continue to hire highly qualified professionals and have entered into select acquisitions of complementary businesses.
To expand our business, we will remain focused on growing our existing relationships and developing new relationships, executing our managing director compensation plan to attract and retain senior practitioners, continuing to promote and provide an integrated approach to service delivery, broadening the scope of our existing services, and acquiring complementary businesses. We will regularly evaluate the performance of our practices to ensure our investments meet these objectives. Furthermore, we intend to enhance our visibility in the marketplace by refining our overarching messaging and value propositions for the organization as well as each practice. We will continue to focus on reaching our client base through clear, concise, and endorsed messages.


3128

Table of Contents








RESULTS OF OPERATIONS
The following table sets forth, for the periods indicated, selected segment and consolidated operating results and other operating data. The results
Segment and Consolidated Operating Results
(in thousands, except per share amounts):
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 2019 2018 2019 2018
Healthcare:        
Revenues $100,000
 $90,417
 $295,621
 $271,812
Operating income $32,863
 $26,640
 $94,058
 $78,172
Segment operating income as a percentage of segment revenues 32.9% 29.5% 31.8% 28.8%
Business Advisory:        
Revenues $62,519
 $57,175
 $183,602
 $170,790
Operating income $11,942
 $11,815
 $32,997
 $35,031
Segment operating income as a percentage of segment revenues 19.1% 20.7% 18.0% 20.5%
Education:        
Revenues $56,770
 $50,856
 $165,265
 $147,069
Operating income $14,413
 $15,014
 $43,235
 $37,694
Segment operating income as a percentage of segment revenues 25.4% 29.5% 26.2% 25.6%
Total Company:        
Revenues $219,289
 $198,448
 $644,488
 $589,671
Reimbursable expenses 23,636
 21,296
 65,787
 59,648
Total revenues and reimbursable expenses $242,925
 $219,744
 $710,275
 $649,319
Statements of Operations reconciliation:        
Segment operating income $59,218
 $53,469
 $170,290
 $150,897
Items not allocated at the segment level:        
Other operating expenses 32,310
 30,460
 105,369
 94,585
Litigation and other losses (gains), net (630) 887
 (1,571) (4,990)
Depreciation and amortization 6,962
 8,561
 21,285
 26,281
Operating income 20,576
 13,561
 45,207
 35,021
Other expense, net (4,456) (3,921) (10,326) (19,767)
Income from continuing operations before taxes 16,120
 9,640
 34,881
 15,254
Income tax expense 2,414
 1,391
 7,256
 4,365
Net income from continuing operations $13,706
 $8,249
 $27,625
 $10,889
Earnings per share from continuing operations:        
Basic $0.62
 $0.38
 $1.26
 $0.50
Diluted $0.61
 $0.37
 $1.23
 $0.50



29

Table of operations for acquired businesses have been included in our results of operations since the date of their respective acquisition.Contents
During the second quarter of 2017, we reorganized our internal financial reporting structure by moving our Life Sciences practice from the Education and Life Sciences segment to the Business Advisory segment. The remaining Education and Life Sciences segment is now referred to as the Education segment. While our consolidated results have not been impacted, we have restated our historical segment information for consistent presentation.



Segment and Consolidated Operating Results
(in thousands, except per share amounts):
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 2017 2016 2017 2016
Healthcare:        
Revenues $79,582
 $103,425
 $261,261
 $323,531
Operating income $25,778
 $38,824
 $83,580
 $119,229
Segment operating income as a percentage of segment revenues 32.4% 37.5% 32.0% 36.9%
Education:        
Revenues $41,422
 $38,621
 $127,629
 $111,816
Operating income $7,762
 $10,896
 $31,772
 $31,474
Segment operating income as a percentage of segment revenues 18.7% 28.2% 24.9% 28.1%
Business Advisory:        
Revenues $55,372
 $41,354
 $157,753
 $112,801
Operating income $12,832
 $8,608
 $34,890
 $23,275
Segment operating income as a percentage of segment revenues 23.2% 20.8% 22.1% 20.6%
Total Company:        
Revenues $176,376
 $183,400
 $546,643
 $548,148
Reimbursable expenses 17,982
 19,093
 55,862
 54,636
Total revenues and reimbursable expenses $194,358
 $202,493
 $602,505
 $602,784
         
Segment operating income $46,372
 $58,328
 $150,242
 $173,978
Items not allocated at the segment level:        
Other operating expenses 29,448
 26,502
 92,643
 84,595
Other losses (gains), net 880
 494
 (222) 494
Depreciation and amortization 9,946
 8,092
 28,549
 23,064
Goodwill impairment charge (1)
 
 
 209,600
 
Total operating income (loss) 6,098
 23,240
 (180,328) 65,825
Other expense, net (3,950) (3,687) (10,607) (11,034)
Income (loss) from continuing operations before income tax expense 2,148
 19,553
 (190,935) 54,791
Income tax expense (benefit) (1,984) 7,265
 (49,740) 19,498
Net income (loss) from continuing operations $4,132
 $12,288
 $(141,195) $35,293
Earnings (loss) per share from continuing operations:        
Basic $0.19
 $0.58
 $(6.59) $1.67
Diluted $0.19
 $0.57
 $(6.59) $1.65



32

Table of Contents




 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
Other Operating Data: 2017 2016 2017 2016 2019 2018 2019 2018
Number of full-time billable consultants (at period end) (2):
        
Number of full-time billable consultants (at period end) (1):
        
Healthcare 761
 1,010
 761
 1,010
 886
 829
 886
 829
Business Advisory 954
 775
 954
 775
Education 536
 466
 536
 466
 727
 618
 727
 618
Total 2,567
 2,222
 2,567
 2,222
Average number of full-time billable consultants (for the period) (1):
        
Healthcare 858
 821
 835
 802
Business Advisory 830
 545
 830
 545
 920
 735
 876
 761
Education 698
 607
 665
 579
Total 2,127
 2,021
 2,127
 2,021
 2,476
 2,163
 2,376
 2,142
Average number of full-time billable consultants (for the period) (2):
        
Full-time billable consultant utilization rate (2):
        
Healthcare 741
 984
 805
 1,005
 81.8% 81.2% 80.4% 81.6%
Business Advisory 72.0% 74.4% 72.7% 71.7%
Education 527
 447
 497
 425
 75.5% 77.3% 76.7% 76.8%
Business Advisory 779
 530
 710
 465
Total 2,047
 1,961
 2,012
 1,895
 76.3% 77.8% 76.5% 76.8%
Full-time billable consultant utilization rate (3):
        
Full-time billable consultant average billing rate per hour (3):
        
Healthcare 80.3% 77.0% 76.6% 78.6% $226
 $211
 $225
 $205
Business Advisory (4)
 $193
 $213
 $195
 $212
Education 70.9% 68.0% 73.6% 71.2% $197
 $205
 $200
 $203
Business Advisory 72.9% 73.5% 73.4% 72.4%
Total 75.0% 73.9% 74.7% 75.3%
Full-time billable consultant average billing rate per hour (4):
        
Healthcare $190
 $203
 $200
 $209
Education $210
 $220
 $215
 $217
Business Advisory $197
 $203
 $195
 $216
Total $197
 $207
 $202
 $212
Total (4)
 $206
 $210
 $207
 $207
Revenue per full-time billable consultant (in thousands):                
Healthcare $69
 $73
 $211
 $231
 $84
 $76
 $247
 $229
Business Advisory $65
 $74
 $202
 $214
Education $69
 $72
 $226
 $224
 $70
 $74
 $217
 $222
Business Advisory $67
 $72
 $212
 $229
Total $68
 $72
 $215
 $229
 $73
 $75
 $222
 $222
Average number of full-time equivalents (for the period) (5):
                
Healthcare 214
 204
 215
 201
 217
 228
 237
 215
Business Advisory 19
 28
 14
 23
Education 35
 40
 36
 37
 52
 40
 44
 41
Business Advisory 26
 25
 21
 19
Total 275
 269
 272
 257
 288
 296
 295
 279
Revenue per full-time equivalent (in thousands):                
Healthcare $134
 $156
 $427
 $456
 $128
 $123
 $375
 $409
Business Advisory $126
 $99
 $465
 $355
Education $138
 $158
 $419
 $436
 $151
 $149
 $480
 $447
Business Advisory $108
 $126
 $342
 $335
Total $132
 $154
 $420
 $444
 $132
 $124
 $395
 $410
(1)The non-cash goodwill impairment charge is not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance.
(2)Consists of our full-time professionals who provide consulting services and generate revenues based on the number of hours worked.
(3)(2)Utilization rate for our full-time billable consultants is calculated by dividing the number of hours all of our full-time billable consultants worked on client assignments during a period by the total available working hours for all of these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days.
(4)(3)Average billing rate per hour for our full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period.
(4)The Business Advisory segment includes operations of Huron Eurasia India. Absent the impact of Huron Eurasia India, the average billing rate per hour for the Business Advisory segment would have been $221 and $241 for the three months ended September 30, 2019 and 2018, respectively; and $220 and $242 for the nine months ended September 30, 2019 and 2018, respectively.
Absent the impact of Huron Eurasia India, Huron's consolidated average billing rate per hour would have been $216 and $218 for the three months ended September 30, 2019 and 2018, respectively; and $216 for both the nine months ended September 30, 2019 and 2018.
(5)Consists of cultural transformation consultants within our Studer Group solution, which includeleadership coaches and their support staff within the Healthcare Leadership solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.



3330

Table of Contents








Non-GAAP Measures
We also assess our results of operations using certain non-GAAP financial measures. These non-GAAP financial measures differ from GAAP because the non-GAAP financial measures we calculate to measure earnings (loss) before interest, taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income (loss) from continuing operations, and adjusted diluted earnings (loss) per share from continuing operations exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows, or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.
Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.
The reconciliations of these financial measures from GAAP to non-GAAP are as follows (in thousands, except per share amounts):
Three Months Ended
September 30,
 Nine Months Ended
September 30,
Three Months Ended
September 30,
 Nine Months Ended
September 30,
2017 2016 2017 20162019 2018 2019 2018
Revenues$176,376
 $183,400
 $546,643
 $548,148
$219,289
 $198,448
 $644,488
 $589,671
Net income (loss) from continuing operations$4,132
 $12,288
 $(141,195) $35,293
Net income from continuing operations$13,706
 $8,249
 $27,625
 $10,889
Add back:              
Income tax expense (benefit)(1,984) 7,265
 (49,740) 19,498
Income tax expense2,414
 1,391
 7,256
 4,365
Interest expense, net of interest income4,880
 4,176
 13,811
 12,270
4,374
 4,628
 13,156
 14,636
Depreciation and amortization12,603
 12,144
 36,937
 34,342
8,124
 9,570
 24,735
 29,476
Earnings (loss) before interest, taxes, depreciation and amortization (EBITDA)19,631
 35,873

(140,187) 101,403
Earnings before interest, taxes, depreciation and amortization (EBITDA)28,618
 23,838

72,772
 59,366
Add back:              
Restructuring charges1,347
 1,049
 5,295
 4,129
127
 (31) 2,156
 2,665
Other losses (gains), net880
 494
 (222) 494
Goodwill impairment charge
 
 209,600
 
Gain on sale of business
 
 (931) 
Foreign currency transaction losses (gains), net(385) 84
 (449) (270)
Litigation and other losses (gains), net(630) 887
 (1,571) (4,990)
Loss on sale of business
 32
 
 5,863
Transaction-related expenses563
 
 2,613
 
Foreign currency transaction losses, net114
 9
 36
 196
Adjusted EBITDA$21,473
 $37,500

$73,106
 $105,756
$28,792
 $24,735

$76,006
 $63,100
Adjusted EBITDA as a percentage of revenues12.2% 20.4%
13.4% 19.3%13.1% 12.5%
11.8% 10.7%


3431

Table of Contents








Three Months Ended
September 30,
 Nine Months Ended
September 30,
Three Months Ended
September 30,
 Nine Months Ended
September 30,
2017 2016 2017 20162019 2018 2019 2018
Net income (loss) from continuing operations$4,132
 $12,288
 $(141,195) $35,293
Net income from continuing operations$13,706
 $8,249
 $27,625
 $10,889
Weighted average shares - diluted21,622
 21,445
 21,413
 21,427
22,561
 22,110
 22,425
 21,947
Diluted earnings (loss) per share from continuing operations$0.19
 $0.57
 $(6.59) $1.65
Diluted earnings per share from continuing operations$0.61
 $0.37
 $1.23
 $0.50
Add back:              
Amortization of intangible assets8,834
 8,771
 26,432
 24,369
4,205
 5,934
 13,036
 18,233
Restructuring charges1,347
 1,049
 5,295
 4,129
127
 (31) 2,156
 2,665
Other losses (gains), net880
 494
 (222) 494
Goodwill impairment charge
 
 209,600
 
Litigation and other losses (gains), net(630) 887
 (1,571) (4,990)
Non-cash interest on convertible notes1,974
 1,883
 5,853
 5,582
2,171
 2,070
 6,436
 6,138
Gain on sale of business
 
 (931) 
Tax effect(5,100) (4,794) (70,362) (13,588)
Loss on sale of business
 32
 
 5,863
Transaction-related expenses563
 
 2,613
 
Tax effect of adjustments(1,673) (2,312) (5,909) (7,109)
Tax benefit related to the enactment of Tax Cut and Jobs Act of 2017
 (747) 
 (615)
Tax benefit related to "check-the-box" election(2,748) 
 (2,748) 
(736) 
 (736) 
Total adjustments, net of tax5,187
 7,403

172,917
 20,986
4,027
 5,833
 16,025
 20,185
Adjusted net income from continuing operations$9,319
 $19,691

$31,722
 $56,279
$17,733
 $14,082
 $43,650
 $31,074
Adjusted weighted average shares - diluted21,622
 21,445
 21,585
 21,427
Weighted average shares - diluted22,561
 22,110
 22,425
 21,947
Adjusted diluted earnings per share from continuing operations$0.43
 $0.92

$1.47
 $2.63
$0.79
 $0.64
 $1.95
 $1.42
These non-GAAP financial measures include adjustments for the following items:
Amortization of intangible assets: We have excluded the effect of amortization of intangible assets from the calculation of adjusted net income from continuing operations presented above. Amortization of intangiblesintangible assets is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.
Restructuring charges: We have incurred charges due to the restructuring of various parts of our business. These restructuring charges have primarily consisted of costs associated with office space consolidations, including thelease impairment charges and accelerated depreciation of certain leasehold improvements,on lease-related property and equipment, and severance charges. We have excluded the effect of the restructuring charges from our non-GAAP measures because the amount of each restructuring charge is significantly affected by the timing and size of the restructured business or component of a business.
OtherLitigation and other losses (gains), net: We have excluded the effects of litigation and other losses (gains), net which primarily consist of net remeasurement losses and gains related to contingent acquisition liabilities and the litigation settlement gain recorded in the second quarter of 2018 to permit comparability with periods that were not impacted by these items.
Goodwill impairment charge: We have excluded the effect of the goodwill impairment charge that occurred in the second quarter of 2017 as this is an infrequent event and its exclusion permits comparability with periods that were not impacted by such charge.
Non-cash interest on convertible notes: We incur non-cash interest expense relating to the implied value of the equity conversion component of our Convertible Notes. The value of the equity conversion component is treated as a debt discount and amortized to interest expense over the life of the Convertible Notes using the effective interest rate method. We exclude this non-cash interest expense that does not represent cash interest payments from the calculation of adjusted net income from continuing operations as management believes that this non-cash expense is not indicative of the ongoing performance of our business.
GainLoss on sale of business:We have excluded the effect of the gainloss on the sale of Life Sciences C&O, as management believes that this one-time gain related to the divestitureMiddle East practice within the Business Advisory segment in the second quarter of a business is2018. Divestitures of businesses are infrequent and are not indicative of the ongoing performance of our business.
Transaction-related expenses: To permit comparability with prior periods, we excluded the impact of transaction-related expenses for acquisitions, whether or not ultimately consummated, and which primarily relate to third-party legal and accounting fees. The transaction-related expenses incurred in the three and nine months ended September 30, 2019 primarily related to the evaluation of a potential acquisition that ultimately did not consummate.
Foreign currency transaction losses, (gains), net: We have excluded the effect of foreign currency transaction losses and gains from the calculation of adjusted EBITDA because the amount of each loss or gain is significantly affected by timing and changes in foreign exchange rates.
Tax effect:effect of adjustments: The non-GAAP income tax adjustment reflects the incremental tax impact applicable to the non-GAAP adjustments.
Tax benefit related to the enactment of Tax Cuts and Jobs Act of 2017 ("2017 Tax Reform"): We have excluded the impact of the 2017 Tax Reform, which was enacted in the fourth quarter of 2017. In the first quarter of 2018, we recorded an adjustment to our estimated one-time income tax expense related to the transition tax on accumulated foreign earnings; and in the third quarter of 2018, we recorded a U.S. federal return to provision

32

Table of Contents




adjustment related to 2017 Tax Reform items on our 2017 corporate tax return. The exclusion of the 2017 Tax Reform impact permits comparability with periods that were not impacted by this item.
Tax benefit related to "check-the-box" election: We have excluded the effectpositive impact of a tax benefit, recorded in the third quarter of 2017,2019, from recognizing a previously unrecognized tax benefit fromdue to the expiration of statute of limitations on our "check-the-box" election made in 20142015 to treat one of ourcertain wholly-owned foreign subsidiaries as a disregarded entityentities for U.S. federal income tax purposes. The exclusion of this discrete tax benefit permits comparability with periods that were not impacted by this item. Refer to Note 13 “Income Taxes”"Income Taxes" within the notes to the consolidated financial statements for additional information.

35

Table of Contents




Income tax expense, Interest expense, net of interest income, Depreciation and amortization: We have excluded the effects of income tax expense, interest expense, net of interest income, and depreciation and amortization in the calculation of EBITDA as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items.
Adjusted weighted average shares - diluted: As we reported a net loss for the nine months ended September 30, 2017, GAAP diluted weighted average shares outstanding equals the basic weighted average shares outstanding for that period. For the nine months ended September 30, 2017, the non-GAAP adjustments described above resulted in an adjusted net income from continuing operations. Therefore, we included the dilutive common stock equivalents in the calculation of adjusted diluted weighted average shares outstanding for that period.
Three Months Ended September 30, 20172019 Compared to Three Months Ended September 30, 20162018
Revenues
Revenues decreased $7.0increased $20.8 million, or 3.8%10.5%, to $176.4$219.3 million for the third quarter of 20172019 from $183.4$198.4 million for the third quarter of 2016. Third quarter 20172018. Of the overall $20.8 million increase in revenues, included $13.4$19.5 million was attributable to an increase in revenues from our acquisitionsfull-time billable consultants and $1.3 million was attributable to an increase in revenues from our full-time equivalents.
The increase in full-time billable consultant revenues reflected strengthened demand for services in all of Innosightour segments, as discussed below in Segment Results, and Pope Woodhead, which were completed subsequentwas primarily attributable to an increase in the average number of billable consultants, partially offset by a decrease in the consultant utilization rate and average billing rate for the third quarter of 2016, as well as revenues from our acquisition of the international assets of ADI Strategies, which was also completed subsequent2019 compared to the third quarter of 2016 and has since been fully integrated into the Business Advisory segment. Third quarter 2017 revenues also included an incremental $1.7 million of revenue from our acquisition of Healthcare Services Management, Inc. ("HSM Consulting"), which was completed mid-third quarter 2016.
Of the overall $7.0 million decrease in revenues, $5.3 million was attributable to our full-time equivalents and $1.7 million was attributable to our full-time billable consultants.same prior year period.
The decreaseincrease in full-time equivalent revenues was primarily attributable to a decrease in revenue from our Studer Group solution within our Healthcare segment and a decrease in license revenue in our Education segment, as discussed below in Segment Results.
The decreaseResults; and reflected an increase in revenue per full-time billable consultant revenues reflectedequivalent; partially offset by a decrease in the average billing ratenumber of full-time equivalents for the third quarter of 2017, partially offset by increases in2019 compared to the average number of billable consultants and consultant utilization rate. As discussed below in Segment Results, this decrease in revenue attributable to our full-time billable consultants reflected decreased demand for our services in the Healthcare segment, largely offset by revenues from our acquisitions of Innosight and Pope Woodhead, as well as strengthened demand for our services in the Business Advisory and Education segments.same prior year period.
Total Direct Costs
Our total direct costs, including amortization of intangible assets and software development costs, increased $4.0$14.6 million, or 3.6%11.3%, to $116.4$144.2 million in the three months ended September 30, 2017,2019, from $112.4$129.6 million in the three months ended September 30, 2016.2018. The $4.0$14.6 million increase primarily related to a $2.1$9.9 million increase in salaries and related expenses for our revenue-generating professionals, which was largely driven by increased headcount from acquisitions and our ongoing cloud-based enterprise resource planning (ERP) investment, partially offset by a decrease in salaries and related expenses in our Healthcare segment asBusiness Advisory and Education segments; a result of headcount reductions. Additional increases included a $1.1 million increase in contractor expense, a $0.9 million increase in signing and retention bonuses for our revenue-generating professionals, a $0.6$3.7 million increase in performance bonus expense for our revenue-generating professionals,professionals; and a $0.5$1.5 million increase in share-based compensation expense for our revenue-generating professionals. All of theseThese increases were partially offset by a $1.4$0.5 million decrease in amortization of intangible assets.signing, retention and other bonus expense for our revenue-generating professionals. As a percentage of revenues, our total direct costs increased to 66.0%65.8% during the third quarter of 20172019 compared to 61.3%65.3% during the third quarter of 2016,2018, primarily due to the items described above.increases in performance bonus expense and share-based compensation expense for our revenue-generating professionals, as percentages of revenues, partially offset by the decrease in signing, retention and other bonus expense for our revenue-generating professionals and revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals.
Total direct costs for the three months ended September 30, 20172019 included $2.7$1.2 million of amortization expense for intangible assets, primarily representing customer contracts and software acquired in business combinations, and internal software development costs and intangible assets, compared to $4.1$1.0 million of amortization expense for the same prior year period. The $1.4$0.2 million decreaseincrease in amortization expense was primarily attributable to an increase in amortization for internal software development costs. Intangible asset amortization included within direct costs for the decreasing amortization expense ofthree months ended September 30, 2019 and 2018 primarily related to technology and software, certain customer relationships and customer contracts acquired in connection with our Studer Group acquisition, due to the accelerated basis of amortization.business acquisitions. See Note 5 "Acquisitions" and Note 64 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information abouton our intangible assets.

36

Table of Contents




Operating Expenses and Other Gains,Losses (Gains), Net
Selling, general and administrative expenses increased $3.3by $2.2 million, or 8.7%4.8%, to $41.6$48.1 million in the third quarter of 20172019 from $38.3$45.9 million in the third quarter of 2016. Selling, general and administrative expenses for the third quarter of 2017 included $3.9 million from Innosight and Pope Woodhead.2018. The overall $3.3$2.2 million increase primarily related to a $1.9$1.2 million increase in salaries and related expensesshare-based compensation expense for our support personnel,personnel; a $0.9$1.0 million increase in facilitiescomputer and other office-related expenses,related equipment expenses; and a $0.7$0.6 million increase in third-party consulting expenses, and a $0.5 million increase in travel related expenses,legal expenses. These increases were partially offset by a $1.1$0.8 million decrease in practice administrationtravel and meetingsentertainment expenses. As a percentage of revenues, selling, general and administrative expenses increaseddecreased to 23.6%21.9% during the third quarter of 20172019 compared to 20.9%23.1% during the third quarter of 2016,2018. This decrease was primarily dueattributable to revenue growth that outpaced an increase in salaries and related expenses for our support personnel, as well as decreases in travel and entertainment expenses and facilities expense. These decreases were partially offset by the items described above.increases in share-based compensation expense for our support personnel and computer and related equipment expenses, as percentages of revenues.
Restructuring charges for the third quarter of 2017 totaled $1.32019 were $0.1 million comparedand netted to $1.0 millionan immaterial amount for the third quarter of 2016. The $1.32018.The $0.1 million charge recognized in the third quarter of 2019 primarily related to workforce reductions as we continue to better align resources with market demand.

33

Table of Contents




The restructuring charges incurred in the third quarter of 2017 primarily related to2018 consisted of a $0.3 million decrease in the accrual of remaining lease obligations,payments, net of estimated sublease income, due to relocatingas a result of updated lease assumptions for our San Francisco office to a smaller space and consolidating our New York officesvacated in the third quarter of 2017, which was accounted for in accordance with ASC 840, Leases; and accelerated depreciation on leasehold improvements for our San Francisco office. The $1.0a net $0.2 million charge incurred in the third quarter of 2016 primarily related to updated lease assumptions of our Washington, D.C. space vacated in the fourth quarter of 2014. workforce reductions to better align resources with market demand. See Note 9 "Restructuring Charges" within the notes to our consolidated financial statements for further discussion ofadditional information on our restructuring expenses.charges.
OtherLitigation and other losses (gains), net totaled $0.9a gain of $0.6 million for the three months ended September 30, 2017,third quarter of 2019, and represents losses dueconsisted of remeasurement gains to decrease the increase in theestimated fair value of the liabilityour liabilities for future expected contingent consideration payments related to acquisitions. Ina business acquisition. Litigation and other losses (gains), net totaled a net loss of $0.9 million for the third quarter of 2016, we recognized $0.5 million2018, and consisted of net remeasurement losses forto increase the increase in theestimated fair value of the contingent consideration liability.liabilities. In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. See Note 11 "Fair Value of Financial Instruments" within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities.
Depreciation and amortization expense increased by $1.9decreased $1.6 million, or 18.7%, to $9.9$7.0 million in the three months ended September 30, 2017 from $8.12019 compared to $8.6 million in the three months ended September 30, 2016.2018. The increase$1.6 million decrease in depreciation and amortization expense was primarily attributable to an increase indecreasing amortization expense for intangible assetsof the trade name and customer relationships acquired in the Innosight and Pope Woodhead acquisitions, which were completed subsequentour Studer Group acquisition, due to the third quarteraccelerated basis of 2016, and an increaseamortization in amortization expense for a customer-related intangible assetprior periods, as well as certain customer relationships acquired in the Studer Group acquisition.other business acquisitions that were fully amortized in prior periods. Intangible asset amortization expense included within operating expenses primarily relatesrelated to certain customer relationships, trade names, and non-competition agreements and trade names acquired in connection with our business acquisitions. See Note 5 "Acquisitions" and Note 64 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information abouton our intangible assets.
Operating Income
Operating income decreased $17.1increased $7.0 million to $6.1$20.6 million in the third quarter of 20172019 from $23.2$13.6 million in the third quarter of 2016.2018. Operating margin, which is defined as operating income expressed as a percentage of revenues, decreased to 3.5%was 9.4% in the three months ended September 30, 2017,2019, compared to 12.7%6.8% in the three months ended September 30, 2016.2018. The decreaseincrease in operating margin was primarily attributable to increasesthe decrease in intangible asset amortization, revenue growth that outpaced the increase in salaries and related expenses for both our revenue-generating professionals and support personnel, contractor expense, facilitiesand the decrease in litigation and other office-related expenses, signinglosses (gains), net; partially offset by the increases in performance bonus expense and retention bonuses for our revenue-generating professionals, and performance bonusshare-based compensation expense for our revenue-generating professionals, for the third quarteras percentages of 2017 compared to the same prior year period.revenues.
Other Expense, Net
Total other expense, net increased by $0.3$0.5 million to $4.0$4.5 million in the third quarter of 20172019 from $3.7$3.9 million in the third quarter of 2016.2018. The increase in total other expense, net was primarily attributable to the immaterial gain recognized during the first nine months of 2019 for the market value of our investments that are used to fund our deferred compensation liability, compared to a gain of $0.7 million increaserecognized during the third quarter of 2018, partially offset by a decrease in interest expense, net of interest income which was due to higher levels of borrowings and higher interest rates under our credit facility duringrecognized in the third quarter of 20172019 compared to the third quarter of 2016. This increase was partially offset by $0.42018. Interest expense, net of interest income decreased $0.3 million of net foreign currency transaction gainsto $4.4 million in the third quarter of 2017 compared to $0.12019 from $4.6 million of net foreign currency transaction losses in the third quarter of 2016.2018. The decrease in interest expense was due to lower levels of borrowing under our credit facility, partially offset by higher interest rates during the third quarter of 2019 compared to the third quarter of 2018.
Income Tax Expense (Benefit)
For the three months ended September 30, 2017,2019, our effective tax rate was (92.4)% as we recognized income tax benefit from continuing operations of $2.0 million on income from continuing operations of $2.1 million. For the third quarter of 2016, our effective tax rate was 37.2%15.0% as we recognized income tax expense from continuing operations of $7.3$2.4 million on income from continuing operations of $19.6$16.1 million. The effective tax rate for the three months ended September 30, 2017of 15.0% was more favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to recognizing a $2.7discrete tax benefit of $0.7 million for U.S. federal return to provision adjustments related to the 2018 corporate income tax return, which had a favorable impact of 4.6% on the effective tax rate. In addition, we recognized a $0.7 million discrete tax benefit related to a previously unrecognized tax benefit fromdue to the expiration of statute of limitations on our "check-the-box" election made in 20142015 to treat one of ourcertain wholly-owned foreign subsidiaries as a

37

Table of Contents




disregarded entityentities for U.SU.S. federal income tax purposes. This benefit was partially offset by $0.6 million of tax expense recorded in the third quarter of 2017 to correct an error that occurred in the second quarter of 2017. During the third quarter of 2017, we also recordedpurposes, which had a $3.1 million adjustment to decrease deferred income taxes, net and increase income tax receivable on our consolidated balance sheet to correct an error that occurred in the second quarter of 2017. These errors have no impact on full year 2017 results, and we concluded that thefavorable impact of both errors was not material to4.6% on the second and third quarter financial statements. The effective tax rate forrate. For the three months ended September 30, 20162018, our effective tax rate was lower14.4% as we recognized income tax expense from continuing operations of $1.4 million on income from continuing operations of $9.6 million. The effective tax rate of 14.4% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to non-taxablea discrete tax benefit of $0.8 million for U.S. federal return to provision adjustments related to the 2017 corporate income valuation allowance reductions, and certain credits and deductions, partially offset by non-deductible business expenses.tax return, which had a favorable impact of 8.6% on the effective tax rate. In addition, the third quarter of 2018 included a discrete tax benefit of $0.4 million for foreign return to provision adjustments, which had a favorable impact of 3.7% on the effective tax rate.

34

Table of Contents




Net Income from Continuing Operations
Net income from continuing operations decreased by $8.2increased $5.5 million to $4.1$13.7 million for the three months ended September 30, 2017,2019 from $12.3$8.2 million for the same period last year. As a result of the decreaseincrease in net income from continuing operations, diluted earningsincome per share from continuing operations for the third quarter of 20172019 was $0.19$0.61 compared to $0.57$0.37 for the third quarter of 2016.2018.
Discontinued OperationsEBITDA and Adjusted EBITDA
Net income from discontinued operations was $0.2EBITDA increased $4.8 million to $28.6 million for the three months ended September 30, 2017 and related to updated lease assumptions for vacated office space directly related to the sale of the Huron Legal segment. See Note 4 "Discontinued Operations" within the notes to our consolidated financial statements for additional information about our discontinued operations.
EBITDA and Adjusted EBITDA
EBITDA decreased $16.2 million to $19.62019 from $23.8 million for the three months ended September 30, 2017 from $35.9 million for the three months ended September 30, 2016.2018. Adjusted EBITDA decreased $16.0increased $4.1 million to $21.5$28.8 million in the third quarter of 20172019 from $37.5$24.7 million in the third quarter of 2016.2018. The decreaseincreases in EBITDA and adjusted EBITDA waswere primarily dueattributable to the decrease in segment operating income, as discussed below in Segment Results, as well as an increase in corporaterevenues for the third quarter of 2019 compared to the third quarter of 2018, partially offset by the increases in selling, general and administrative expenses, primarily due tosalaries and related expenses for our acquisitions of Innosightrevenue-generating professionals, and Pope Woodhead.performance bonus expense for our revenue-generating professionals.
Adjusted Net Income from Continuing Operations
Adjusted net income from continuing operations decreased $10.4increased $3.7 million to $9.3$17.7 million in the third quarter of 20172019 compared to $19.7$14.1 million in the third quarter of 2016.2018. As a result of the decreaseincrease in adjusted net income from continuing operations, adjusted diluted earnings per share from continuing operations was $0.43$0.79 for the third quarter of 2017,2019, compared to $0.92$0.64 for the third quarter of 2016.2018.
Segment Results
Healthcare
Revenues
Healthcare segment revenues decreased $23.8increased $9.6 million, or 23.1%10.6%, to $79.6$100.0 million for the third quarter of 20172019 from $103.4$90.4 million for the third quarter of 2016. Revenues for the third quarter of 2017 included an incremental $1.7 million from our acquisition of HSM Consulting, which was completed mid-third quarter 2016.2018.
During the three months ended September 30, 2017,2019, revenues from fixed-fee engagements,engagements; time-and-expense engagements,engagements; performance-based arrangements,arrangements; and software support, and maintenance and subscription arrangements represented 68.5%65.6%, 16.6%12.3%, 6.7%16.3%, and 8.2%5.8% of this segment’s revenues, respectively, compared to 67.0%66.8%, 13.4%17.4%, 13.4%9.3%, and 6.2%6.5% of this segment’s revenues, respectively, for the same prior year period.
Of the overall $23.8 million decrease in revenues, $20.4 million was attributable to a decrease in revenue from our full-time billable consultants and $3.4 million was attributable to a decrease in revenue generated by our full-time equivalents.
The decrease in revenue attributable to our full-time billable consultants reflected decreases in the average number of full-time billable consultants and the average billing rate, partially offset by an increase in the consultant utilization rate. This decrease in revenue was primarily driven by a decreased demand for our performance improvement solution. Performance-based fee revenue was $5.3$16.3 million duringfor the third quarter of 20172019 compared to $13.8$8.4 million duringfor the third quarter of 2016.2018. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide. Performance-based fee arrangements may also cause significant variations
The overall $9.6 million increase in revenues operating results, and average billing rates duewas attributable to an increase in revenues from our level of execution and the timing of achievement of the performance-based criteria.

38

Table of Contents




full-time billable consultants. The decreaseincrease in revenuerevenues attributable to our full-time equivalents was primarily driven by a decreased demand for our Studer Group solution andbillable consultants reflected a decreaseincreases in revenue per full-time equivalent, partially offset by an increase inthe average billing rate, the average number of full-time equivalents.billable consultants and the consultant utilization rate in the third quarter of 2019 compared to the same prior year period.
Operating Income
Healthcare segment operating income decreased $13.0increased $6.2 million, or 33.6%23.4%, to $25.8$32.9 million for the three months ended September 30, 20172019 from $38.8$26.6 million for the three months ended September 30, 2016.2018. The Healthcare segment operating margin, defined as segment operating income expressed as a percentage of segment revenues, decreasedincreased to 32.4%32.9% for the third quarter of 20172019 from 37.5%29.5% in the same period last year. The decreaseincrease in this segment’s operating margin was primarily attributable to anrevenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals and support personnel, as well as decreases in contractor expense and restructuring charges; partially offset by an increase in performance bonus expense and share-based compensation expense for our revenue-generating professionals, as a percentage of revenues, as well as increases in contractor expenses, product and event costs, and signing and retention bonus expense for our revenue-generating professionals. These decreases to the operating margin are partially offset by decreases in performance bonus expense for our revenue-generating professionals, practice administration and meetings expenses, and intangible asset amortization expense, all as a percentage of revenues.
EducationBusiness Advisory
Revenues
EducationBusiness Advisory segment revenues increased $2.8$5.3 million, or 7.3%9.3%, to $41.4$62.5 million for the third quarter of 20172019 from $38.6$57.2 million for the third quarter of 2016.2018.
During the three months ended September 30, 2017,2019, revenues from fixed-fee engagements,engagements; time-and-expense engagements,engagements; performance-based arrangements; and software support, and maintenance and subscription arrangements represented 16.2%38.9%, 78.1%56.3%, 2.6%, and 5.7%2.2% of this segment’s revenues, respectively. During the three months ended September 30, 2016,2018, revenues from fixed-fee engagements,engagements; time-and-expense engagements, performance-based arrangements,engagements; and software support, and maintenance and subscription arrangements represented 12.2%42.2%, 80.4%, 1.6%56.3%, and 5.8%1.5% of this segment’ssegment's revenues, respectively.respectively, for the same prior year period. Performance-based fee revenue was $1.6 million for the third quarter of 2019 and was immaterial for the third quarter of 2018. The level of performance-based fees earned may vary based on our clients’ preferences and the mix of services we provide.

35

Table of Contents




Of the overall $2.8$5.3 million increase in revenues, $4.3$5.8 million was attributable to an increase in revenues from our full-time billable consultants, which wasconsultants; partially offset by a $1.5$0.4 million decrease in revenue attributable torevenues generated by our full-time equivalents. The increase in revenue attributable torevenues from our full-time billable consultants reflected increasesan increase in the average number of billable consultants, partially offset by decreases in the average billing rate and the consultant utilization rate in the third quarter of 2019 compared to the same prior year period. The decrease in revenues generated by our full-time equivalents was driven by a decreased use of contractors; and reflected a decrease in the average number of full-time billable consultants and the consultant utilization rate,equivalents, partially offset by a decreasean increase in the average billing rate. The decrease in revenue from our full-time equivalents was largely driven by a decrease in license revenues, and reflected decreases in both revenue per full-time equivalent and the average number of full-time equivalents in the third quarter of 20172019 compared to the same prior year period.
Operating Income
EducationBusiness Advisory segment operating income decreased $3.1increased by $0.1 million, or 28.8%1.1%, to $7.8$11.9 million for the three months ended September 30, 20172019 from $10.9$11.8 million for the three months ended September 30, 2016. Segment2018. The Business Advisory segment operating margin decreased to 18.7%19.1% for the third quarter of 20172019 from 28.2%20.7% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to increases in salaries and related expenses, performance bonus expense and salaries and related expensesshare-based compensation expense for our revenue-generating professionals, as well as an increase in performance bonus expense for our support personnel, all as a percentagepercentages of revenues. The increase in bonus expense was primarily the result of a significant performance bonus adjustment in the third quarter of 2017 to increase our year-to-date performance bonus accrual due to a revised full year forecast. These increases wererevenues; partially offset by decreases in trainingsigning, retention and other bonus expense for our revenue-generating professionals, practice and administration expenses, and practice administration and meetings expenses.contractor expense.
Business AdvisoryEducation
Revenues
Business AdvisoryEducation segment revenues increased $14.0$5.9 million, or 33.9%11.6%, to $55.4$56.8 million for the third quarter of 20172019 from $41.4$50.9 million for the third quarter of 2016. Revenues for the third quarter of 2017 included $13.4 million from our acquisitions of Innosight and Pope Woodhead, which were completed subsequent to the third quarter of 2016. Third quarter 2017 revenues also included revenues from our acquisition of the international assets of ADI Strategies, which was completed in April 2017 and has since been fully integrated into the Business Advisory segment.2018.
During the three months ended September 30, 2017,2019, revenues from fixed-fee engagements,engagements; time-and-expense engagements, performance-based arrangements,engagements; and software support, and maintenance and subscription arrangements represented 37.5%21.9%, 57.7%, 3.0%69.9%, and 1.8%8.2% of this segment’s revenues, respectively, compared to 18.5%18.2%, 78.2%, 1.7%74.0%, and 1.6%7.8% of this segment’s revenues, respectively, for the same prior year period. Performance-based fee revenue was $1.7 million for the third quarter of 2017, compared to $0.7 million for the same prior year period. The level of performance-based fees earned may vary based on our clients’ preferences

39

Table of Contents




and the mix of services we provide. Performance-based fee arrangements may also cause significant variations in revenues, operating results, and average billing rates due to our level of execution and the timing of achievement of the performance-based criteria.
Of the overall $14.0$5.9 million increase in revenues, $14.4$4.1 million was attributable to our full-time billable consultants whichand $1.9 million was partially offset by a $0.4 million decrease in revenues attributable to our full-time equivalents. The increase in revenue fromrevenues attributable to our full-time billable consultants was primarily driven by our acquisitions of Innosight, Pope Woodhead, and the international assets of ADI Strategies, and reflected an increase in the average number of full-time billable consultants, partially offset by decreases in the average billing rate and the consultant utilization rate.rate in the third quarter of 2019 compared to the same prior year period. The decreaseincrease in revenuerevenues from our full-time equivalents reflected a decrease in revenue per full-time equivalent, partially offsetwas primarily driven by an increase in software and data hosting revenues; and reflected increases in the average number of full-time equivalents and revenue per full-time equivalent in the third quarter of 20172019 compared to the same prior year period.
Operating Income
Business AdvisoryEducation segment operating income increased by $4.2decreased $0.6 million, or 49.1%4.0%, to $12.8$14.4 million for the three months ended September 30, 20172019 from $8.6$15.0 million for the three months ended September 30, 2016. Segment2018. The Education segment operating margin increaseddecreased to 23.2%25.4% for the third quarter of 20172019 from 20.8%29.5% in the same period last year. The increasedecrease in this segment’s operating margin was primarily attributable to revenue growth that outpaced increases in salaries and related expenses for our revenue generating professionals; contractor expense; share-based compensation expense and performance bonus expense for our revenue-generating professionals, salariesprofessionals; and related expenses for our revenue-generating professionalspromotion and our support personnel, and contractor expenses. These increases to segment operating margin were partially offset by increases in travel related costs, signing and retention bonuses for our revenue-generating professionals, and third-party consulting expenses,marketing expense, all as a percentagepercentages of revenues.
Nine Months Ended September 30, 20172019 Compared to Nine Months Ended September 30, 20162018
Revenues
Revenues decreased $1.5increased $54.8 million, or 0.3%9.3%, to $546.6$644.5 million for the first nine months of 20172019 from $548.1$589.7 million for the first nine months of 2016. Revenues for2018. Of the first nine months of 2017 included $34.1overall $54.8 million from our acquisitions of Innosight and Pope Woodhead, which were completed subsequentincrease in revenues, $53.1 million was attributable to the third quarter of 2016, and $13.9 million of incremental revenues due to the full period impact of our acquisition of MyRounding Solutions, LLC ("MyRounding") and HSM Consulting, which we completed mid-first quarter 2016 and mid-third quarter 2016, respectively. Revenues for the first nine months of 2017 also included a full period impact of our acquisition of the U.S. assets of ADI Strategies andan increase in revenues from our acquisition of the international assets of ADI Strategies. These acquisitions were completed in May 2016full-time billable consultants and April 2017, respectively, and have since been fully integrated into the Business Advisory segment.
The overall $1.5$1.7 million decrease in revenues was primarily attributable to our full-time billable consultants. equivalents.
The decreaseincrease in full-time billable consultant revenues was attributable to strengthened demand for services in all of our segments, as discussed below in Segment Results; and reflected decreases in the average billing rate and consultant utilization rate, mostly offset by an overall increase in the average number of full-time billable consultants. Asconsultants during the first nine months of 2019 compared to the same prior year period.
The increase in full-time equivalent revenues was attributable to increases in full-time equivalent revenues in our Education and Healthcare segments, largely offset by a decrease in full-time equivalent revenues in our Business Advisory segment, as discussed below in Segment Results, thisResults; and reflected an overall increase in the average number of full-time equivalents, partially offset by an overall decrease in revenue was largely driven by decreased demand for services in our Healthcare segment, mostly offset by revenues from our acquisitions of Innosight and Pope Woodhead, as well as strengthened demand for services in our Business Advisory and Education segments.per full-time equivalent.
Total Direct Costs
Our total direct costs, including amortization of intangible assets and software development costs, increased $17.0$33.7 million, or 5.1%8.6%, to $351.6$425.9 million for the nine months ended September 30, 2017,2019, from $334.6$392.2 million for the nine months ended September 30, 2016.2018. The overall $17.0$33.7 million

36

Table of Contents




increase primarily related to a $14.3an $18.2 million increase in salaries and related expenses for our revenue-generating professionals, which was largely driven by increased headcount from acquisitions and our ongoing cloud-based ERP investment, partially offset by a decrease in salaries and related expenses in our Healthcare segment as a result of headcount reductions. Additional increases included a $2.8Education and Business Advisory segments; an $11.5 million increase in contractor expense, a $2.1 million increase in signing and retention bonus expense for our revenue-generating professionals, a $0.8 million increase in product and event costs, a $0.5 million increase in project costs, and a $0.5 million increase in technology expenses. These increases were partially offset by a $2.9 million decrease in intangible asset amortization expense and a $0.5 million decrease in performance bonus expense for our revenue-generating professionals.professionals; a $2.9 million increase in share-based compensation expense for our revenue-generating professionals; and a $1.2 million increase in contractor expense. As a percentage of revenues, our total direct costs increaseddecreased to 64.3%66.1% during the first nine months of 20172019 compared to 61.0%66.5% during the first nine months of 20162018 primarily due to revenue growth that outpaced the items described above.increase in salaries and related expenses for our revenue-generating professionals, partially offset by the increase in performance bonus expense for our revenue-generating professionals, as a percentage of revenues.
Total direct costs for the nine months ended September 30, 20172019 included $8.4$3.5 million of amortization expense for intangible assets, primarily representing customer contracts and software acquired in business combinations and internal software development costs and intangible assets, compared to $11.3$3.2 million of amortization expense for the same prior year period. The $2.9$0.3 million decreaseincrease in amortization expense was primarily attributable to the decreasinga $0.9 million increase in amortization expense of customer contractsfor internal software development costs, partially offset by a $0.6 million decrease in intangible asset amortization attributable to certain intangible assets acquired in our Studer Group acquisition duewhich were fully amortized in prior periods. Intangible asset amortization included within direct costs for the nine months ended September 30, 2019 and 2018 related to the accelerated basis of amortization, partially offset by the amortization of intangible assetstechnology and software, certain customer relationships, publishing content and customer contracts acquired in the Innosight acquisition, which we completed in the first quarter of 2017.connection with our business acquisitions. See Note 5 "Acquisitions" and Note 64 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information about our intangible assets.

40

Table of Contents




Operating Expenses and Other Gains,Losses (Gains), Net
Selling, general and administrative expenses increased $12.2$12.9 million, or 10.2%9.3%, to $132.1$151.4 million in the nine months ended September 30, 2017,2019, from $119.9$138.5 million in the nine months ended September 30, 2016. Selling, general and administrative expenses for the first nine months of 2017 included $9.8 million from Innosight and Pope Woodhead.2018. The overall $12.2$12.9 million increase was primarily related to an $8.5a $5.0 million increase in salaries and related expenses for our support personnel,personnel; a $2.2$2.4 million increase in facilities and other office-related expenses,share-based compensation expense for our support personnel; a $1.4$2.3 million increase in travelcomputer and related costs,equipment expenses; a $1.2$1.9 million increase in third-party consulting expenses, a $1.0 million increase in promotion and sponsorship expenses,legal expenses; and a $0.7 million increase in signing and retention bonus expense for our support personnel. These increases were partially offset by a $2.5 million decrease in performance bonus expense for our support personnel andpersonnel. The increase in legal fees was primarily due to third-party transaction-related expenses related to the evaluation of a $0.8 million decrease in share-based compensation expense for our support personnel.potential acquisition that ultimately did not consummate. As a percentage of revenues, selling, general and administrative expenses increased to 24.2% duringwas 23.5% for both the first nine months of 2017 compared to 21.9% during the first nine months of 2016 primarily due to the items described above.2019 and 2018.
Restructuring charges for the first nine months of 20172019 totaled $5.3$2.2 million, compared to $4.1$2.7 million for the first nine months of 2016.2018. During the first quarter of 2019, we exited a portion of our Lake Oswego, Oregon corporate office resulting in a $0.7 million lease impairment charge on the related operating lease right-of-use ("ROU") asset and leasehold improvements and $0.2 million of accelerated depreciation on furniture and fixtures in that office. The lease impairment charge recognized in the first quarter of 2019 was recognized in accordance with ASC 842, Leases, which we adopted on a modified retrospective basis on January 1, 2019. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" within the notes to our consolidated financial statements for additional information on our adoption of ASC 842. See Note 5 "Leases" within the notes to our consolidated financial statements for additional information on the long-lived asset impairment test performed in the first quarter of 2019. In the second quarter of 2019, we exited the remaining portion of our Middleton, Wisconsin office and an office space in Houston, Texas, resulting in restructuring charges forof $0.4 million and $0.1 million, respectively, which primarily related to accelerated depreciation on related furniture and fixtures. Additional restructuring charges during the first nine months of 20172019 include $0.5 million related to workforce reductions as we continue to better align resources with market demand.
The $2.7 million restructuring charge incurred in the first nine months of 2018 primarily consisted of $2.5$1.2 million related to workforce reductions to better align resources with market demand; $0.7 million related to the accrual of remaining lease obligations,payments, net of estimated sublease income, and accelerated depreciation on leasehold improvements due to relocatingexiting a portion of our Middleton, Wisconsin office in the second quarter of 2018; $0.3 million related to updated lease assumptions for our San Francisco office vacated in the third quarter of 2017; and $0.3 million related to the divestiture of our Middle East practice within the Business Advisory segment in the second quarter of 2018. During the second quarter of 2018, we sold our Middle East practice to a smaller spaceformer employee who was the practice leader of that business at the time; and consolidatingwe recorded a $5.9 million loss for the nine months ended September 30, 2018, which is included in other income (expense), net in our Chicago and New York officesconsolidated statements of operations. The restructuring charges recorded in the first nine months of 2017, and accelerated depreciation on leasehold improvements for our San Francisco office, $2.0 million2018 related to workforceoffice space reductions were accounted for in accordance with ASC 840, Leases. See Note 9 "Restructuring Charges" within the notes to our Healthcare segment to better alignconsolidated financial statements for additional information on our resources with market demand,restructuring charges.
Litigation and $0.4 million related to workforce reductions in our corporate operations primarily to adjust our infrastructure to align with the decreased workforce in the Healthcare segment. The charges for the first nine months of 2016 primarily consisted of $1.5 million related to updated assumptions for lease accruals for our Washington, D.C. space vacated in the fourth quarter of 2014, $1.2 million related to workforce reductions in our Healthcare segment to better align resources with market demand, $0.9 million related to workforce reductions in our corporate operations as we adjusted our infrastructure to align with our Huron Legal divestiture, and $0.2 million related to the wind down of our foreign consulting operations based in the Middle East.
Other gains,other losses (gains), net totaled $0.2a gain of $1.6 million for the nine months ended September 30, 2017, and represents2019, which primarily consisted of $1.5 million of remeasurement gains due to decrease the decrease in theestimated fair value of the liabilityour liabilities for future expected contingent consideration payments related to business acquisitions. InLitigation and other losses (gains), net totaled a gain of $5.0 million for the first nine months ended September 30, 2018, which consisted of 2016, we recognized $0.5a $2.5 million litigation settlement gain for the resolution of Huron's claim in a class action lawsuit in the second quarter of 2018 and $2.5 million of net remeasurement losses forgains to decrease the increase in theestimated fair value of theour contingent consideration liability.liabilities. In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. See Note 11 "Fair Value of Financial Instruments" within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities.

37

Table of Contents




Depreciation and amortization expense increaseddecreased by $5.5$5.0 million, or 19.0%, to $28.5$21.3 million in the nine months ended September 30, 2017,2019, from $23.1$26.3 million in the nine months ended September 30, 2016.2018. The increasedecrease was primarily attributable to decreasing amortization expense for intangible assetsof the trade name and customer relationships acquired in the Innosight, ADI Strategies, Pope Woodhead,our Studer Group acquisition and HSM Consulting acquisitions, and an increase in amortization expense for a customer-related intangible assetcertain customer relationships acquired in other business acquisitions, due to the Studer Group acquisition.accelerated basis of amortization in prior periods, as well as certain other customer relationships acquired in business acquisitions that were fully amortized in prior periods. Intangible asset amortization included within operating expenses for the nine months ended September 30, 2019 and 2018 primarily relatesrelated to certain customer relationships, trade names and non-competition agreements acquired in connection with our business acquisitions. See Note 5 "Acquisitions" and Note 64 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information about our intangible assets.
During the quarter ended June 30, 2017, we recorded a $209.6 million non-cash pretax goodwill impairment charge related to our Healthcare reporting unit. This charge is non-cash in nature and does not affect our liquidity or debt covenants. See the "Critical Accounting Policies" section below and Note 6 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for further discussion of this charge.
Operating Income (Loss)
Operating income decreased $246.2increased $10.2 million to a loss of $180.3$45.2 million in the first nine months of 20172019 from income of $65.8$35.0 million in the first nine months of 2016. This decrease is primarily attributable to the $209.6 million non-cash pretax goodwill impairment charge recorded in the second quarter of 2017 related to our Healthcare segment. See the "Critical Accounting Policies" section below and Note 6 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information on the non-cash goodwill impairment charge.2018. Operating margin, decreasedwhich is defined as operating income expressed as a percentage of revenues, increased to (33.0)%7.0% for the nine months ended September 30, 2017,2019, compared to 12.0%5.9% for the nine months ended September 30, 2016.2018. The decreaseincrease in operating margin was primarily attributable to the goodwill impairment charge, as well as increasesrevenue growth that outpaced the increase in salaries and related expenses for both our revenue-generating professionals and support personnel, contractor expenses, and signing and retention bonusesthe decrease in intangible asset amortization expense; partially offset by the increase in performance bonus expense for our revenue-generating professionals, during the first nine monthsas a percentage of 2017 compared to the same prior year period.

41

Table of Contents




revenues.
Other Expense, Net
Total other expense, net decreased by $0.4$9.4 million to $10.6$10.3 million in the first nine months of 20172019 from $11.0$19.8 million in the first nine months of 2016.2018. The decrease in total other expense, net was primarily attributable to a $0.9$5.9 million gain on saleloss recorded in the first nine months of 2018 related to the divestiture of our Life Sciences Compliance and Operations solutionMiddle East practice within our Business Advisory segment insegment. During the second quarter of 2017. See Note 6 "Goodwill and Intangible Assets" within2018, we sold our Middle East business to a former employee who was the notes to our consolidated financial statements for additional information onpractice leader of that business at the sale.time. The decrease in total other expense, net was also attributable to a $1.8$2.8 million gain inrecognized during the first nine months of 2019 for the market value of our investments that are used to fund our deferred compensation liability, compared to a $1.0gain of $0.9 million gainduring the first nine months of 2018. Interest expense, net of interest income decreased $1.5 million to $13.2 million in the first nine months of 2016. These decreases were partially offset by a $1.52019 from $14.6 million increase in interest expense, net of interest income in the first nine months of 2017 compared to the same prior year period.2018. The increasedecrease in interest expense was due to higherlower levels of borrowings and higher interest ratesborrowing under our credit facility during the first nine months of 20172019 compared to the same prior year period, partially offset by higher interest rates during the first nine months of 2016.2019 compared to the same prior year period.
Income Tax Expense (Benefit)
For the nine months ended September 30, 2017,2019, our effective tax rate was 26.1%20.8% as we recognized income tax benefitexpense from continuing operations of $49.7$7.3 million on a lossincome from continuing operations of $190.9$34.9 million. The effective tax rate of 20.8% was more favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to $1.0 million of discrete tax benefit recognized primarily in the third quarter of 2019 related to U.S. federal and foreign return to provision adjustments, which had a favorable impact of 2.8% on the effective tax rate. In addition, we recognized a $0.7 million discrete tax benefit in the third quarter of 2019 related to a previously unrecognized tax benefit due to the expiration of statute of limitations on our "check-the-box" election made in 2015 to treat certain wholly-owned foreign subsidiaries as disregarded entities for U.S. federal income tax purposes, which had a favorable impact of 2.1% on the effective tax rate. For the nine months ended September 30, 2016,2018, our effective tax rate was 35.6%28.6% as we recognized income tax expense from continuing operations of $19.5$4.4 million on income from continuing operations of $54.8$15.3 million. The effective tax rate for the nine months ended September 30, 2017of 28.6% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to the $61.2 million non-deductible portion of the goodwill impairment charge recorded in the second quarter of 2017, as well as $1.8 million of discrete tax expense of $1.2 million for share-based compensation related toawards that vested during the adoptionfirst quarter of ASU 2016-09 Improvements to Employee Share-Based Payment Accounting. Refer to Note 3 "New Accounting Pronouncements" for additional information2018, which had an unfavorable impact of 8.1% on the adoption of ASU 2016-09. Theseeffective tax rate. This unfavorable discrete items wereitem was partially offset by a $2.7$0.9 million discrete tax benefit recorded in the third quarter of 20172018 related to U.S. federal and foreign return to provision adjustments, which had a previously unrecognized tax benefit from our 2014 "check-the-box" election. Thefavorable impact of 6.1% on the effective tax rate for the nine months ended September 30, 2016 was lower than the statutory rate, inclusive of state income taxes, primarily due to the year-to-date impact of a discrete favorable adjustment to our state tax rate in the second quarter of 2016, non-taxable income, valuation allowance reductions, certain credits and deductions, and a discrete tax benefit related to share-based compensation, partially offset by non-deductible business expenses.rate.
Net Income (Loss) from Continuing Operations
Net income from continuing operations decreasedincreased by $176.5$16.7 million to a net loss from continuing operations of $141.2$27.6 million for the nine months ended September 30, 2017,2019, from net income from continuing operations of $35.3$10.9 million for the same prior year period. This decrease is primarily attributable to the $209.6 million non-cash pretax goodwill impairment charge related to our Healthcare segment. As a result of the decreaseincrease in net income from continuing operations, diluted loss per share from continuing operations for the first nine months of 2017 was $6.59 compared to diluted earnings per share from continuing operations of $1.65 for the first nine months of 2016. The non-cash goodwill impairment charge had a $7.16 unfavorable impact on diluted earnings per share from continuing operations for the first nine months of 2017.
Discontinued Operations
Net income from discontinued operations2019 was $1.23 compared to $0.50 for the first nine months ended September 30, 2017 was $0.7 million and primarily related to updated lease assumptions for vacated office space directly related to the sale of the Huron Legal segment. Net loss from discontinued operations for the nine months ended September 30, 2016 was $1.8 million and primarily related to obligations for former employees, legal fees, and updated lease assumptions for vacated office space directly related to the sale of the Huron Legal segment. See Note 4 "Discontinued Operations" within the notes to our consolidated financial statements for additional information about our discontinued operations.2018.
EBITDA and Adjusted EBITDA
EBITDA decreased $241.6increased $13.4 million to a loss of $140.2$72.8 million for the nine months ended September 30, 2017,2019, from earnings of $101.4$59.4 million for the nine months ended September 30, 2016.2018. Adjusted EBITDA decreased $32.7increased $12.9 million to $73.1$76.0 million in the first nine months of 20172019 from $105.8$63.1 million in the first nine months of 2016.2018. The decreaseincrease in EBITDA was primarily attributable to the non-cash goodwill impairment chargeincrease in revenues for the first nine months of $209.6 million2019 compared to the same prior year period and the loss on the divestiture of our Middle East business within our Business Advisory segment recorded in the second quarterfirst nine months of 2017.2018. These increases to EBITDA were partially offset by the increases in salaries and related expenses for our revenue-generating professionals, selling, general and administrative expenses, and performance bonus expense for our revenue-generating professionals; as well as the decrease in litigation and other gains, net recognized in the first nine months of 2019 compared to the same prior year period. The decreaseincrease in adjusted EBITDA was primarily dueattributable to the decrease in segment operating income, as discussed below in Segment Results, as well as an increase in corporaterevenues, partially offset by the increases in salaries and related expenses primarily duefor our

38

Table of Contents




revenue-generating professionals, selling, general and administrative expenses, and performance bonus expense for our revenue-generating professionals in the first nine months of 2019 compared to our acquisitions of Innosight and Pope Woodhead.the same prior year period.
Adjusted Net Income from Continuing Operations
Adjusted net income from continuing operations decreased $24.6increased $12.6 million to $31.7$43.7 million in the first nine months of 20172019 compared to $56.3$31.1 million in the first nine months of 2016.2018. As a result of the decreaseincrease in adjusted net income from continuing operations, adjusted

42

Table of Contents




diluted earnings per share from continuing operations for the first nine months of 20172019 was $1.47$1.95 compared to $2.63$1.42 for the first nine months of 2016.2018.
Segment Results
Healthcare
Revenues
Healthcare segment revenues decreased $62.3increased $23.8 million, or 19.2%8.8%, to $261.3$295.6 million for the first nine months of 20172019 from $323.5$271.8 million for the first nine months of 2016. Revenues for the first nine months of 2017 included $13.9 million of incremental revenues due to the full period impact of our acquisitions of HSM Consulting and MyRounding, which we completed mid-first quarter 2016 and mid-third quarter 2016, respectively.2018.
During the nine months ended September 30, 2017,2019, revenues from fixed-fee engagements,engagements; time-and-expense engagements,engagements; performance-based arrangements,arrangements; and software support, and maintenance and subscription arrangements represented 67.4%63.9%, 16.8%13.3%, 8.3%17.0%, and 7.5%5.8% of this segment’s revenues, respectively, compared to 70.4%67.2%, 10.7%15.7%, 13.1%10.2%, and 5.8%6.9% of this segment’s revenues, respectively, for the same prior year period.
The overall $62.3 million decrease in revenues was primarily attributable to a decrease in revenue from our full-time billable consultants. The decrease in revenue attributable to our full-time billable consultants was primarily driven by a decreased demand for our performance improvement solution and reflected decreases in the average number of full-time billable consultants, average billing rate, and consultant utilization rate. Performance-based fee revenue was $21.6$50.1 million during the first nine months of 20172019, compared to $42.5$27.8 million during the first nine months of 2016.2018. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide. Performance-based fee arrangements may also cause significant variations
Of the overall $23.8 million increase in revenues, operating results,$22.7 million was attributable to an increase in revenues from our full-time billable consultants and $1.1 million was attributable to our full-time equivalents. The increase in revenues attributable to our full-time billable consultants reflected increases in the average billing rates duerate and the average number of full-time billable consultants, partially offset by a decrease in the consultant utilization rate in the first nine months of 2019 compared to the same prior year period. The increase in revenues attributable to our levelfull-time equivalents reflected an increase in the average number of execution andfull-time equivalents, partially offset by a decrease in revenue per full-time equivalent in the timingfirst nine months of achievement of2019 compared to the performance-based criteria.same prior year period.
Operating Income
Healthcare segment operating income decreased $35.6increased $15.9 million, or 29.9%20.3%, to $83.6$94.1 million for the nine months ended September 30, 2017,2019, from $119.2$78.2 million for the nine months ended September 30, 2016.2018. The Healthcare segment operating margin decreasedincreased to 32.0%31.8% for the first nine months of 20172019 from 36.9%28.8% in the same period last year. The increase in this segment’s operating margin was primarily attributable to revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals, partially offset by an increase in performance bonus expense for our revenue-generating professionals, as a percentage of revenues.
Business Advisory
Revenues
Business Advisory segment revenues increased $12.8 million, or 7.5%, to $183.6 million for the first nine months of 2019 from $170.8 million for the first nine months of 2018.
During the first nine months of 2019, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 39.6%, 56.8%, 1.5%, and 2.1% of this segment’s revenues, respectively, compared to 41.0%, 55.3%, 1.8%, and 1.9% of this segment’s revenues, respectively, during the same prior year period. Performance-based fee revenue was $2.8 million for the first nine months of 2019, compared to $3.1 million for the first nine months of 2018. The level of performance-based fees earned may vary based on our clients’ preferences and the mix of services we provide.
Of the overall $12.8 million increase in revenues, $14.7 million was attributable to an increase in revenues from our full-time billable consultants, partially offset by a $1.9 million decrease in revenues attributable to our full-time equivalents. The increase in revenues from our full-time billable consultants was primarily driven by increases in the average number of full-time billable consultants and the consultant utilization rate, partially offset by a decrease in the average billing rate in the first nine months of 2019 compared to the same prior year period. The decrease in revenues from our full-time equivalents was driven by a decreased use of contractors and our part-time project consultants; and reflected a decrease in the average number of full-time equivalents, partially offset by an increase in revenue per full-time equivalent in the first nine months of 2019 compared to the same prior year period.

39

Table of Contents




Operating Income
Business Advisory segment operating income decreased by $2.0 million, or 5.8%, to $33.0 million for the nine months ended September 30, 2019, from $35.0 million for the nine months ended September 30, 2018. The Business Advisory segment operating margin decreased to 18.0% for the first nine months of 2019 from 20.5% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to an increase in salaries and related expensesperformance bonus expense for our revenue-generating professionals, as a percentage of revenues, as well as increases in salaries and related expenses for our support personnel, contractor expenses, product and event costs, and restructuring charges, partially offset by decreases in performance bonus expense for our revenue-generating professionals and support personnel as a percentage of revenues.
The non-cash goodwill impairment charge discussed above within the consolidated results is not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance. See the "Critical Accounting Policies" section below and Note 6 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for further discussion of this charge. We will continue to evaluate goodwill for impairment during future periods. Any future significant decline in the performance of the Healthcare segment compared to our internal forecasts could result in another non-cash goodwill impairment charge.
Education
Revenues
Education segment revenues increased $15.8$18.2 million, or 14.1%12.4%, to $127.6$165.3 million for the first nine months of 20172019 from $111.8$147.1 million for the first nine months of 2016.2018.
For the nine months ended September 30, 2017,2019, revenues from fixed-fee engagements,engagements; time-and-expense engagements, performance-based arrangements,engagements; and software support, and maintenance and subscription arrangements represented 15.8%22.9%, 78.5%, 0.3%69.1%, and 5.4%8.0% of this segment’s revenues, respectively, compared to 14.5%19.5%, 78.6%, 0.9%73.5%, and 6.0%7.0% of this segment's revenues, respectively, during the same prior year period.
Of the overall $15.8$18.2 million increase in revenues, $16.9$15.7 million was attributable to revenues generated by our full-time billable consultants whichand $2.5 million was partially offset by a $1.1 million decrease in revenues attributable to revenues generated by our full-time equivalents. The increase in revenuerevenues from our full-time billable consultants reflected increasesan increase in the average number of full-time billable consultants and consultant utilization rate,consultants; partially offset by a decrease in the average billing rate.rate in the first nine months of 2019 compared to the same prior year period. The decreaseincrease in revenuerevenues from our full-time equivalents was largelyprimarily driven by

43

Table of Contents




a decrease an increase in license revenues,software and data hosting revenues; and reflected decreasesincreases in both revenue per full-time equivalent and the average number of full-time equivalents in the first nine months of 20172019 compared to the same prior year period.
Operating Income
Education segment operating income increased $0.3$5.5 million, or 0.9%14.7%, to $31.8$43.2 million for the nine months ended September 30, 2017,2019, from $31.5$37.7 million for the nine months ended September 30, 2016.2018. The Education segment operating margin decreasedincreased to 24.9%26.2% for the first nine months of 20172019 from 28.1% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to increases in performance bonus expense for both our revenue-generating professionals and support personnel, as well as an increase in salaries and related expenses for our revenue-generating professionals, all as a percentage of revenues, partially offset by decreases in training expenses and practice administration and meetings expenses.
Business Advisory
Revenues
Business Advisory segment revenues increased $45.0 million, or 39.9%, to $157.8 million for the first nine months of 2017 from $112.8 million for the first nine months of 2016. Revenues for the first nine months of 2017 included $34.1 million from our acquisitions of Innosight and Pope Woodhead, which were completed subsequent to the third quarter of 2016. Revenues for the first nine months of 2017 also included a full period impact of our acquisition of the U.S. assets of ADI Strategies and revenues from our acquisition of the international assets of ADI Strategies. These acquisitions were completed in May 2016 and April 2017, respectively, and have since been fully integrated into the Business Advisory segment.
During the first nine months of 2017, revenues from fixed-fee engagements, time-and-expense engagements, performance-based arrangements, and software support and maintenance and subscription arrangements represented 34.7%, 62.6%, 1.2%, and 1.5% of this segment’s revenues, respectively, compared to 19.5%, 74.0%, 5.4%, and 1.1% of this segment’s revenues, respectively, during the same prior year period. Performance-based fee revenue was $1.9 million for the first nine months of 2017 compared to $6.2 million for the same prior year period. The level of performance-based fees earned may vary based on our clients’ preferences and the mix of services we provide. Performance-based fee arrangements may also cause significant variations in revenues, operating results, and average billing rates due to our level of execution and the timing of achievement of the performance-based criteria.
Of the overall $45.0 million increase in revenues, $44.1 million was attributable to our full-time billable consultants and $0.9 million was attributable to our full-time equivalents. The increase in revenue from our full-time billable consultants was primarily driven by our acquisitions of Innosight, ADI Strategies, and Pope Woodhead, and reflected increases in the average number of full-time billable consultants and consultant utilization rate, partially offset by a decrease in the average billing rate. The increase in revenue from our full-time equivalents reflected increases in the average number of full-time equivalents and revenue per full-time equivalent.
Operating Income
Business Advisory segment operating income increased by $11.6 million, or 49.9%, to $34.9 million for the nine months ended September 30, 2017, from $23.3 million for the nine months ended September 30, 2016. The Business Advisory segment operating margin increased to 22.1% for the first nine months of 2017 from 20.6%25.6% in the same period last year. The increase in this segment’s operating margin was primarily attributable to a decrease in performance bonus expense for our revenue-generating professionals, as a percentage of revenues, as well as decreases in share-based compensation expense for our revenue-generating professionals and contractor expense, partially offset by increases, as a percentage of revenues,revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals third-party consulting expenses, signing and retention bonuses for our revenue-generating professionals,a decrease in practice administration and travel related costs.meetings expenses; partially offset by an increase in contractor expense, as a percentage of revenues.

44

Table of Contents




LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents decreased $8.4increased $16.3 million to $49.4 million at September 30, 2019 from $17.0$33.1 million at December 31, 2016 to $8.7 million at September 30, 2017.2018. As of September 30, 2017,2019, our primary sources of liquidity are cash on hand, cash flows from our U.S. operations, and borrowing capacity available under our credit facility.
 Nine Months Ended
September 30,
 Nine Months Ended
September 30,
Cash Flows (in thousands): 2017 2016 2019 2018
Net cash provided by operating activities $52,432
 $79,745
 $51,745
 $48,867
Net cash used in investing activities (125,253) (81,233) (24,420) (13,496)
Net cash provided by (used in) financing activities 64,262
 (47,979)
Net cash used in financing activities (11,060) (43,141)
Effect of exchange rate changes on cash 192
 133
 38
 (114)
Net decrease in cash and cash equivalents $(8,367) $(49,334)
Net increase (decrease) in cash and cash equivalents $16,303
 $(7,884)
Operating Activities
Net cash provided by operating activities totaled $52.4$51.7 million for the nine months ended September 30, 2017 and $79.72019, compared to of $48.9 million for the same period last year.nine months ended September 30, 2018, respectively. Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, and deferred revenues. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses, and related benefits to employees affect these account balances.
The decreaseincrease in cash provided by operationsoperating activities for the first nine months of 20172019 compared to cash provided by operating activities in the same prior year period was primarily attributable to lower net income, the collection of a settlement receivable in the first quarter of 2016 and a decreasean increase in cash collections from clients infor the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, largely offset by the amount paid for annual performance bonuses during the first nine monthsquarter of 2017, partially offset by decreased vendor and tax payments.2019 compared to the first quarter of 2018.

40

Table of Contents




Investing Activities
Net cash used in investing activities was $125.3$24.4 million and $13.5 million for the nine months ended September 30, 20172019 and $81.2 million for the same period last year.2018, respectively.
The use of cash in the first nine months of 20172019 primarily consisted of $106.9 million for the purchases of businesses and $20.1$10.0 million for purchases of property and equipment, primarily related to leasehold improvements and purchases of furniturecomputers and fixturesrelated equipment and leasehold improvements for new office spaces in certain locations.locations; $7.5 million for payments related to internally developed software; $4.4 million for contributions to our life insurance policies which fund our deferred compensation plan; and $2.5 million for the purchase of a business in the third quarter of 2019.
The use of cash in the first nine months of 20162018 primarily consisted of $69.1$6.7 million for the purchases of businesses and $9.4 million for purchases of property and equipment.equipment, primarily related to purchases of computers and related equipment; $3.6 million for payments related to internally developed software; $2.4 million for payments related to the divestiture of our Middle East practice within the Business Advisory segment; and $1.7 million for contributions to our life insurance policies which fund our deferred compensation plan.
We estimate that cash utilized for purchases of property and equipment and software development in 20172019 will be approximately $25.0$20 million to $24 million, primarily consisting of software development costs, leasehold improvements furniture and fixtures,for certain office locations, and information technology related equipment to support our corporate infrastructure.
Financing Activities
Net cash provided byused in financing activities was $64.3$11.1 million for the nine months ended September 30, 2017.2019. During the first nine months of 2017,2019, we paid $10.0 million to the sellers of certain business acquisitions for achieving specified financial performance targets in accordance with the related purchase agreements. Of the total $10.0 million payments made, $4.7 million is classified as a cash outflow from financing activities and represents the amount paid up to the fair value of the contingent consideration liability recorded as of the acquisition date. The remaining $5.3 million is classified as a cash outflow from operating activities. During the first nine months of 2019, we borrowed $241.0$105.5 million under our credit facility, primarily to fund our acquisitions of Innosight and Pope Woodhead and our annual performance bonus payment, and made repayments on our credit facilityborrowings of $170.0$105.9 million.
Net cash used in financing activities was $48.0$43.1 million for the nine months ended September 30, 2016.2018. During the first nine months of 2016,2018, we repurchased and retired $55.3 million of our common stock under our Share Repurchase Program, as defined below, and had net borrowings of $12.0borrowed $179.8 million under our credit facility primarilyand made repayments on our borrowings of $213.7 million. During the first nine months of 2018, we paid $7.8 million to fund the sellers of certain business acquisitions for achieving specified financial performance targets in accordance with the related purchase agreements. Of the total $7.8 million payments made, $4.9 million is classified as a cash outflow from financing activities and represents the amount paid up to the fair value of HSM Consulting and the U.S. assetscontingent consideration liability recorded as of ADI Strategies and our annual performance bonus payment.the acquisition date. The remaining $2.9 million is classified as a cash outflow from operating activities.
Share Repurchase Program
As of September 30, 2017, we hadWe currently have a share repurchase program permitting us to repurchase up to $125 million of our common stock through October 31, 20172019 (the "Share Repurchase Program"). During the fourth quarter of 2017,2019, our board of directors authorized an extension of the Share Repurchase Program through October 31, 2018.2020. The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. During the first nine months of 2016, we

45

Table of Contents




repurchased and retired 982,192 shares for $55.3 million. No shares were repurchased in the first nine months of 2017.2019 or 2018. As of September 30, 2017,2019, $35.1 million remains available for share repurchases.
Financing Arrangements
At September 30, 2017,2019, we had $250.0 million principal amount of our 1.25% convertible senior notes outstanding, $139.0$50.0 million outstanding under our senior secured credit facility, and $5.0$4.0 million outstanding under a promissory note, as discussed below.
1.25% Convertible Senior Notes
In September 2014, we issued $250.0 million principal amount of the Convertible Notes in a private offering. The Convertible Notes are senior unsecured obligations of the Company and will paypaid interest semi-annually on April 1 and October 1 of each year at an annual rate of 1.25%. The Convertible Notes will maturematured on October 1, 2019, unless earlier repurchased by the Company or converted in accordance with their terms.
2019. Upon conversion, the Convertible Notes will be settled, at our election, in cash, sharesmaturity, we refinanced $217.0 million of the Company’s common stock, or a combination of cash and shares of the Company’s common stock. Our current intent and policy is to settle conversions with a combination of cash and shares of common stock with the principal amount of the outstanding Convertible Notes paid in cash, in accordance with the settlement provisions ofborrowing capacity available under our revolving credit facility and funded the Indenture.
The initial conversion rate for the Convertible Notes is 12.5170 shares of our common stock per $1,000remaining $33.0 million principal amount of the Convertible Notes, which is equal to an initial conversion price of approximately $79.89 per share of our common stock.payment with cash on hand.
In connection with the issuance of the Convertible Notes, we entered into convertible note hedge transactions and warrant transactions. The convertible note hedge transactions arewere intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raiseraised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. The convertible note hedge transactions expired in the third quarter of 2019. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date.

41

Table of Contents




The carrying amount of our Convertible Notes as of September 30, 2019 and December 31, 2018, was $250.0 million and $242.6 million, respectively, which represented the $250.0 million principal amount net of unamortized debt discount and issuance costs. The carrying amount of our Convertible Notes is included in current maturities of long-term debt on the consolidated balance sheet.
For further information, see Note 8 “Financing Arrangements” within the notes to our consolidated financial statements.
Senior Secured Credit Facility
The Company has a $500$600 million senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Facility"Agreement"), that becomes due and payable in full upon maturity on March 31, 2020.September 27, 2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $100$150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $600$750 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.
Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.25%1.125% per annum and 2.00%1.875% per annum, in the case of LIBOR borrowings, or between 0.25%0.125% per annum and 1.00%0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.
Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including a requirement to pay all amounts outstanding under the Amended Credit Agreement 90 days prior to the Convertible Indebtedness Maturity Date (as defined in the Amended Credit Agreement) unless (1) the Convertible Indebtedness Maturity Date is waived or extended to a later date, (2) the Company can demonstrate (a) Liquidity (as defined in the Amended Credit Agreement) in an amount at least equal to the principal amount due on the Convertible Indebtedness Maturity Date, and (b) financial covenant compliance after giving effect to such payments and any additional indebtedness incurred on a pro forma basis, or (3) this requirement is waived by the Required Lenders (as defined in the Amended Credit Agreement).circumstances. In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.
The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) ranging from 3.25of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.00 to 1.00 to 3.75 to 1.00, depending onupon the measurement period,occurrence of certain transactions, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial

46

Table of Contents




covenants is calculated on a continuing operations basis and includes adjustments to add back share-based compensation costs, non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, and pro forma historical EBITDA for businesses acquired.acquired, and other specified items in accordance with the Amended Credit Agreement. At September 30, 2017,2019, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 3.522.42 to 1.00 and a Consolidated Interest Coverage Ratio of 12.6015.33 to 1.00.
The Amended Credit Agreement contains restricted payment provisions, including a potential limit on the amount of dividends we may pay. Pursuant to the terms of the Amended Credit Agreement, if our Consolidated Leverage Ratio is greater than 3.00,3.25, the amount of dividends and other Restricted Payments (as defined in the Amended Credit Agreement) we may pay is limited to an amount up to $50 million plus 50% of cumulative consolidated net income (as defined in the Amended Credit Agreement) from the closing date of the Amended Credit Agreement plus 50% of the net cash proceeds from equity issuances after the closing date of the Amended Credit Agreement.$25 million.
Borrowings outstanding under the Amended Credit Agreement at September 30, 20172019 totaled $139.0$50.0 million. These borrowings carried a weighted average interest rate of 3.4%3.3%, including the impact of the interest rate swap in effect as of September 30, 20172019 and described in Note 10 “Derivative InstrumentsInstrument and Hedging Activity” within the notes to the consolidated financial statements. Borrowings outstanding under the Amended Credit Agreement at December 31, 20162018 were $68.0$50.0 million and carried a weighted average interest rate of 2.5%.3.7%, including the impact of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity” within the notes to the consolidated financial statements. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At September 30, 2017,2019, we had outstanding letters of credit totaling $2.7$1.5 million, which are primarily used as security deposits for our office facilities. As of September 30, 2017,2019, the unused borrowing capacity under the revolving credit facility was $358.3$548.5 million.
On October 1, 2019, we refinanced $217.0 million of the $250.0 million outstanding principal amount of the Convertible Notes with the borrowing capacity available under our revolving credit facility, which resulted in outstanding borrowings of $267.0 million. As of October 1, 2019, the unused borrowing capacity under the revolving credit facility was $331.5 million and our pro forma Consolidated Leverage Ratio was 2.16 to 1.00.

42

Table of Contents




Promissory Note due 2024
On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At September 30, 2017,2019, the outstanding principal amount of the promissory note was $5.0 million. As of September 30, 2017,$4.0 million, and the aircraft had a carrying amount of $6.6$5.3 million. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million, and the aircraft had a carrying amount of $5.8 million.
For further information, see Note 8 “Financing Arrangements” within the notes to the consolidated financial statements.
Future Needs
Our primary financing need has been to fund our growth. Our growth strategy is to expand our service offerings, which may require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related capital expenditures. We believe our internally generated liquidity, together with our available cash, the borrowing capacity available under our revolving credit facility, and access to external capital resources will be adequate to fund our long-term growth and capital needs arising from cash commitments and debt service obligations. Our ability to secure short-term and long-term financing in the future will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.
CONTRACTUAL OBLIGATIONS
For a summary of our commitments to make future payments under contractual obligations, see “ItemItem 7. Management’s"Management’s Discussion and Analysis of Financial Condition and Results of Operations – Contractual Obligations”Obligations" in our Annual Report on Form 10-K for the year ended December 31, 2016.2018.
In connection with certain business acquisitions completed during the first nine months of 2017,On September 27, 2019, we entered into contingent consideration arrangements, under which we may be required to pay post-closing considerationthe fourth amendment (the "Fourth Amendment") to the sellers if specific financial performance targets are met over a numberSecond Amended and Restated Credit Agreement dated as of yearsMarch 31, 2015, as specified inamended to date (as amended and modified the related purchase agreements."Amended Credit Facility"). The aggregate fair value of these contingent consideration liabilities on the dates of acquisition was $15.5 million. Refer to Note 5 “Acquisitions” within the notes to the consolidated financial statements for additional information on the businesses acquired during the first nine months of 2017. At September 30, 2017, the aggregate fair value of all contingent consideration liabilities outstanding was $22.5 million.
As discussed above in "Liquidity and Capital Resources," on June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments untilFourth Amendment extended the maturity date from March 23, 2023 to September 27, 2024. In addition, the Fourth Amendment provided for, among other things, i) an increase to the Aggregate Revolving Commitments from $500 million to $600 million; ii) a more favorable pricing structure; iii) unlimited Restricted Payments when the Consolidated Leverage Ratio is less than 3.25 to 1.00, and establishes a base amount of March 1, 2024,allowable Restricted Payments of $25 million when the Consolidated Leverage Ratio is greater than 3.25 to 1.00; and iv) an increase to the maximum permitted Consolidated Leverage Ratio to 3.75 to 1.00, and provides an additional increase to the maximum permitted Consolidated Leverage Ratio to 4.00 to 1.00 upon the occurrence of certain transactions. Borrowings outstanding under the Amended Credit Agreement at which time a final payment of $1.5 million, plus any accrued and unpaid interest will be due. UnderSeptember 30, 2019 totaled $50.0 million.
The capitalized terms above are defined in the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-month LIBOR plus 1.97% per annum.

47

Table of Contents




Amended Credit Facility or Fourth Amendment, as applicable. Refer to "Liquidity and Capital Resources" and Note 8 "Financing Arrangements" within the notes to the consolidated financial statements for additionalmore information on our outstanding borrowings, includingborrowings.
During October 2019, we entered into an amendment to the schedule of monthlyoffice lease agreement for our principal payments.
The following table providesexecutive offices in Chicago, Illinois. Among other items, this amendment i) extends the scheduled future paymentsterm of the contingent consideration arrangementslease from September 30, 2024 to September 30, 2029; ii) terminates the lease with respect to certain leased spaces previously vacated; iii) modifies the future base rent payments; and promissory note described aboveiv) provides abatement of the future base rent payments from October 1, 2019 through January 15, 2021. The amendment increased the contractual obligations related to our Chicago office lease as of October 1, 2019 by $12.7 million, primarily related to the contractual lease payments for the extended term beyond September 30, 2017:
2024.
   Payments Due by Period
 Total 
Less than
1 Year
 1-3 Years 3-5 Years 
More than
5 Years
Contingent consideration$22,469
 $7,743
 $13,126
 $1,600
 $
Promissory note—principal and interest$5,682
 $650
 $1,293
 $1,283
 $2,456
There have been no other material changes to our contractual obligations since December 31, 2016.2018. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" within the notes to our consolidated financial statements for information on our adoption of ASC 842, Leases. See Note 5 "Leases" within the notes to our consolidated financial statements for information on our future lease payments and a reconciliation of those lease payments to our operating lease liabilities recorded on our consolidated balance sheet.
OFF-BALANCE SHEET ARRANGEMENTS
We are not a party to any material off-balance sheet arrangements.
CRITICAL ACCOUNTING POLICIES
Management’s discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with GAAP. We regularly review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported

43

Table of Contents




amounts of revenues and expenses during the reporting period. Critical accounting policies are those policies that we believe present the most complex or subjective measurements and have the most potential to impact our financial position and operating results. While all decisions regarding accounting policies are important, we believe there are five accounting policies that could be considered critical: revenue recognition, allowances for doubtful accounts and unbilled services, business combinations, carrying values of goodwill and other intangible assets, and accounting for income taxes. For a detailed discussion of these critical accounting policies, see “ItemItem 7. Management’s"Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2016. Below is an update to our critical accounting policy related to the carrying value of goodwill and other intangible assets. There have been no material changes to our other critical accounting policies during the first nine months of 2017.
Carrying Values of Goodwill and Other Intangible Assets
Acquisition of Innosight
On March 1, 2017, we completed our acquisition of Innosight, a growth strategy firm focused on helping companies navigate disruptive change, enable innovation, and manage strategic transformation. Innosight's results of operations have been included in our consolidated financial statements and results of operations of our Business Advisory segment from the date of acquisition. The goodwill recorded as part of the allocation of the purchase price of Innosight has been assigned to Innosight as a separate reporting unit, which is referred to as Strategy and Innovation.
Adoption of ASU 2017-04
In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminated Step 2 of the goodwill impairment test, which required us to determine the implied fair value of goodwill by allocating the reporting unit's fair value to each of its assets and liabilities as if the reporting unit was acquired in a business acquisition. Instead, the updated guidance requires an entity to perform its annual or interim goodwill impairment test by comparing the fair value of the reporting unit to its carrying value, and recognizing a non-cash impairment charge for the amount by which the carrying value exceeds the reporting unit's fair value with the loss not exceeding the total amount of goodwill allocated to that reporting unit. We adopted this guidance in the second quarter of 2017 on a prospective basis and applied the new guidance to our goodwill impairment tests described below.
Second Quarter 2017 Goodwill Reallocation
Effective June 1, 2017, we reorganized our internal financial reporting structure, which management uses to assess performance and allocate resources, by moving our Life Sciences practice from the Education and Life Sciences reporting unit and segment to its own reporting unit within the Business Advisory segment. The remaining Education and Life Sciences segment is now referred to as the Education segment. We will continue to operate under three reportable segments: Healthcare, Education, and Business Advisory.

48

Table of Contents




These three reportable segments will be comprised of the following six reporting units for goodwill impairment testing purpose: Healthcare, Education, Business Advisory, Enterprise Solutions and Analytics, Strategy and Innovation, and Life Sciences. The Business Advisory, Enterprise Solutions and Analytics, Strategy and Innovation, and Life Sciences reporting units comprise our Business Advisory segment.
As a result of the reorganization, we reallocated $10.8 million of the goodwill balance associated with the previous Education and Life Sciences reporting unit to the new Life Sciences reporting unit based on the relative fair values of the Life Sciences reporting unit and the remaining Education reporting unit. The estimated fair values were determined using a combination of the income approach and the market approach, utilizing the guideline company method, with a fifty-fifty weighting.
In conjunction with the goodwill reallocation, we performed a goodwill impairment test for the goodwill balances within our Education reporting unit and Life Sciences reporting unit as of June 1, 2017. Based on the results of the goodwill impairment test, we determined that the fair values of our Education reporting unit and Life Sciences reporting unit exceeded their carrying values. As such, we concluded there was no indication of goodwill impairment for either reporting unit.
Second Quarter 2017 Goodwill Impairment Analysis
Since the first quarter of 2016, the Healthcare segment, which is also a reporting unit, has experienced declining revenues, primarily driven by softness in our revenue cycle offering within our performance improvement solution. This softness is attributable to decreased demand for our services, the winding down of some of our larger projects and a growing trend toward smaller projects, as well as fewer large integrated projects. In light of these challenges, several initiatives have been undertaken to improve the segment's financial performance, including repositioning our solutions to address the most critical needs of our clients, the expansion of our existing services such as those in our Studer Group, strategy, physician and technology offerings, and workforce reductions to better align resources with market demand. While the initiatives undertaken to improve the financial performance of our Healthcare segment are yielding some positive impacts, hospitals and health systems continue to face regulatory and funding uncertainty; therefore, we remain cautious about near-term growth. As we have previously disclosed in prior quarters, if the financial performance of our Healthcare segment continued to decline and did not meet our expectations, we could be required to perform an interim impairment analysis with respect to our carrying value of goodwill for the Healthcare reporting unit prior to our usual annual test. Based on forecasts prepared in connection with our quarterly forecasting cycle during the second quarter of 2017, we determined that the likely time frame to improve the financial results of this segment will take longer than originally anticipated. As such, we concluded, during the second quarter of 2017, that the fair value of the Healthcare reporting unit may no longer exceed its carrying value. In connection with the preparation of our financial statements for the quarter ended June 30, 2017, we performed an interim impairment test on the Healthcare reporting unit.
Based on the estimated fair value of the Healthcare reporting unit described below, we recorded a $209.6 million non-cash pretax charge in the second quarter of 2017 to reduce the carrying value of goodwill in our Healthcare reporting unit.
Our goodwill impairment test was performed by comparing the fair value of the Healthcare reporting unit with its carrying value and, in accordance with ASU 2017-04, which we adopted in the second quarter of 2017, recognizing an impairment charge for the amount by which the carrying value exceeded the fair value. To estimate the fair value of the Healthcare reporting unit, we relied on a combination of the income approach and the market approach, with a fifty-fifty weighting.
In the income approach, we utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by the reporting unit and then discounting those cash flows to present value reflecting the relevant risks associated with the reporting unit and the time value of money. This approach requires the use of significant estimates and assumptions, including long-term projections of future cash flows, market conditions, and a discount rate that reflects the risk inherent in the future cash flows. In estimating future cash flows, we relied on an internally generated 11-year forecast. For periods after the 11-year forecast, we assumed a long-term annual revenue growth rate of 3.5%. Our forecast is based on historical experience, current backlog, expected market demand, and other industry information. Our discounted cash flow analysis assumed a 10.0% weighted average cost of capital discount rate.
In the market approach, we utilized the guideline company method, which involved calculating valuation multiples based on operating data from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples are evaluated and adjusted based on specific characteristics of the Healthcare reporting unit relative to the selected guideline companies and applied to the reporting unit's operating data to arrive at an indication of value.
Determining the fair value of any reporting unit requires us to make significant judgments, estimates, and assumptions. While we believe that the estimates and assumptions underlying our valuation of the Healthcare reporting unit are reasonable, these estimates and assumptions could have a significant impact on whether or not another non-cash impairment charge is recognized in the future and also the magnitude of any such charge. The results of an impairment analysis are as of a point in time. There is no assurance that the

49

Table of Contents




actual future earnings or cash flows of our Healthcare reporting unit will be consistent with our projections. We will monitor any changes to our assumptions and will evaluate goodwill as part of our annual goodwill impairment testing in the fourth quarter of 2017, or on an interim basis, if required. Any future significant decline in our operations compared to our internal forecast could result in another non-cash goodwill impairment charge, which could be material.
As discussed above, as of September 30, 2017, we have six reporting units with goodwill balances: our Healthcare and Education segments, and our Business Advisory, Enterprise Solutions and Analytics, Strategy and Innovation, and Life Sciences practices, which together make up our Business Advisory operating segment.
The carrying values of goodwill for each of our reporting units as of September 30, 2017 are as follows (in thousands):
Reporting Unit 
Carrying Value
of Goodwill
Healthcare $427,209
Education 102,830
Business Advisory 16,094
Enterprise Solutions and Analytics 45,119
Strategy and Innovation 87,432
Life Sciences 10,691
Total $689,375
Three of our reporting units have been established primarily or entirely through recent business acquisitions: Enterprise Solutions and Analytics, Strategy and Innovation, and Life Sciences. Our Enterprise Solutions and Analytics reporting unit was established with the acquisition of Blue Stone International, LLC in October 2013. Since that time, we have completed five additional business acquisitions within the reporting unit, most recently the acquisitions of the U.S. assets and international assets of ADI Strategies in May 2016 and April 2017, respectively. Our Strategy and Innovation reporting unit was established with the acquisition of Innosight in March 2017. Our Life Sciences reporting unit is primarily comprised of two recent acquisitions: The Frankel Group Associates LLC in January 2014 and Pope Woodhead in January 2017.
We record the assets acquired and liabilities assumed in business combinations, including identifiable intangible assets, at their estimated fair values as of the acquisition date, and goodwill is recorded as the excess of the fair value of consideration transferred, including any contingent consideration, over the fair value of the net assets acquired. Therefore, the initial accounting for an acquisition results in no headroom, as its fair value equals its carrying value.
Our most recent goodwill impairment test for the Enterprise Solutions and Analytics reporting unit was performed as of November 30, 2016, as part of our annual goodwill impairment test, pursuant to our policy, and based on the results of the first step of that analysis, the reporting unit’s fair value exceeded its carrying value by 11%.

Our most recent goodwill impairment test for the Life Sciences reporting unit was performed as of June 1, 2017, as part of the reorganization of our internal financial reporting structure, as discussed above under the section titled Second Quarter 2017 Goodwill Reallocation. Based on the results of that analysis, the reporting unit’s fair value exceeded its carrying value by 16%.

We have not yet performed a goodwill impairment test for the Strategy and Innovation reporting unit, as the reporting unit was established during the current year with the acquisition of Innosight in March 2017 and there have been no triggering events requiring an interim goodwill impairment test to date.

Since the date of the most recent goodwill impairment tests for the Enterprise Solutions and Analytics and Life Sciences reporting units, and since the inception of the Strategy and Innovation reporting unit, the performance of these three reporting units has continued to reasonably meet our expectations such that no triggering event for an interim goodwill impairment analysis was identified. We will monitor any changes to our assumptions and will evaluate goodwill as part of our annual goodwill impairment testing in the fourth quarter of 2017, or on an interim basis, if required. Any future significant decline in our operations compared to our internal forecast could result in a non-cash goodwill impairment charge as a result of any such test.

For further discussion of our 2016 annual goodwill impairment test, see "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies" in our Annual Report on Form 10-K for the year ended December 31, 2016.2018. There have been no material changes to our critical accounting policies during the first nine months of 2019.

50

Table of Contents




NEW ACCOUNTING PRONOUNCEMENTS
Refer to Note 3 “New"New Accounting Pronouncements”Pronouncements" within the notes to the consolidated financial statements for information on new accounting pronouncements.
ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
We are exposed to market risks primarily from changes in interest rates and changes in the market value of our investments.
Market Risk and Interest Rate Risk
The value of our Convertible Notes is exposed to interest rate risk. Generally, the fair value of our fixed interest rate Convertible Notes will increase as interest rates fall and decrease as interest rates rise. In addition, the fair value of our Convertible Notes is affected by our stock price. The carrying value of our Convertible Notes was $230.8$250.0 million as of September 30, 2017,2019, which represents the liability component ofequaled the $250.0 million principal balance.balance due on October 1, 2019. The estimated fair value of our Convertible Notes at September 30, 20172019 was $233.6$249.5 million, and was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market as of the last day of trading for the quarter ended September 30, 2017,2019, which was $93.438$99.810 per $100 principal amount. At December 31, 2018, the carrying value of our Convertible Notes was $242.6 million, and the estimated fair value of our Convertible Notes was $242.9 million, which was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market as of the last day of trading for the year ended December 31, 2018, which was $97.176 per $100 principal amount.
Concurrent with the issuance of the Convertible Notes, we entered into separate convertible note hedge and warrant transactions. The convertible note hedge transactions arewere intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raiseraised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. Under the convertible note hedge transactions, we havehad the option to purchase a total of approximately 3.1 million shares of our common stock, which is the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89, which corresponds to the initial conversion price of the Convertible Notes, subject to customary anti-dilution adjustments substantially similar to those in the Convertible Notes. The convertible note hedge transactions expired in the third quarter of 2019. Under the warrant transactions, the holders of the warrants have the option to purchase a total of approximately 3.1 million shares of our common stock at a price of approximately $97.12. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date.
We have exposure to changes in interest rates associated with borrowings under our bank credit facility, which has variable interest rates tied to LIBOR or an alternate base rate, at our option. At September 30, 2017,2019, we had borrowings outstanding under the credit facility totaling $139.0$50.0 million that carried a weighted average interest rate of 3.4%3.3%, including the impact of the interest rate swap described below. A hypothetical 100 basis point change in this interestAs of September 30, 2019, these variable rate would have a $0.9 million effect on our pretax income, on an annualized basis, including the effect of the interest rate swap. At December 31, 2016, our borrowings outstanding under the credit facility totaled $68.0 million and carried a weighted average interest rate of 2.5%, including the effect of the interest rate swap described below. The outstanding borrowings at December 31, 2016 were fully hedged against changes in interest rates by ourthe interest rate swap, which had a notional amount of $68.0 million at December 31, 2016.
On April 4, 2013, we entered into$50.0 million. As our variable rate borrowings were fully hedged as of September 30, 2019, a forward amortizing interest rate swap agreement effective March 31, 2014 and ending August 31, 2017. We entered into this derivative instrument to hedge againstchange in the interest rate risks ofwould have had no impact on our variable-rate borrowings. The swapconsolidated financial statements. At December 31, 2018, we had an initial notional amount of $60.0borrowings outstanding under the credit facility totaling $50.0 million and amortized quarterly until April 2016. In April 2016, the notional amount of thisthat carried a weighted average interest rate swap increased to $86.0 million and continued to amortize quarterly until it expired in August 2017. Underof 3.7% including the termsimpact of the interest rate swap agreement, we received fromdescribed below. As of December 31, 2018, these variable rate borrowings were fully hedged against changes in interest rates by the counterparty interest on therate swap, which had a notional amount basedof $50.0 million. As our variable rate borrowings were fully hedged as of December 31, 2018, a change in the interest rate would have had no impact on one-month LIBOR and we paid to the counterparty a fixed rate of 0.985%.our consolidated financial statements.
On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to continue to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 1.900%.
We also have exposure to changes in interest rates associated with the promissory note assumed on June 30, 2017 in connection with our purchase of an aircraft, which has variable interest rates tied to LIBOR. At September 30, 2017,2019, the outstanding principal amount of the promissory note was $5.0$4.0 million and carried an interest rate of 3.2%4.2%. A hypothetical 100 basis point change in this interest rate would not have a $0.1material effect on our

44

Table of Contents




pretax income. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million and carried an interest rate of 4.3%. A hypothetical 100 basis point change in the interest rate as of December 31, 2018 would not have had a material effect on our pretax income, on an annualized basis.income.
We do not use derivative instruments for trading or other speculative purposes. From time to time, we invest excess cash in short-term marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of these investments, we have concluded that we do not have material market risk exposure.

51

Table of Contents




We have a non-interest bearing convertible debt investment in a privately-held company, which we account for as an available-for-sale debt security. As such, the investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. As of September 30, 2017,2019, the fair value of the investment was $31.9$60.9 million, with a total cost basis of $27.9 million. At December 31, 2018, the fair value of the investment was $50.4 million, with a total cost basis of $27.9 million.
ITEM 4.CONTROLS AND PROCEDURES.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”"Exchange Act")) as of September 30, 2017.2019. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2017,2019, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or submit under the Exchange Act, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended September 30, 20172019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II—OTHER INFORMATION
ITEM 1.LEGAL PROCEEDINGS.
The information required by this Item is incorporated by reference from Note 14 "Commitments, Contingencies and Guarantees" included in Part I, Item 1 of this Quarterly Report on Form 10-Q. 
From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.
ITEM 1A.RISK FACTORS.
The following information updates, and should be read in conjunction with, the information disclosed inSee Part 1, Item 1A, “Risk
Factors” of"Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016,2018, which was filed with the Securities and
Exchange Commission on February 23, 2017.
Our goodwill and other intangible assets represent27, 2019, for a substantial amount of our total assets, and we may be required to recognize a non-cash impairment charge for these assets if the performance of one or more of our reporting units falls below our expectations.
Our total assets reflect a substantial amount of intangible assets, primarily goodwill. At December 31, 2016, goodwill and other intangible assets totaled $881.2 million, or 76%, of our total assets. During the second quarter of 2017, we wrote off $209.6 million of goodwill related to our Healthcare segment as discussed below. At September 30, 2017, goodwill and other intangible assets totaled $770.2 million, or 71%, of our total assets. The goodwill results from our acquisitions, representing the excesscomplete description of the fair value of consideration transferred over the fair value of the net assets acquired. We test goodwill for impairment, at the reporting unit level, annually and whenever events or circumstances make it more likely than not that an impairment may have occurred.
Since the first quarter of 2016, the Healthcare segment, which is also a reporting unit, has experienced declining revenues, primarily driven by softness in our revenue cycle offering within our performance improvement solution. This softness is attributable to decreased demand for our services, the winding down of some of our larger projects and a growing trend toward smaller projects, as well as fewer large integrated projects. In light of these challenges, several initiatives have been undertaken to improve the segment's financial performance, including repositioning our solutions to address the most critical needs of our clients, the expansion of our existing services such as those in our Studer Group, strategy, physician and technology offerings, and workforce reductions to better align resources with market demand. While the initiatives undertaken to improve the financial performance of our Healthcare segment are yielding some positive impacts, hospitals and health systems continue to face regulatory and funding uncertainty; therefore, we

52

Table of Contents




remain cautious about near-term growth. Asmaterial risks we have previously disclosed in prior quarters, if the financial performance of our Healthcare segment continued to decline and did not meet our expectations, we could be required to perform an interim impairment analysis with respect to our carrying value of goodwill for the Healthcare reporting unit prior to our usual annual test. Based on forecasts prepared in connection with our quarterly forecasting cycle during the second quarter of 2017, we determined that the likely time frame to improve the financial results of this segment will take longer than originally anticipated. As such, we concluded, during the second quarter of 2017, that the fair value of the Healthcare reporting unit may no longer exceed its carrying value. In connection with the preparation of our financial statements for the quarter ended June 30, 2017, we performed an interim impairment test on the Healthcare reporting unit. Based on the estimated fair value of the Healthcare reporting unit, we recorded a $209.6 million non-cash pretax charge in the second quarter of 2017 to reduce the carrying value of goodwill in our Healthcare reporting unit.face.
Determining the fair value of any reporting unit requires us to make significant judgments, estimates, and assumptions. While we believe that the estimates and assumptions underlying our valuation of the Healthcare reporting unit are reasonable, these estimates and assumptions could have a significant impact on whether or not another non-cash impairment charge is recognized in the future and also the magnitude of any such charge. The results of an impairment analysis are as of a point in time. There is no assurance that the actual future earnings or cash flows of our Healthcare reporting unit will be consistent with our projections. We will monitor any changes to our assumptions and will evaluate goodwill as part of our annual goodwill impairment testing in the fourth quarter of 2017, or on an interim basis, if required. Any future significant decline in our operations compared to our internal forecast could result in another non-cash goodwill impairment charge, which could be material.
Three of our reporting units have been established primarily or entirely through recent business acquisitions: Enterprise Solutions and Analytics, Strategy and Innovation, and Life Sciences. Our Enterprise Solutions and Analytics reporting unit was established with the acquisition of Blue Stone International, LLC in October 2013. Since that time, we have completed five additional business acquisitions within the reporting unit, most recently the acquisitions of the U.S. assets and international assets of ADI Strategies in May 2016 and April 2017, respectively. Our Strategy and Innovation reporting unit was established with the acquisition of Innosight in March 2017. Our Life Sciences reporting unit is primarily comprised of two recent acquisitions: The Frankel Group Associates LLC in January 2014 and Pope Woodhead in January 2017.
We record the assets acquired and liabilities assumed in business combinations, including identifiable intangible assets, at their estimated fair values as of the acquisition date, and goodwill is recorded as the excess of the fair value of consideration transferred, including any contingent consideration, over the fair value of the net assets acquired. Therefore, the initial accounting for an acquisition results in no headroom, as its fair value equals its carrying value.
Our most recent goodwill impairment test for the Enterprise Solutions and Analytics reporting unit was performed as of November 30, 2016, as part of our annual goodwill impairment test, pursuant to our policy, and based on the results of the first step of that analysis, the reporting unit’s fair value exceeded its carrying value by 11%.
Our most recent goodwill impairment test for the Life Sciences reporting unit was performed as of June 1, 2017, as part of the reorganization of our internal financial reporting structure, as discussed in the "Critical Accounting Policies" section within Part I - Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations." Based on the results of that analysis, the reporting unit’s fair value exceeded its carrying value by 16%.
We have not yet performed a goodwill impairment test for the Strategy and Innovation reporting unit, as the reporting unit was established during the current year with the acquisition of Innosight in March 2017 and there have been no triggering events requiring an interim goodwill impairment test to date.
Since the date of the most recent goodwill impairment tests for the Enterprise Solutions and Analytics and Life Sciences reporting units, and since the inception of the Strategy and Innovation reporting unit, the performance of these three reporting units has continued to reasonably meet our expectations such that no triggering event for an interim goodwill impairment analysis was identified. We will monitor any changes to our assumptions and will evaluate goodwill as part of our annual goodwill impairment testing in the fourth quarter of 2017, or on an interim basis, if required. Any future significant decline in our operations compared to our internal forecast could result in a non-cash goodwill impairment charge as a result of any such test.
Refer to “Critical Accounting Policies” within Part I - Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Note 6 “Goodwill and Intangible Assets” within the notes to our consolidated financial statements for further discussion of business combinations, goodwill, intangible assets, and impairment tests performed in 2017.


53

Table of Contents




ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
Our Stock Ownership Participation Program, 2012 Omnibus Incentive Plan, and 2004 Omnibus Stock Plan, which was replaced by the 2012 Omnibus Incentive Plan, permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended September 30, 2017,2019, we reacquired 4,79812,657 shares of common stock with a weighted average fair market value of $39.78$58.91 as a result of such tax withholdings.
Our board of directors authorizedWe currently have a share repurchase program pursuantpermitting us to which we may, from time to time, repurchase up to $125 million of our common stock through October 31, 20172019 (the "Share Repurchase Program"). During the fourth quarter of 2017,2019, our board of directors authorized an extension of the ShareShares Repurchase Program through October 31, 2018.2020. The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our line of credit, general market and business conditions, and applicable legal requirements.
The following table provides information with respect to purchases we made of our common stock during the quarter ended September 30, 2017.2019.

45

Table of Contents




Period 
Total Number of Shares Purchased (1)
 
Average Price
Paid per Share
 
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
 
Dollar Value of Shares
that may yet be
Purchased under the
Plans or Programs (2)
July 1, 2017 - July 31, 2017 3,194
 $43.08
 
 $35,143,546
August 1, 2017 - August 31, 2017 796
 $35.47
 
 $35,143,546
September 1, 2017 - September 30, 2017 808
 $30.95
 
 $35,143,546
Total 4,798
 $39.78
 
  
Period 
Total Number of Shares Purchased (1)
 
Average Price
Paid per Share
 
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
 
Dollar Value of Shares
that may yet be
Purchased under the
Plans or Programs (2)
July 1, 2019 - July 31, 2019 2,489
 $50.38
 
 $35,143,546
August 1, 2019 - August 31, 2019 9,342
 $60.91
 
 $35,143,546
September 1, 2019 - September 30, 2019 826
 $62.02
 
 $35,143,546
Total 12,657
 $58.91
 
  
(1)The number of shares repurchased for each period represents shares to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the Share Repurchase Program.
(2)As of the end of the period.
ITEM 3.DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4.MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 5.OTHER INFORMATION.
None.


5446

Table of Contents








ITEM 6.EXHIBITS.
(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q.
Incorporated by Reference
Exhibit
Number
Exhibit Description
Filed
herewith
Furnished
herewith
Form
Period
Ending
Exhibit
Filing
Date
10.1X
31.1X
31.2X
32.1X
32.2X
101.INSXBRL Instance DocumentX
101.SCHXBRL Taxonomy Extension Schema DocumentX
101.CALXBRL Taxonomy Extension Calculation Linkbase DocumentX
101.LABXBRL Taxonomy Extension Label Linkbase DocumentX
101.PREXBRL Taxonomy Extension Presentation Linkbase DocumentX
101.DEFXBRL Taxonomy Extension Definition Linkbase DocumentX
        Incorporated by Reference
Exhibit
Number
 Exhibit Description 
Filed
herewith
 
Furnished
herewith
 Form 
Period
Ending
 Exhibit 
Filing
Date
10.1      8-K   10.1 9/16/2019
10.2      8-K   10.1 10/3/2019
10.3      8-K   10.1 10/16/2019
31.1  X          
31.2  X          
32.1    X        
32.2    X        
101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. X          
101.SCH Inline XBRL Taxonomy Extension Schema Document X          
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document X          
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X          
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X          
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document X          
104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) X          




5547

Table of Contents








SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
    Huron Consulting Group Inc.
    (Registrant)
    
Date:November 1, 2017October 29, 2019  
/S/    JOHN D. KELLY
    John D. Kelly
    
Executive Vice President,
Chief Financial Officer and Treasurer




5648